Gene expression elucidates functional impact of polygenic risk for schizophrenia
Open accessPublished version of a preprint
Abstract
Over 100 genetic loci harbor schizophrenia-associated variants, yet how these variants confer liability is uncertain. The CommonMind Consortium sequenced RNA from dorsolateral prefrontal cortex of people with schizophrenia (N = 258) and control subjects (N = 279), creating a resource of gene expression and its genetic regulation. Using this resource, ∼20% of schizophrenia loci have variants that could contribute to altered gene expression and liability. In five loci, only a single gene was involved: FURIN, TSNARE1, CNTN4, CLCN3 or SNAP91. Altering expression of FURIN, TSNARE1 or CNTN4 changed neurodevelopment in zebrafish; knockdown of FURIN in human neural progenitor cells yielded abnormal migration. Of 693 genes showing significant case-versus-control differential expression, their fold changes were ≤ 1.33, and an independent cohort yielded similar results. Gene co-expression implicates a network relevant for schizophrenia. Our findings show that schizophrenia is polygenic and highlight the utility of this resource for mechanistic interpretations of genetic liability for brain diseases.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 84 cited sources checked · 0 supported · 0 flagged
- Findingown data
Only five genes in the MHC locus were ranked highly by Sherlock and passed concordance evaluation: C4A, HCG17, VARS2, HLA-DMB, and BRD2.
“Nevertheless, only five genes in this locus were ranked highly by Sherlock and passed evaluation for concordance of associations (Supplementary data file 2): C4A, HCG17, VARS2, HLA-DMB, and BRD2.”
Quote in the paperSubstantial claim - Findingown data
When CMC eQTLs at FDR ≤ 5% were intersected with HBCC eQTLs at FDR ≤ 20%, 93% showed the same direction of allelic effect.
“Moreover, concordance of the direction of allelic effect was high, with 93% of eQTL showing the same direction of effect when intersecting CMC eQTL (FDR ≤ 5%) with even a liberally defined set of HBCC eQTL (FDR ≤ 20%).”
Quote in the paperSubstantial claim - Findingown data
Schizophrenia cases carried more common variant alleles previously associated with schizophrenia risk than controls, with P = 1.6 × 10−8.
“As expected3, SCZ cases inherited an increased number of common variant alleles previously associated with SCZ risk (P = 1.6 × 10−8, Supplementary Fig. 1D).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014). source
Not checked in the free run.
- Findingown data
Of the 108 previously reported schizophrenia GWAS loci, 73 contain cis-eQTL SNPs for one or more genes at FDR ≤ 5%.
“Of the 108 SCZ GWAS loci previously reported3, 73 harbor cis-eQTL SNPs for one or more genes (FDR ≤ 5%).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014). source
Not checked in the free run.
- Findingown data
Overexpression of TSNARE1 in zebrafish embryos significantly decreased head size by 9.5%, P < 0.001.
“Relative to control embryos, overexpression of TSNARE1 or CNTN4 resulted in a significant decrease in head size, 9.5% (P < 0.001) and 3.5% (P = 0.018), respectively, while SNAP91 or CLCN3 showed no statistically significant effect (Fig. 3A, B).”
Quote in the paperSubstantial claim
- Findingown data
The observed number of 73 loci with cis-eQTL SNPs is consistent with chance expectation.
“To determine if 73 out of 108 loci were larger than that expected by chance, we conducted an experiment that randomly chose such loci in the genome; it showed that 73 loci with cis-eQTL SNPs is consistent with chance expectation (data not shown).”
Quote in the paperSubstantial claim - Findingown data
Overexpression of TSNARE1 increased proliferating PH3-positive cells by 9.5%, P = 0.018.
“Overexpression of CNTN4 and suppression of furin_a led to a 9.8% (P = 0.003) and a 29.8% (P < 0.001) decrease, respectively, in proliferating cells marked by phospho-histone3 (PH3), and overexpression of TSNARE1 led to a 9.5% increase (P = 0.018) in proliferating cells (N = 20 per experiment; Fig. 3C, D).”
Quote in the paperSubstantial claim - Findingown data
Overexpression of CNTN4 in zebrafish embryos significantly decreased head size by 3.5%, P = 0.018.
“Relative to control embryos, overexpression of TSNARE1 or CNTN4 resulted in a significant decrease in head size, 9.5% (P < 0.001) and 3.5% (P = 0.018), respectively, while SNAP91 or CLCN3 showed no statistically significant effect (Fig. 3A, B).”
Quote in the paperSubstantial claim - Findingown data
After removing genes with inconsistent evidence, 33 genes remained highlighted in 18 of the 108 GWAS loci.
“After removing genes where additional evaluation indicated lack of consistency (Supplementary Fig. 7B), there were 33 genes highlighted in 18 of the 108 GWAS loci (Supplementary data file 2).”
Quote in the paperSubstantial claim - Findingown data
Sherlock analysis suggested co-localization of GWAS risk and eQTL association signals for 84 genes in 30 of the 108 schizophrenia GWAS loci at adjusted P < 0.05.
“The results suggested that GWAS risk and eQTL association signals co-localized for 84 genes in 30 of these loci (adjusted P < 0.05; Supplementary Fig. 6A, Supplementary data file 2).”
Quote in the paperSubstantial claim - Findingown data
Body length and somitic structures were similar across embryos, suggesting the head-size observations were unlikely due to gross developmental delay.
“Body length and somitic structures were similar across all embryos, suggesting that our observations were unlikely due to gross developmental delay.”
Quote in the paperSubstantial claim - Findingown data
Modulation of FURIN, TSNARE1, and CNTN4 led to a significant increase in apoptotic cells in the head region, P < 0.001.
“we performed TUNEL staining on injected embryos, and determined that modulation of all three target genes led to a significant increase in apoptotic cells in the head region corresponding to our head size measurements (N = 20 per experiment; P < 0.001; Fig. 3E, F).”
Quote in the paperSubstantial claim - Findingown data
There was a strong correlation between schizophrenia risk alleles and up-regulation of C4A expression, Spearman ρ = 0.66 and P < 10−16.
“we found a strong correlation between the risk alleles for SCZ and up-regulation of expression of C4A (complement component 4A; Spearman’s ρ = 0.66, P < 10−16).”
Quote in the paperSubstantial claim - Findingown data
IGF2 was the most strongly down-regulated gene, with a 1.33-fold change.
“Insulin-like growth factor 2 (IGF2), the most strongly down-regulated gene (1.33-fold, Fig. 5D), can rescue neurogenesis and cognitive deficits in certain mouse models of schizophrenia44.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [44] Ouchi, Y. et al. Reduced adult hippocampal neurogenesis and working memory deficits in the Dgcr8-deficient mouse model of 22q11.2 deletion-associated schizophrenia can be rescued by IGF2. J. Neurosci. 33, 9408–9419 (2013). source
Not checked in the free run.
- Findingown data
The study found no evidence of differential expression between schizophrenia cases and controls among the genes implicated by GWAS risk loci.
“In contrast, we did not find evidence for case-control differential expression among the implicated GWAS risk genes.”
Quote in the paperSubstantial claim - Findingown data
FURIN knockdown in hiPSC neural progenitor cells significantly decreased total radial migration for all three individuals, with decreases of 1.16-fold, 1.23-fold, and 1.22-fold.
“FURIN knockdown in the hiPSC NPCs resulted in significantly decreased total radial migration for all three individuals (C1: 1.16-fold decrease, P < 0.0017; C2: 1.23-fold decrease, P < 3 × 10−6; C3: 1.22-fold decrease, P < 2 × 10−6) (Fig. 4).”
Quote in the paperSubstantial claim - Findingown data
Four co-expression modules contained an excess of differentially expressed genes.
“Four modules stand out in harboring an excess of differentially expressed genes (Fig. 6A, Supplementary data file 6).”
Quote in the paperNot a substantial claim - Findingown data
A model incorporating allele frequency differences and predicted allele effects on expression produced a distribution of expected differential expression across genes that closely matched the observed distribution in the CMC dataset.
“Modeling the differential in allele frequencies and the predicted effect of alleles on gene expression demonstrates that the distribution of expected differential expression, across genes, is quite similar to the observed distribution from the CMC data (Fig. 7A).”
- Also stated in: § DISCUSSION · boosted
“Our model demonstrates that the distribution of expected differential expression, across genes, is quite similar to the observed distribution from the CMC data (Fig. 7).”
Quote in the paperSubstantial claim - Also stated in: § DISCUSSION · boosted
- Findingown data
The M2c module was enriched for gene sets from prior genetic studies, including the ARC protein complex, FMRP targets, neuronal markers, PSD proteins, and NMDA receptors.
“Gene sets identified in prior genetic studies that highlighted certain neurobiological functions are also enriched in the M2c module, including the activity-regulated cytoskeleton-associated (ARC) protein complex, targets of fragile X mental retardation protein (FMRP), neuronal markers, post-synaptic density (PSD) proteins, and NMDA receptors (Fig. 6A).”
Quote in the paperSubstantial claim - Findingown data
TACR3 was the most highly up-regulated protein-coding gene, with a 1.24-fold change.
“The most highly up-regulated protein-coding gene is tachykinin receptor 3 (TACR3, NK3 receptor, 1.24-fold, Fig. 5D).”
Quote in the paperNot a substantial claim - Findingown data
The M2c module was enriched for axon guidance, postsynaptic membrane, transmission across chemical synapses, and voltage-gated potassium channel complexes.
“In particular, the M2c module is enriched for multiple categories, including axon guidance, postsynaptic membrane, transmission across chemical synapses, and voltage-gated potassium channel complexes (Fig. 6C).”
Quote in the paperNot a substantial claim - Findingown data
No obvious unifying biological theme emerged from the differentially expressed genes and isoforms on the basis of pathway enrichment analysis.
“No obvious unifying biological theme emerges from this set of genes and isoforms on the basis of pathway enrichment analysis (Supplementary data file 4).”
Quote in the paperNot a substantial claim - Findingown data
Analyses of cell composition do not support global differences in cellular composition in DLPFC tissue between schizophrenia cases and controls.
“Analyses of cell composition, however, do not support global differences in the cellular composition in DLPFC tissue from SCZ versus control subjects.”
Quote in the paperSubstantial claim - Findingown data
Gene co-expression was organized into modules of distinct cellular and functional categories, consistent with prior brain transcriptome studies.
“Consistent with prior studies of the brain transcriptome15,47–50, we find gene co-expression to be organized into modules of distinct cellular and functional categories (Supplementary data file 7).”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [15] Zhang, B. et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell 153, 707–720 (2013). source
Not checked in the free run.
- cites [47] Voineagu, I. et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474, 380–384 (2011). source
Not checked in the free run.
- cites [48] Torkamani, A., Dean, B., Schork, N.J. & Thomas, E.A. Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia. Genome Res. 20, 403–412 (2010). source
Not checked in the free run.
- cites [49] Oldham, M.C. et al. Functional organization of the transcriptome in human brain. Nat. Neurosci. 11, 1271–1282 (2008). source
Not checked in the free run.
- cites [50] Roussos, P., Katsel, P., Davis, K.L., Siever, L.J. & Haroutunian, V. A system-level transcriptomic analysis of schizophrenia using postmortem brain tissue samples. Arch. Gen. Psychiatry 69, 1205–1213 (2012). source
Not checked in the free run.
- Findingown data
There were 239 differentially expressed isoforms between schizophrenia cases and controls: 94 up-regulated and 145 down-regulated.
“We identified 239 isoforms differentially expressed between SCZ cases and controls: 94 up-regulated and 145 down-regulated.”
Quote in the paperSubstantial claim - Findingreasoning
To achieve 80% power for detecting a significant case-control difference in FURIN expression, 11,784 cases and 11,784 controls would be required.
“For example, 11,784 cases and 11,784 controls would be needed to have 80% power to detect a significant case-control difference in FURIN expression.”
Quote in the paperSubstantial claim - Findingreasoning
The pattern of large observed differential expression is not observed when the sample size is increased to 250.
“Notably, this pattern not seen when the N is raised to 250.”
Quote in the paperSubstantial claim - Findingown data
Only a handful of disease-genotype interaction associations were significant after FDR control.
“Nevertheless, to potentially identify eQTL that differ by disease state, a disease-genotype interaction term was also explicitly tested, but only a handful of such associations were found to be significant after controlling for FDR.”
Quote in the paperNot a substantial claim - Findingown data
Across the 20 samplings, the median number of FDR < 5% differentially expressed genes was 216 (mean = 315, sd = 261, 25th percentile = 92, 75th percentile = 562).
“Across the 20 samplings, the median number of FDR < 5% differentially expressed genes was 216 (mean = 315, sd = 261, 25th percentile = 92, 75th percentile = 562).”
Quote in the paperSubstantial claim - Findingown data
1,584 genes had no cis-eQTL at FDR ≤ 5% but had at least one significant isoQTL.
“There were, however, 1,584 genes having no cis-eQTL (FDR ≤ 5%) that nevertheless had at least one significant isoQTL.”
Quote in the paperNot a substantial claim - Findingown data
If 5% of the 693 genes were false, the threshold of 34.7 genes was exceeded in 9 of 1000 experiments, slightly less than 1%.
“If 5% of the 693 were false, the threshold established of 34.7 genes is exceed in 9 out of 1000 experiments, slightly less than 1%.”
Quote in the paperNot a substantial claim - Findingown data
In permutation experiments, the average number of significant genes at FDR ≤ 0.05 was 4.3, well below the 693 found in the sample.
“Of these experiments, the average number of significant genes at FDR ≤ 0.05 was 4.3, well below 693 found in our sample.”
Quote in the paperSubstantial claim - Findingown data
When the 20-60 age group (172 samples, mean age 45.5) and the complementary 60-or-older group (362 cases and controls, mean age 77.8) were processed independently, their differential expression t-statistics correlated at r = 0.18, P < 2 × 10−16.
“we explicitly compared the differential expression between the aged 20–60 individuals (172 samples, mean age 45.5) to an analysis of the complementary age 60 or older cohort (362 cases and controls, mean age 77.8) by independently processing the data for each of those sub-cohorts. The differential t-statistics between these independent sub-cohorts were correlated (r = 0.18, P < 2 × 10−16)”
Quote in the paperSubstantial claim - Findingown data
For discovery differentially expressed genes, the median Pearson correlation of t-statistics with the replication cohort was 0.79 (mean = 0.75, sd = 0.16, 25th percentile = 0.67, 75th percentile = 0.88).
“For these FDR < 5% “discovery” differentially expressed genes, the median Pearson correlation of t-statistics with the “replication” cohort was 0.79 (mean = 0.75, sd = 0.16, 25th percentile = 0.67, 75th percentile = 0.88).”
Quote in the paperSubstantial claim - Findingown data
The stricter filter increased replication in HBCC to 36% at FDR ≤ 5% in both cohorts.
“This stricter filter increases the replication rate in HBCC to 36% at FDR ≤ 5% in both cohorts.”
Quote in the paperSubstantial claim - Findingown data
The stricter trans-eQTL filter yielded 13,114 trans-eQTL (about 7% of all trans-eQTL SNP-gene pairs at P < 10−5) across 661 genes.
“yielded a final reduced subset of 13,114 trans-eQTL (~7% of all trans-eQTL SNP-gene pairs at P < 10−5) across 661 genes.”
Quote in the paperSubstantial claim - Findingown data
In the M2c module, genes with de novo mutations have higher intramodular connectivity than genes not genetically associated with schizophrenia (T test t=5.1, P=2.9×10−6).
“We found a significant effect for PGC SCZ2 GWAS loci (T test: t = 2.6; P = 0.013) and de novo mutations (T test: t = 5.1; P = 2.9 × 10−6) but no CNVs (T test: t = 0.88; P = 0.4), where genes associated with SCZ have higher intramodular connectivity.”
Quote in the paperSubstantial claim - Findingown data
In the M2c module, genes with CNVs do not have higher intramodular connectivity than genes not genetically associated with schizophrenia (T test t=0.88, P=0.4).
“We found a significant effect for PGC SCZ2 GWAS loci (T test: t = 2.6; P = 0.013) and de novo mutations (T test: t = 5.1; P = 2.9 × 10−6) but no CNVs (T test: t = 0.88; P = 0.4), where genes associated with SCZ have higher intramodular connectivity.”
Quote in the paperNot a substantial claim - Findingown data
For schizophrenia cases, the cross-validation of module reproducibility yielded a median connectivity correlation between discovery and replication cohorts of 0.77 (mean 0.76, SD 0.06, IQR 0.73-0.78).
“The median Pearson correlation of connectivity values among the “discovery” and “replication” cohorts was 0.77 (mean = 0.76, sd = 0.06, 25th percentile = 0.73, 75th percentile = 0.78) and 0.80 (mean = 0.78, sd = 0.07, 25th percentile = 0.70, 75th percentile = 0.84) for cases with SCZ and controls, respectively.”
Quote in the paperSubstantial claim - Findingown data
The overlap between drug signature datasets and M2c was significant after multiple-testing correction.
“While the overlap was significant after correcting for multiple testing”
Quote in the paperNot a substantial claim - Findingown data
Three out of 18 drug signature datasets overlapped with the M2c module.
“identified an overlap for 3 out of 18 drug signature datasets with M2c.”
Quote in the paperNot a substantial claim - Findingown data
There was a small positive correlation (Pearson r = 0.095, p < 10−16) between the independent t-statistics for PRS effects on expression in controls and the case-control expression differences in the full cohort.
“there was a significantly positive, but small, correlation (Pearson r = 0.095, p < 10−16) between the independent t-statistics for the effect of PRS on expression in controls and those we found for case-control expression differences in the full cohort”
Quote in the paperSubstantial claim - Findingown data
In the M2c module, genes with PGC SCZ2 GWAS loci have higher intramodular connectivity than genes not genetically associated with schizophrenia (T test t=2.6, P=0.013).
“We found a significant effect for PGC SCZ2 GWAS loci (T test: t = 2.6; P = 0.013) and de novo mutations (T test: t = 5.1; P = 2.9 × 10−6) but no CNVs (T test: t = 0.88; P = 0.4), where genes associated with SCZ have higher intramodular connectivity.”
Quote in the paperSubstantial claim - Findingown data
At nominal P < 0.05, module eigengenes M0c, M16c, M6c, M26c, M28c, M32c, M7s and M12s were associated with Institution, RIN or Library batch.
“At nominal P value < 0.05 we found an association of M0c, M16c, M6c, M26c, M28c, M32c, M7s and M12s MEs with Institution, RIN or Library batch.”
Quote in the paperNot a substantial claim - Findingown data
The WGCNA module label permutation approach showed a strong dependency on module size in this cohort (fitting index r2 > 0.95 based on a quadratic model).
“The permutation approach implemented in the WGCNA package (module label permutation in the test network) shows a strong dependency on module size in our cohort (fitting index r2 > 0.95 based on a quadratic model).”
Quote in the paperSubstantial claim - Findingown data
For rodent drug signatures, the direction of effect was significantly less concordant than expected by chance: 1 of 8 genes (P = 0.004), 10 of 55, and 122 of 388 for sets appearing in ≥4, ≥3, and ≥2 studies, respectively.
“for each of these gene signatures, the direction of effect was significantly less concordant than expected by chance (1 of 8 [P = 0.004], 10 of 55, and 122 of 388 for those in ≥4 studies, ≥3 studies, and ≥2 studies, respectively).”
Quote in the paperSubstantial claim - Findingown data
There was no significant effect of Drug versus NonDrug signatures within M2c on loss or gain of connectivity in controls compared to schizophrenia cases (Kolmogorov-Smirnov test P=0.054).
“We did not observe any significant effect (Kolmogorov–Smirnov test: P = 0.054).”
Quote in the paperSubstantial claim - Findingown data
There was no significant association between clinical/technical covariates and module eigengene values from control and schizophrenia networks at FDR < 20% (range of Pearson's r: −0.16 to 0.21).
“There was no significant association at FDR < 20% (range of Pearson’s r: −0.16 to 0.21).”
Quote in the paperSubstantial claim - Findingown data
For control subjects, the same cross-validation yielded a median connectivity correlation between discovery and replication cohorts of 0.80 (mean 0.78, SD 0.07, IQR 0.70-0.84).
“The median Pearson correlation of connectivity values among the “discovery” and “replication” cohorts was 0.77 (mean = 0.76, sd = 0.06, 25th percentile = 0.73, 75th percentile = 0.78) and 0.80 (mean = 0.78, sd = 0.07, 25th percentile = 0.70, 75th percentile = 0.84) for cases with SCZ and controls, respectively.”
Quote in the paperSubstantial claim - Findingown data
The blue (M2c) module showed no association with any clinical/technical covariate at P < 0.1.
“We found no association of the blue (M2c) module with any covariate at P < 0.1”
Quote in the paperSubstantial claim - Findingown data
The distribution of differential expression significance (−log10 P) did not differ significantly between M2c genes with and without a drug signature (Kolmogorov-Smirnov test P=0.54).
“We did not find a significant difference in the distribution of −log10 P values for genes that have or do not have drug signature (drug versus non-drug: Kolmogorov–Smirnov test: P = 0.54).”
Quote in the paperSubstantial claim - Findingown data
In the macaque antipsychotic treatment analysis, no genes were differentially expressed after multiple test correction.
“While no genes were considered differentially expressed after multiple test correction”
Quote in the paperNot a substantial claim - Findingown data
No convincing patterns were found for the primary or exploratory gene set enrichment hypotheses after correction for multiple set testing, adjustment for confounders such as gene size, and combining results over multiple enrichment tests.
“we found no convincing patterns to the primary or exploratory hypotheses, after correction for multiple set testing, confounders such as gene size, and after combining results over multiple enrichment tests.”
Quote in the paperSubstantial claim - Findingown data
Knockdown of FURIN in human neural progenitor cells yields abnormal migration.
“knockdown of FURIN in human neural progenitor cells yields abnormal migration”
- Also stated in: § Functional dissection of genes highlighted · plain
“FURIN knockdown in the hiPSC NPCs resulted in significantly decreased total radial migration for all three individuals”
Quote in the paperSubstantial claim - Also stated in: § Functional dissection of genes highlighted · plain
- Findingown data
About 20% of schizophrenia risk loci contain variants that could contribute to altered gene expression and liability.
“Using this resource, ~20% of schizophrenia loci have variants that could contribute to altered gene expression and liability.”
- Also stated in: § eQTL signatures at SCZ risk loci point to specific genes · hedged
“Combining the gene and isoform data, 20 of 108 GWAS loci (19%) had evidence suggesting that mis-regulated gene expression could, in part, explain the genetic association with schizophrenia”
Quote in the paperSubstantial claim - Also stated in: § eQTL signatures at SCZ risk loci point to specific genes · hedged
- Findingown data
The CommonMind Consortium sequenced RNA from dorsolateral prefrontal cortex of 258 schizophrenia cases and 279 controls, producing a resource of gene expression and its genetic regulation.
“The CommonMind Consortium sequenced RNA from dorsolateral prefrontal cortex of schizophrenia cases (N = 258) and control subjects (N = 279), creating a resource of gene expression and its genetic regulation.”
Quote in the paperSubstantial claim - Findingown data
In five schizophrenia risk loci, only a single gene was implicated: FURIN, TSNARE1, CNTN4, CLCN3, or SNAP91.
“In five loci, only a single gene was involved: FURIN, TSNARE1, CNTN4, CLCN3, or SNAP91.”
- Also stated in: § eQTL signatures at SCZ risk loci point to specific genes · plain
“For functional follow-up, we focused on the five single-gene loci encoding known proteins implicated at the gene level.”
Quote in the paperSubstantial claim - Also stated in: § eQTL signatures at SCZ risk loci point to specific genes · plain
- Findingown data
An independent cohort yields similar differential expression results.
“and an independent cohort yields similar results”
- Also stated in: § Gene expression is subtly disrupted in schizophrenia · plain
“there was high correlation of test statistics for differential expression in CMC compared to HBCC for the differentially expressed genes also present in the HBCC data (480 of 693), Pearson correlation r = 0.58 (P < 10−16)”
Quote in the paperSubstantial claim - Also stated in: § Gene expression is subtly disrupted in schizophrenia · plain
- Findingown data
Of 693 genes showing significant case-control differential expression, their fold changes are at most 1.33.
“Of 693 genes showing significant case/control differential expression, their fold changes are ≤ 1.33”
- Also stated in: § Gene expression is subtly disrupted in schizophrenia · plain
“All had modest fold changes (Fig. 5B), with a mean of 1.09 and range 1.03–1.33”
Quote in the paperSubstantial claim - Also stated in: § Gene expression is subtly disrupted in schizophrenia · plain
- Findingown data
Of 108 schizophrenia GWAS loci, 73 harbor cis-eQTL SNPs for one or more genes at FDR ≤ 5%.
“Of the 108 SCZ GWAS loci previously reported3, 73 harbor cis-eQTL SNPs for one or more genes (FDR ≤ 5%).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014). source
Not checked in the free run.
- Findingown data
The eQTL model identified 2,154,331 significant cis-eQTLs at FDR ≤ 5% for 13,137 (80%) of 16,423 genes.
“The model identified 2,154,331 significant cis-eQTLs, (i.e., within 1 Mb of a gene) at a false discovery rate (FDR) ≤ 5%, for 13,137 (80%) of 16,423 genes.”
Quote in the paperSubstantial claim - Findingown data
Combining gene and isoform data, 20 of 108 GWAS loci (19%) had evidence that mis-regulated gene expression could partly explain the genetic association with schizophrenia.
“Combining the gene and isoform data, 20 of 108 GWAS loci (19%) had evidence suggesting that mis-regulated gene expression could, in part, explain the genetic association with schizophrenia”
Quote in the paperSubstantial claim - Findingown data
32.8% of eQTL SNPs predict expression of more than one gene.
“32.8% of eQTL SNPs (“eSNPs”) predict expression of more than one gene.”
Quote in the paperNot a substantial claim - Findingown data
Sherlock identified co-localization of GWAS risk and eQTL association signals for 84 genes in 30 of the 108 loci (adjusted P < 0.05).
“The results suggested that GWAS risk and eQTL association signals co-localized for 84 genes in 30 of these loci (adjusted P < 0.05; Supplementary Fig. 6A, Supplementary data file 2).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [25] He, X. et al. Sherlock: detecting gene-disease associations by matching patterns of expression QTL and GWAS. Am. J. Hum. Genet. 92, 667–680 (2013). source
Not checked in the free run.
- Findingnone given
The CommonMind Consortium cohort is an order of magnitude larger than prior RNA sequencing studies.
“We sequenced a cohort of SCZ and control subjects that is an order of magnitude larger than prior RNA sequencing studies.”
Quote in the paperNot a substantial claim - Findingown data
Schizophrenia cases inherited an increased number of common variant alleles previously associated with schizophrenia risk (P = 1.6 × 10−8).
“As expected3, SCZ cases inherited an increased number of common variant alleles previously associated with SCZ risk (P = 1.6 × 10−8, Supplementary Fig. 1D).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014). source
Not checked in the free run.
- Findingown data
A random experiment showed that 73 loci with cis-eQTL SNPs is consistent with chance expectation.
“To determine if 73 out of 108 loci were larger than that expected by chance, we conducted an experiment that randomly chose such loci in the genome; it showed that 73 loci with cis-eQTL SNPs is consistent with chance expectation (data not shown).”
Quote in the paperNot a substantial claim - Findingown data
After removing genes where additional evaluation indicated lack of consistency, 33 genes in 18 of the 108 GWAS loci were highlighted.
“After removing genes where additional evaluation indicated lack of consistency (Supplementary Fig. 7B), there were 33 genes highlighted in 18 of the 108 GWAS loci (Supplementary data file 2).”
Quote in the paperSubstantial claim - Findingown data
The CommonMind Consortium sample finds a substantial number of genes with previously undetected eQTLs.
“In addition to containing the vast majority of eQTL found in the literature, the CMC sample finds a substantial number of genes with previously undetected eQTL (Table 1).”
Quote in the paperSubstantial claim - Findingown data
93% of eQTLs showed the same direction of allelic effect when intersecting CommonMind Consortium eQTLs with HBCC eQTLs.
“Moreover, concordance of the direction of allelic effect was high, with 93% of eQTL showing the same direction of effect when intersecting CMC eQTL (FDR ≤ 5%) with even a liberally defined set of HBCC eQTL (FDR ≤ 20%).”
Quote in the paperSubstantial claim - Findingreasoning
The pattern of large observed differential expression in small studies is not seen when the sample size is raised to 250.
“Notably, this pattern not seen when the N is raised to 250.”
Quote in the paperSubstantial claim - Findingown data
No obvious unifying biological theme emerges from pathway enrichment analysis of the differentially expressed genes and isoforms.
“No obvious unifying biological theme emerges from this set of genes and isoforms on the basis of pathway enrichment analysis (Supplementary data file 4).”
Quote in the paperNot a substantial claim - Findingown data
Modeling allele frequency differences and predicted allele effects on expression shows that the expected distribution of differential expression across genes closely matches the observed distribution in the CMC data.
“Modeling the differential in allele frequencies and the predicted effect of alleles on gene expression demonstrates that the distribution of expected differential expression, across genes, is quite similar to the observed distribution from the CMC data (Fig. 7A).”
- Also stated in: § DISCUSSION · boosted
“Our model demonstrates that the distribution of expected differential expression, across genes, is quite similar to the observed distribution from the CMC data (Fig. 7).”
Quote in the paperSubstantial claim- Rests on an assumption: Case-control differences in allele frequencies for schizophrenia risk variants are small.
- Also stated in: § DISCUSSION · boosted
- Findingreasoning
The analyses show that smaller studies would have notably larger variability in differential expression estimates.
“Our analyses show that these studies would have notably larger variability”
Quote in the paperSubstantial claim - Findingreasoning
Using PGC schizophrenia allele frequencies, 11,784 cases and 11,784 controls would be needed for 80% power to detect a significant case-control difference in FURIN expression.
“For example, 11,784 cases and 11,784 controls would be needed to have 80% power to detect a significant case-control difference in FURIN expression.”
Quote in the paperSubstantial claim - Findingown data
Hierarchical clustering of differentially expressed genes showed case-control distinctions independent of institution, sex, age at death, ethnicity, and RIN.
“As expected, hierarchical clustering of the differentially expressed genes showed case-control distinctions but were independent of institution, sex, age at death, ethnicity, and RIN (Fig. 5A).”
Quote in the paperSubstantial claim - Findingreasoning
Studies with only 25 cases and 25 controls can yield estimates of differential expression exceeding twofold even when no gene is differentially expressed.
“even when no gene is differentially expressed, studies with only 25 cases and 25 controls can lead to estimates of differential expression exceeding twofold.”
Quote in the paperSubstantial claim - Findingown data
Only five genes in the MHC locus were ranked highly by Sherlock and passed evaluation for concordance: C4A, HCG17, VARS2, HLA-DMB, and BRD2.
“Nevertheless, only five genes in this locus were ranked highly by Sherlock and passed evaluation for concordance of associations (Supplementary data file 2): C4A, HCG17, VARS2, HLA-DMB, and BRD2.”
Quote in the paperSubstantial claim - Findingown data
Modulation of FURIN, TSNARE1, and CNTN4 led to a significant increase in apoptotic cells in the head region corresponding to head size measurements.
“we performed TUNEL staining on injected embryos, and determined that modulation of all three target genes led to a significant increase in apoptotic cells in the head region corresponding to our head size measurements (N = 20 per experiment; P < 0.001; Fig. 3E, F).”
Quote in the paperSubstantial claim - Findingown data
The study found no evidence of case-control differential expression among genes implicated by GWAS risk for schizophrenia.
“In contrast, we did not find evidence for case-control differential expression among the implicated GWAS risk genes.”
Quote in the paperSubstantial claim - Findingown data
There is a strong correlation between schizophrenia risk alleles and up-regulation of C4A expression (Spearman's ρ = 0.66, P < 10−16).
“we found a strong correlation between the risk alleles for SCZ and up-regulation of expression of C4A (complement component 4A; Spearman’s ρ = 0.66, P < 10−16).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [32] Sekar, A. et al. Schizophrenia risk from complex variation of complement component 4. Nature 530, 177–183 (2016). source
Not checked in the free run.
- Findingown data
Gene co-expression is organized into modules of distinct cellular and functional categories.
“Consistent with prior studies of the brain transcriptome15,47–50, we find gene co-expression to be organized into modules of distinct cellular and functional categories (Supplementary data file 7).”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [15] Zhang, B. et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell 153, 707–720 (2013). source
Not checked in the free run.
- cites [47] Voineagu, I. et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474, 380–384 (2011). source
Not checked in the free run.
- cites [48] Torkamani, A., Dean, B., Schork, N.J. & Thomas, E.A. Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia. Genome Res. 20, 403–412 (2010). source
Not checked in the free run.
- cites [49] Oldham, M.C. et al. Functional organization of the transcriptome in human brain. Nat. Neurosci. 11, 1271–1282 (2008). source
Not checked in the free run.
- cites [50] Roussos, P., Katsel, P., Davis, K.L., Siever, L.J. & Haroutunian, V. A system-level transcriptomic analysis of schizophrenia using postmortem brain tissue samples. Arch. Gen. Psychiatry 69, 1205–1213 (2012). source
Not checked in the free run.
- Findingown data
Gene sets from prior genetic studies are enriched in the M2c module, including the ARC protein complex, FMRP targets, neuronal markers, PSD proteins, and NMDA receptors.
“Gene sets identified in prior genetic studies that highlighted certain neurobiological functions are also enriched in the M2c module, including the activity-regulated cytoskeleton-associated (ARC) protein complex, targets of fragile X mental retardation protein (FMRP), neuronal markers, post-synaptic density (PSD) proteins, and NMDA receptors (Fig. 6A).”
Quote in the paperSubstantial claim - Findingown data
TACR3 is the most highly up-regulated protein-coding gene (1.24-fold).
“The most highly up-regulated protein-coding gene is tachykinin receptor 3 (TACR3, NK3 receptor, 1.24-fold, Fig. 5D).”
Quote in the paperNot a substantial claim - Findingown data
IGF2 is the most strongly down-regulated gene (1.33-fold).
“Insulin-like growth factor 2 (IGF2), the most strongly down-regulated gene (1.33-fold, Fig. 5D)”
Quote in the paperNot a substantial claim - Findingown data
FURIN knockdown in hiPSC neural progenitor cells significantly decreased total radial migration for all three individuals (C1: 1.16-fold, C2: 1.23-fold, C3: 1.22-fold).
“FURIN knockdown in the hiPSC NPCs resulted in significantly decreased total radial migration for all three individuals (C1: 1.16-fold decrease, P < 0.0017; C2: 1.23-fold decrease, P < 3 × 10−6; C3: 1.22-fold decrease, P < 2 × 10−6) (Fig. 4).”
Quote in the paperSubstantial claim - Findingown data
The M2c module is enriched for axon guidance, postsynaptic membrane, transmission across chemical synapses, and voltage-gated potassium channel complexes.
“In particular, the M2c module is enriched for multiple categories, including axon guidance, postsynaptic membrane, transmission across chemical synapses, and voltage-gated potassium channel complexes (Fig. 6C).”
Quote in the paperNot a substantial claim - Findingown data
Four modules harbor an excess of differentially expressed genes.
“Four modules stand out in harboring an excess of differentially expressed genes (Fig. 6A, Supplementary data file 6).”
Quote in the paperSubstantial claim - Findingown data
A set of 1,584 genes lacked any cis-eQTL at FDR ≤ 5% yet had at least one significant isoQTL.
“There were, however, 1,584 genes having no cis-eQTL (FDR ≤ 5%) that nevertheless had at least one significant isoQTL.”
Quote in the paperNot a substantial claim - Findingown data
Applying the stricter trans-eQTL filter raised the HBCC replication rate to 36% at FDR ≤ 5% in both cohorts.
“This stricter filter increases the replication rate in HBCC to 36% at FDR ≤ 5% in both cohorts.”
Quote in the paperSubstantial claim - Findingown data
The P value distribution for PRS association with expression showed inflation consistent with a non-uniform distribution (π1 = 0.22).
“there was inflation of the P value distribution101 consistent with a non-uniform distribution (π1 = 0.22).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [101] Storey, J.D. & Tibshirani, R. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. USA 100, 9440–9445 (2003). source
Not checked in the free run.
- Rests on an assumption: The CMC cases carry an aggregate common polygenic schizophrenia risk burden.
- Findingown data
In independent processing of the age 20-60 sub-cohort (172 samples, mean age 45.5) and the age 60+ sub-cohort (362 cases and controls, mean age 77.8), the differential expression t-statistics correlated at r = 0.18 (P < 2 × 10−16).
“The differential t-statistics between these independent sub-cohorts were correlated (r = 0.18, P < 2 × 10−16)”
Quote in the paperSubstantial claim - Findingown data
After removing trans-eQTL in which the eSNP lay within 10 Mb of the associated gene, the final subset had 13,114 trans-eQTL (about 7% of all trans-eQTL SNP-gene pairs at P < 10^-5) across 661 genes.
“Additionally excluding trans-eQTL where the eSNP was within 10 Mb of the associated gene (since such scenarios are perhaps instances of cis-eQTL for regions with larger LD blocks), yielded a final reduced subset of 13,114 trans-eQTL (~7% of all trans-eQTL SNP-gene pairs at P < 10−5) across 661 genes.”
Quote in the paperSubstantial claim - Findingown data
For each rodent signature, directional concordance was significantly below chance (1 of 8 [P = 0.004], 10 of 55, and 122 of 388 for ≥4, ≥3, and ≥2 studies).
“However, for each of these gene signatures, the direction of effect was significantly less concordant than expected by chance (1 of 8 [P = 0.004], 10 of 55, and 122 of 388 for those in ≥4 studies, ≥3 studies, and ≥2 studies, respectively).”
Quote in the paperNot a substantial claim- The authors state this as an assumption: The directional-concordance hypergeometric test assumes that drug-responsive up- and down-regulated genes were drawn at random from genes up- or down-regulated in the CMC SCZ differential expression tests.
- Findingown data
In 20 random splits, the discovery cohort had a median of 216 genes with FDR < 5% differential expression (mean = 315, sd = 261, 25th percentile = 92, 75th percentile = 562).
“Across the 20 samplings, the median number of FDR < 5% differentially expressed genes was 216 (mean = 315, sd = 261, 25th percentile = 92, 75th percentile = 562).”
Quote in the paperSubstantial claim - Findingown data
The clozapine signature showed significant directional concordance (22 of 31 genes concordant, one-sided P = 0.013).
“while the clozapine signature showed significant concordance, despite the lack of enrichment in the previous test (22 of 31 genes concordant, one-sided P = 0.013).”
Quote in the paperSubstantial claim- The authors state this as an assumption: The directional-concordance hypergeometric test assumes that drug-responsive up- and down-regulated genes were drawn at random from genes up- or down-regulated in the CMC SCZ differential expression tests.
- Findingown data
In the monkey drug analysis, multiple-testing correction left no gene as differentially expressed.
“While no genes were considered differentially expressed after multiple test correction”
Quote in the paperNot a substantial claim - Findingown data
The correlation between control PRS-expression t-statistics and full-cohort case-control expression t-statistics was positive but small (Pearson r = 0.095, p < 10−16).
“there was a significantly positive, but small, correlation (Pearson r = 0.095, p < 10−16) between the independent t-statistics for the effect of PRS on expression in controls and those we found for case-control expression differences in the full cohort”
Quote in the paperSubstantial claim- Rests on an assumption: The CMC cases carry an aggregate common polygenic schizophrenia risk burden.
- Findingown data
For GWAS loci, intersection with DLPFC-expressed genes left 87 loci covering at least one gene and 489 genes in total.
“After intersecting with DLPFC-expressed genes from this paper, there were 87 loci spanning one or more genes, encompassing a total of 489 genes.”
Quote in the paperSubstantial claim - Findingown data
In the controls-only PRS expression analysis, no gene reached significance after FDR correction at 5%.
“While no single gene was found to be significantly associated with PRS after correction for multiple testing using an FDR approach (cutoff of 5%)”
Quote in the paperNot a substantial claim- Rests on an assumption: The CMC cases carry an aggregate common polygenic schizophrenia risk burden.
- Findingown data
The haloperidol signature was significantly less concordant in direction than expected by chance (35 of 237 genes concordant, one-sided P < 1 × 10−4).
“We found the haloperidol signature significantly less concordant than expected by chance (35 out of 237 genes concordant, one-sided P < 1 × 10−4)”
Quote in the paperSubstantial claim- The authors state this as an assumption: The directional-concordance hypergeometric test assumes that drug-responsive up- and down-regulated genes were drawn at random from genes up- or down-regulated in the CMC SCZ differential expression tests.
- Findingown data
Two rodent signatures showed significantly lower directional concordance than chance after multiple-testing correction (Pbonferroni = 0.01 and 0.01).
“though two signatures were significantly less concordant than expected by chance after multiple test correction (Pbonferroni = 0.01 and 0.01, Supplementary Table 2B).”
Quote in the paperNot a substantial claim- The authors state this as an assumption: The directional-concordance hypergeometric test assumes that drug-responsive up- and down-regulated genes were drawn at random from genes up- or down-regulated in the CMC SCZ differential expression tests.
- Findingown data
For CNV regions, conditioning on DLPFC expression left 12 regions spanning 127 genes.
“After conditioning on DLPFC expression, the 12 regions spanned 127 genes.”
Quote in the paperNot a substantial claim - Findingown data
After Bonferroni correction, no rodent gene signature reached strict significance (Pbonferroni > 0.05).
“none of the gene signatures were strictly significant after Bonferroni correction (Pbonferroni > 0.05)”
Quote in the paperNot a substantial claim - Findingown data
For genes with FDR < 5% in discovery, the median correlation of t-statistics between discovery and replication cohorts was 0.79 (mean = 0.75, sd = 0.16, 25th percentile = 0.67, 75th percentile = 0.88).
“For these FDR < 5% “discovery” differentially expressed genes, the median Pearson correlation of t-statistics with the “replication” cohort was 0.79 (mean = 0.75, sd = 0.16, 25th percentile = 0.67, 75th percentile = 0.88).”
Quote in the paperSubstantial claim - Findingown data
The number of samples with mRIN P values below 0.05 and 0.01 was smaller than expected by chance.
“There were 17 and 3 samples with P value < 0.05 and < 0.01, respectively. One would expect a total of 29 and 5 samples to have P values of this magnitude by chance alone.”
Quote in the paperSubstantial claim - Findingown data
After multiple-set correction, adjustment for confounders like gene size, and combining enrichment tests, neither primary nor exploratory gene sets showed convincing patterns.
“we found no convincing patterns to the primary or exploratory hypotheses, after correction for multiple set testing, confounders such as gene size, and after combining results over multiple enrichment tests.”
Quote in the paperSubstantial claim - Findingown data
In the CMC cohort, the differential expression t-statistics for the 172 youngest cases and controls (mean age 45.5, range 20-60) correlated with those from the full cohort at Pearson r = 0.62.
“for the 172 cases and controls whose age of death was youngest (mean age 45.5, range 20–60), the t-statistics for differential expression were highly correlated with those from the full cohort (Pearson r = 0.62)”
Quote in the paperSubstantial claim - Findingown data
If 5% of the 693 differentially expressed genes were false positives, the threshold of 34.7 genes would be exceeded in 9 out of 1,000 permutation experiments, slightly less than 1%.
“If 5% of the 693 were false, the threshold established of 34.7 genes is exceed in 9 out of 1000 experiments, slightly less than 1%.”
Quote in the paperSubstantial claim - Findingown data
Testing a disease-by-genotype interaction yielded only a few significant associations after FDR correction.
“Nevertheless, to potentially identify eQTL that differ by disease state, a disease-genotype interaction term was also explicitly tested, but only a handful of such associations were found to be significant after controlling for FDR.”
Quote in the paperNot a substantial claim - Findingown data
The correlation for the youngest subset was not significantly lower than that for 100 random subsets of the same size (mean r = 0.69, SD = 0.13; P = 0.28).
“yet somewhat lower (though not significantly, P = 0.28) than for 100 random subsets of the same size (mean r = 0.69, standard deviation = 0.13)”
Quote in the paperSubstantial claim - Findingown data
At nominal P < 0.05, the M0c, M16c, M6c, M26c, M28c, M32c, M7s, and M12s module eigengenes were associated with Institution, RIN, or Library batch.
“At nominal P value < 0.05 we found an association of M0c, M16c, M6c, M26c, M28c, M32c, M7s and M12s MEs with Institution, RIN or Library batch.”
Quote in the paperNot a substantial claim - Findingown data
In this cohort, the WGCNA module-label permutation method depended strongly on module size (quadratic-model fitting index r2 > 0.95).
“The permutation approach implemented in the WGCNA package (module label permutation in the test network) shows a strong dependency on module size in our cohort (fitting index r2 > 0.95 based on a quadratic model).”
Quote in the paperSubstantial claim - Findingown data
There was no significant effect of Drug versus NonDrug signatures within the M2c module on loss or gain of connectivity in controls compared with schizophrenia cases (Kolmogorov-Smirnov P=0.054).
“We also explored whether “Drug” versus “NonDrug” signatures within the M2c module show a different effect for loss or gain of connectivity in controls compared to SCZ. We did not observe any significant effect (Kolmogorov–Smirnov test: P = 0.054).”
Quote in the paperSubstantial claim - Findingown data
Permuted sets also showed large module-size differences in network statistics.
“In the permuted sets, we again observed large differences of the network statistics with module size.”
Quote in the paperSubstantial claim - Findingown data
No significant association was found between clinical or technical covariates and module eigengene values at FDR < 20% (range of Pearson r: −0.16 to 0.21).
“There was no significant association at FDR < 20% (range of Pearson’s r: −0.16 to 0.21).”
Quote in the paperSubstantial claim - Findingown data
There was no significant difference in the distribution of −log10 P values for differentially expressed genes with versus without a drug signature (Kolmogorov-Smirnov P=0.54).
“We did not find a significant difference in the distribution of −log10 P values for genes that have or do not have drug signature (drug versus non-drug: Kolmogorov–Smirnov test: P = 0.54).”
Quote in the paperSubstantial claim - Findingown data
In the M2c module, genes with de novo mutations had higher intramodular connectivity than genes not associated with schizophrenia (t=5.1, P=2.9×10−6).
“We found a significant effect for PGC SCZ2 GWAS loci (T test: t = 2.6; P = 0.013) and de novo mutations (T test: t = 5.1; P = 2.9 × 10−6) but no CNVs (T test: t = 0.88; P = 0.4), where genes associated with SCZ have higher intramodular connectivity.”
Quote in the paperSubstantial claim - Findingown data
In cross-validation, the median Pearson correlation of connectivity between discovery and replication cohorts was 0.77 for schizophrenia cases and 0.80 for controls.
“The median Pearson correlation of connectivity values among the “discovery” and “replication” cohorts was 0.77 (mean = 0.76, sd = 0.06, 25th percentile = 0.73, 75th percentile = 0.78) and 0.80 (mean = 0.78, sd = 0.07, 25th percentile = 0.70, 75th percentile = 0.84) for cases with SCZ and controls, respectively.”
Quote in the paperSubstantial claim - Findingown data
In the M2c module, genes associated with PGC SCZ2 GWAS loci had higher intramodular connectivity than genes not associated with schizophrenia (t=2.6, P=0.013).
“We found a significant effect for PGC SCZ2 GWAS loci (T test: t = 2.6; P = 0.013) and de novo mutations (T test: t = 5.1; P = 2.9 × 10−6) but no CNVs (T test: t = 0.88; P = 0.4), where genes associated with SCZ have higher intramodular connectivity.”
Quote in the paperSubstantial claim - Findingown data
The blue (M2c) module showed no association with any covariate at P < 0.1.
“We found no association of the blue (M2c) module with any covariate at P < 0.1, indicating that our differential co-regulated results are not biased from clinical or technical covariates.”
Quote in the paperSubstantial claim - Findingown data
In the M2c module, there was no significant difference in intramodular connectivity between genes with CNVs and genes not associated with schizophrenia (t=0.88, P=0.4).
“We found a significant effect for PGC SCZ2 GWAS loci (T test: t = 2.6; P = 0.013) and de novo mutations (T test: t = 5.1; P = 2.9 × 10−6) but no CNVs (T test: t = 0.88; P = 0.4), where genes associated with SCZ have higher intramodular connectivity.”
Quote in the paperNot a substantial claim - Premisecitation
Schizophrenia risk is highly polygenic, arising from many genetic variants each with small effects.
“SCZ is truly complex and appears to result from a myriad of genetic variants exerting small effects on disease risk4,5, conforming closely to a classical polygenic model.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [4] Purcell, S.M. et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748–752 (2009). source
Not checked in the free run.
- cites [5] Purcell, S.M. et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506, 185–190 (2014). source
Not checked in the free run.
- Premisecitation
Post-mortem expression studies in schizophrenia suggest subtle abnormalities across several brain regions and cell types.
“Post-mortem gene expression studies of SCZ cases suggest subtle abnormalities in multiple brain regions including the prefrontal and temporal cortices, hippocampus, and several specific cell types8.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] Horváth, S., Janka, Z. & Mirnics, K. Analyzing schizophrenia by DNA microarrays. Biol. Psychiatry 69, 157–162 (2011). source
Not checked in the free run.
- Premisecitation
Existing expression studies are probably underpowered to detect the subtle effects expected from a complex disease in tightly regulated brain tissue.
“These studies are probably underpowered to detect subtle effects that might be expected to arise as a result of this complex disease and within tightly regulated brain tissue9, among other limitations of existing microarray-based gene expression studies10.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [9] Mistry, M., Gillis, J. & Pavlidis, P. Meta-analysis of gene coexpression networks in the post-mortem prefrontal cortex of patients with schizophrenia and unaffected controls. BMC Neurosci. 14, 105 (2013). source
Not checked in the free run.
- cites [10] Hitzemann, R. et al. Introduction to sequencing the brain transcriptome. Int. Rev. Neurobiol. 116, 1–19 (2014). source
Not checked in the free run.
- Study design and conductown data
PCR validation showed high correlation, r > 0.5, with normalized RNA-seq expression for most genes tested.
“Validation using PCR showed high correlation (r > 0.5) with normalized expression from RNA-seq for the majority of genes assessed (Supplementary Fig. 3).”
Quote in the paperNot a substantial claim - Premisecitation
Schizophrenia GWAS SNPs occur more often than chance in cis-regulatory functional genomic elements such as enhancers or eQTL SNPs.
“Indeed, GWAS SNPs associated with SCZ risk occur more often than expected by chance in cis-regulatory functional genomic elements, such as enhancers or eQTL SNPs3,21–24.”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [3] Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014). source
Not checked in the free run.
- cites [21] Roussos, P. et al. A role for noncoding variation in schizophrenia. Cell Rep. 9, 1417–1429 (2014). source
Not checked in the free run.
- cites [22] Richards, A.L. et al. Schizophrenia susceptibility alleles are enriched for alleles that affect gene expression in adult human brain. Mol. Psychiatry 17, 193–201 (2012). source
Not checked in the free run.
- cites [23] Trynka, G. et al. Chromatin marks identify critical cell types for fine mapping complex trait variants. Nat. Genet. 45, 124–130 (2013). source
Not checked in the free run.
- cites [24] Bharadwaj, R. et al. Conserved higher-order chromatin regulates NMDA receptor gene expression and cognition. Neuron 84, 997–1008 (2014). source
Not checked in the free run.
- Study design and conductown data
In the CMC cohort, ethnicity was similar between schizophrenia cases and controls.
“Ethnicity was similar between cases and controls (Caucasian 80.7%, African-American 14.7%, Hispanic 7.7%, East Asian 0.6%, Supplementary Figs. 1B, C).”
Quote in the paperNot a substantial claim - Interpretationown data
Combining gene and isoform data, 20 of 108 schizophrenia GWAS loci, about 19%, had evidence that mis-regulated gene expression could partly explain the genetic association with schizophrenia.
“Combining the gene and isoform data, 20 of 108 GWAS loci (19%) had evidence suggesting that mis-regulated gene expression could, in part, explain the genetic association with schizophrenia: 18 cis-QTL loci (cis-eQTL for 33 genes + 2 genes with cis-isoQTL), one locus implicated only by cis-isoQTL (SNX19), and one trans-eQTL association for IMMP1L at a GWAS locus on chr7.”
Quote in the paperSubstantial claim - Study design and conductown data
Human FURIN mRNA rescued the phenotype induced by either morpholino, providing evidence for specificity.
“Importantly, expression of human FURIN mRNA could rescue the phenotype induced by either morpholino, providing evidence for specificity (Supplementary Fig. 8).”
Quote in the paperSubstantial claim - Interpretationown data
The possibility of cell-type-specific effects does not compromise the majority of the study's results.
“We do not expect, however, that the scenario will compromise the bulk of our results, all of which complement the genomic studies of this disease.”
Quote in the paperSubstantial claim - Interpretationreasoning
The larger differential expression in earlier studies is consistent with Winner's Curse or false positives because those studies had much smaller sample sizes.
“because earlier studies tend to be far smaller in sample size, their larger differential expression is consistent with either the well-known “Winner’s Curse”41 or false positives that may occur in smaller samples.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [41] Xiao, R. & Boehnke, M. Quantifying and correcting for the winner's curse in genetic association studies. Genet. Epidemiol. 33, 453–462 (2009). source
Not checked in the free run.
- Study design and conductnone given
The dysregulation of M2c in schizophrenia was not due to medication effect or clinical and technical confounds.
“The dysregulation of M2c in SCZ is not due to medication effect or clinical and technical confounds.”
Quote in the paperNot a substantial claim - Study design and conductown data
Hierarchical clustering of differentially expressed genes showed case-control distinctions that were independent of institution, sex, age at death, ethnicity, and RIN.
“As expected, hierarchical clustering of the differentially expressed genes showed case-control distinctions but were independent of institution, sex, age at death, ethnicity, and RIN (Fig. 5A).”
Quote in the paperSubstantial claim - Interpretationown data
Changes in FURIN, TSNARE1, and CNTN4 expression levels induce subtle neuroanatomical variation in multiple brain regions.
“Taken together, the data support the hypothesis that changes in FURIN, TSNARE1, and CNTN4 expression levels induce subtle neuroanatomical variation in multiple brain regions.”
Quote in the paperSubstantial claim - Interpretationown data
Schizophrenia is polygenic.
“Our findings show schizophrenia is polygenic and highlight the utility of this resource for mechanistic interpretations of genetic liability for brain diseases.”
Quote in the paperSubstantial claim - Interpretationreasoning
Thousands of samples are needed to ensure 80% statistical power to observe differential expression between cases and controls for genes implicated at schizophrenia-associated eQTLs.
“Finally, our results imply a need for thousands of samples to ensure 80% statistical power to observe differential expression between cases and controls for the genes implicated at SCZ-associated eQTL, e.g., the five genes of interest above.”
Quote in the paperSubstantial claim - Interpretationreasoning
The results from smaller studies that report large differential expression are called into question.
“This calls into question results from smaller studies that report large differential expression.”
Quote in the paperSubstantial claim - Interpretationown data
The cross-validation results strongly support the robustness of the differential expression results.
“This strongly supports the robustness of the differential expression results described herein.”
Quote in the paperSubstantial claim - Interpretationown data
Genome-wide RNA-seq-based quantification gives good estimates of true gene expression in DLPFC tissue.
“We thus conclude that the genome-wide RNA-seq-based quantification provides good estimates of true gene expression in DLPFC tissue.”
Quote in the paperSubstantial claim - Interpretationown data
Age at death has only a modest impact on case-control expression differences among adult cohorts.
“suggesting that age at death may have only a modest impact among adult cohorts.”
Quote in the paperNot a substantial claim - Premisecitation
Sherlock's underlying principle is that genetic-driven expression changes in risk genes should also appear as genetic association of the same SNPs with disease.
“Its underlying principle is that genetic-driven changes in expression levels of risk genes (discovered as eSNPs) should ultimately also manifest as genetic association of those same SNPs with disease (GWAS SNPs).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [25] He, X. et al. Sherlock: detecting gene-disease associations by matching patterns of expression QTL and GWAS. Am. J. Hum. Genet. 92, 667–680 (2013). source
Not checked in the free run.
- Study design and conductown data
Analysis using the mRIN software concluded that the RNA quality of the samples was adequate.
“We therefore conclude the RNA quality of the samples is adequate.”
Quote in the paperSubstantial claim - Interpretationown data
In the M2c module, genes associated with schizophrenia have higher intramodular connectivity than genes not associated.
“where genes associated with SCZ have higher intramodular connectivity.”
Quote in the paperSubstantial claim - Study design and conductown data
The replication of connectivity in the cross-validation used a completely independent sub-cohort comprising 20% of the brain samples.
“since this replication process occurs in a completely independent sub-cohort of 20% of the brain samples.”
Quote in the paperSubstantial claim - Interpretationown data
The high connectivity correlations between discovery and replication cohorts strongly support the robustness of the gene-gene correlation structure.
“This strongly supports the robustness of the gene-gene correlation structure, since this replication process occurs in a completely independent sub-cohort of 20% of the brain samples.”
Quote in the paperSubstantial claim - Interpretationown data
The analysis provides additional evidence that density loss in schizophrenia is not driven by medication effects.
“This analysis provides additional evidence that the density loss in SCZ is not driven by medication effects.”
Quote in the paperSubstantial claim - Interpretationown data
At least some of the schizophrenia case-control expression differences in CMC may be driven by underlying genetic differences between cases and controls.
“consistent with at least some of the SCZ case-control differences in CMC perhaps being driven by underlying genetic differences between the SCZ cases and controls.”
Quote in the paperSubstantial claim - Interpretationown data
Case-control expression differences show some consistency across the lifespan.
“arguing for some consistency of case-control differences across the lifespan.”
Quote in the paperNot a substantial claim - Study design and conductown data
The differential co-regulated results are not biased by clinical or technical covariates.
“indicating that our differential co-regulated results are not biased from clinical or technical covariates.”
Quote in the paperSubstantial claim - Interpretationown data
The results do not support the hypothesis that drugs drive loss of density in schizophrenia modules through altered transcript abundance of target genes.
“Therefore, our results do not support the hypothesis that drugs drive the loss of density through alteration in the transcript abundance of target genes.”
Quote in the paperSubstantial claim - Interpretationown data
The CommonMind Consortium resource is useful for mechanistic interpretations of genetic liability for brain diseases.
“highlight the utility of this resource for mechanistic interpretations of genetic liability for brain diseases”
Quote in the paperSubstantial claim - Interpretationown data
Gene co-expression implicates a network relevant for schizophrenia.
“Gene co-expression implicates a network relevant for schizophrenia.”
Quote in the paperSubstantial claim - Interpretationown data
The findings show that schizophrenia is polygenic.
“Our findings show schizophrenia is polygenic”
Quote in the paperSubstantial claim - Premisecitation
More than one hundred genetic loci contain variants associated with schizophrenia.
“Over 100 genetic loci harbor schizophrenia associated variants”
- Also stated in: § INTRODUCTION · plain
“>100 common variants3”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014). source
Not checked in the free run.
- Also stated in: § INTRODUCTION · plain
- Premisecitation
Schizophrenia results from many genetic variants with small effects, fitting a polygenic model.
“SCZ is truly complex and appears to result from a myriad of genetic variants exerting small effects on disease risk4,5, conforming closely to a classical polygenic model.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [4] Purcell, S.M. et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748–752 (2009). source
Not checked in the free run.
- cites [5] Purcell, S.M. et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506, 185–190 (2014). source
Not checked in the free run.
- Interpretationown data
The CommonMind Consortium resource can serve as a catalogue of regulatory variants underlying the molecular basis of schizophrenia and other brain disorders.
“This resource can serve as a useful catalogue of regulatory variants underlying the molecular basis of SCZ and other brain disorders.”
Quote in the paperSubstantial claim - Study design and conductown data
PCR validation showed high correlation (r > 0.5) with normalized RNA-seq expression for most genes assessed.
“Validation using PCR showed high correlation (r > 0.5) with normalized expression from RNA-seq for the majority of genes assessed (Supplementary Fig. 3).”
Quote in the paperNot a substantial claim - Premisecitation
Prior gene expression studies are probably underpowered to detect subtle effects expected from schizophrenia and tightly regulated brain tissue.
“These studies are probably underpowered to detect subtle effects that might be expected to arise as a result of this complex disease and within tightly regulated brain tissue9, among other limitations of existing microarray-based gene expression studies10.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [9] Mistry, M., Gillis, J. & Pavlidis, P. Meta-analysis of gene coexpression networks in the post-mortem prefrontal cortex of patients with schizophrenia and unaffected controls. BMC Neurosci. 14, 105 (2013). source
Not checked in the free run.
- cites [10] Hitzemann, R. et al. Introduction to sequencing the brain transcriptome. Int. Rev. Neurobiol. 116, 1–19 (2014). source
Not checked in the free run.
- Premisecitation
GWAS SNPs associated with schizophrenia risk occur more often than expected by chance in cis-regulatory functional genomic elements, such as enhancers or eQTL SNPs.
“Indeed, GWAS SNPs associated with SCZ risk occur more often than expected by chance in cis-regulatory functional genomic elements, such as enhancers or eQTL SNPs3,21–24.”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [3] Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014). source
Not checked in the free run.
- cites [21] Roussos, P. et al. A role for noncoding variation in schizophrenia. Cell Rep. 9, 1417–1429 (2014). source
Not checked in the free run.
- cites [22] Richards, A.L. et al. Schizophrenia susceptibility alleles are enriched for alleles that affect gene expression in adult human brain. Mol. Psychiatry 17, 193–201 (2012). source
Not checked in the free run.
- cites [23] Trynka, G. et al. Chromatin marks identify critical cell types for fine mapping complex trait variants. Nat. Genet. 45, 124–130 (2013). source
Not checked in the free run.
- cites [24] Bharadwaj, R. et al. Conserved higher-order chromatin regulates NMDA receptor gene expression and cognition. Neuron 84, 997–1008 (2014). source
Not checked in the free run.
- Study design and conductown data
Ethnicity was similar between schizophrenia cases and controls.
“Ethnicity was similar between cases and controls (Caucasian 80.7%, African-American 14.7%, Hispanic 7.7%, East Asian 0.6%, Supplementary Figs. 1B, C).”
Quote in the paperNot a substantial claim - Premisecitation
Post-mortem gene expression studies suggest subtle abnormalities in multiple brain regions and cell types in schizophrenia.
“Post-mortem gene expression studies of SCZ cases suggest subtle abnormalities in multiple brain regions including the prefrontal and temporal cortices, hippocampus, and several specific cell types8.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] Horváth, S., Janka, Z. & Mirnics, K. Analyzing schizophrenia by DNA microarrays. Biol. Psychiatry 69, 157–162 (2011). source
Not checked in the free run.
- Premisecitation
Prior analyses using brain eQTL datasets derived from older technologies pointed to fewer than a handful of associations between schizophrenia GWAS risk loci and gene expression.
“Prior analyses using brain eQTL datasets derived from older technologies have pointed to less than a handful of such associations3.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014). source
Not checked in the free run.
- Interpretationown data
The data support that changes in FURIN, TSNARE1, and CNTN4 expression levels induce subtle neuroanatomical variation in multiple brain regions.
“Taken together, the data support the hypothesis that changes in FURIN, TSNARE1, and CNTN4 expression levels induce subtle neuroanatomical variation in multiple brain regions.”
Quote in the paperSubstantial claim - Interpretationreasoning
The study's modeling results call into question findings from smaller studies that report large differential expression.
“This calls into question results from smaller studies that report large differential expression.”
Quote in the paperSubstantial claim - Study design and conductown data
An assessment of age at death or cell type proportions suggests these variables do not explain significant differential expression.
“An assessment of the impact of age at death or cell type proportions suggests that these variables do not explain significant differential expression (Supplementary Fig. 12).”
Quote in the paperSubstantial claim - Interpretationreasoning
Because genome-wide surveys test many genes, variability in differential expression estimates can produce large observed differential expression even when no gene is differentially expressed.
“and because genome-wide surveys test a large number of genes, that variability can translate into large observed differential expression”
Quote in the paperSubstantial claim - Interpretationreasoning
The results imply a need for thousands of samples to ensure 80% statistical power to observe differential expression for genes implicated at schizophrenia-associated eQTLs.
“Finally, our results imply a need for thousands of samples to ensure 80% statistical power to observe differential expression between cases and controls for the genes implicated at SCZ-associated eQTL, e.g., the five genes of interest above.”
Quote in the paperSubstantial claim - Study design and conductown data
The RNA quality of the samples is adequate.
“We therefore conclude the RNA quality of the samples is adequate.”
Quote in the paperSubstantial claim - Study design and conductown data
Expression of human FURIN mRNA rescued the phenotype induced by either morpholino, providing evidence for specificity.
“Importantly, expression of human FURIN mRNA could rescue the phenotype induced by either morpholino, providing evidence for specificity (Supplementary Fig. 8).”
Quote in the paperSubstantial claim - Interpretationown data
Genes identified by differential expression analysis display various degrees of cell-type specificity.
“The data suggest that genes identified by DE analysis display various degrees of cell-type specificity.”
Quote in the paperNot a substantial claim - Interpretationown data
RNA-seq quantification across the genome yields accurate estimates of true gene expression in dorsolateral prefrontal cortex tissue.
“We thus conclude that the genome-wide RNA-seq-based quantification provides good estimates of true gene expression in DLPFC tissue.”
Quote in the paperSubstantial claim - Interpretationreasoning
The Pitt and non-Pitt groups differ in ways other than age.
“other factors besides age also differ between the Pitt and non-Pitt samples”
Quote in the paperNot a substantial claim - Interpretationown data
Among adult cohorts, age at death appears to have at most a small influence on differential expression.
“suggesting that age at death may have only a modest impact among adult cohorts”
Quote in the paperNot a substantial claim - Interpretationown data
Case-control differences in gene expression show some consistency across the lifespan.
“arguing for some consistency of case-control differences across the lifespan”
Quote in the paperNot a substantial claim - Interpretationown data
Some CMC case-control expression differences may reflect genetic differences between cases and controls.
“consistent with at least some of the SCZ case-control differences in CMC perhaps being driven by underlying genetic differences between the SCZ cases and controls.”
Quote in the paperSubstantial claim- Rests on an assumption: The CMC cases carry an aggregate common polygenic schizophrenia risk burden.
- Interpretationown data
Cross-validation provides strong evidence that the differential expression findings are robust.
“This strongly supports the robustness of the differential expression results described herein.”
Quote in the paperSubstantial claim - Interpretationown data
The results do not support the hypothesis that drugs drive loss of density through altered transcript abundance of target genes.
“Therefore, our results do not support the hypothesis that drugs drive the loss of density through alteration in the transcript abundance of target genes.”
Quote in the paperSubstantial claim - Interpretationown data
This analysis provides additional evidence that density loss in schizophrenia is not driven by medication effects.
“This analysis provides additional evidence that the density loss in SCZ is not driven by medication effects.”
Quote in the paperSubstantial claim - Interpretationown data
The high connectivity correlations support the robustness of the gene-gene correlation structure.
“This strongly supports the robustness of the gene-gene correlation structure, since this replication process occurs in a completely independent sub-cohort of 20% of the brain samples.”
Quote in the paperSubstantial claim
- May combine two claims. 158
- The quote only partly states this claim. 1
- Classified as probably not a substantial claim. 103
May combine two claims.
Findingown dataSuppression of furin_a in zebrafish led to a 24% decrease in head size, and this was replicated in CRISPR/Cas9 mutants and with a second splice-blocking morpholino.
“Suppression of furin_a led to a 24% decrease in head size (Fig. 3A, B); this observation was replicated in CRISPR/Cas9 mutants (Supplementary Fig. 8) and in embryos injected with a second sbMO targeting exon 5 (data not shown)”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOverexpression of CNTN4 and suppression of furin_a decreased proliferating PH3-positive cells by 9.8%, P = 0.003, and 29.8%, P < 0.001, respectively.
“Overexpression of CNTN4 and suppression of furin_a led to a 9.8% (P = 0.003) and a 29.8% (P < 0.001) decrease, respectively, in proliferating cells marked by phospho-histone3 (PH3), and overexpression of TSNARE1 led to a 9.5% increase (P = 0.018) in proliferating cells (N = 20 per experiment; Fig. 3C, D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAmong 19 GWAS loci with schizophrenia-associated cis-eQTLs, eight implicated only a single gene: FURIN down-regulated, TSNARE1 up-regulated, CNTN4 up-regulated, CLCN3 up-regulated, SNAP91 up-regulated, ENSG00000259946 up-regulated, ENSG00000253553 down-regulated, and the ENST00000528555 isoform of SNX19 down-regulated.
“Of the 19 GWAS loci harboring SCZ-associated cis-eQTLs, eight involved only a single gene (i.e., no additional gene with relaxed adjusted Sherlock p < 0.5): furin (FURIN, down-regulated by risk allele), t-SNARE domain containing 1 (TSNARE1, up), contactin 4 (CNTN4, up), voltage-sensitive chloride channel 3 (CLCN3, up), synaptosomal-associated protein of 91 kDa (SNAP91, up), ENSG00000259946 (up),”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn ROS/MAP, the top GWAS SNP was also a significant eQTL with the same direction of effect as CMC for FURIN, CLCN3, and SNAP91; TSNARE1 and CNTN4 had the same direction but did not reach significance.
“The most significant GWAS SNP was also a significant eQTL with the same direction of effect as in CMC for FURIN (rs4702: P = 1 × 10−6), CLCN3 (rs10520163: P = 9 × 10−6), and SNAP91 (rs3798869: P = 3 × 10−4); TSNARE1 (rs4129585: P = 0.057) and CNTN4 (rs17194490: P = 0.07) also had alleles in the same direction of effect as in CMC but did not reach significance.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe CMC sample contains most eQTLs reported in the literature and also finds many genes with previously undetected eQTLs.
“In addition to containing the vast majority of eQTL found in the literature, the CMC sample finds a substantial number of genes with previously undetected eQTL (Table 1).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTrans-eQTLs were not enriched for brain enhancers, but were enriched in genic regions and depleted in intergenic regions, especially when restricted to trans-eQTLs at least 10 Mb from the gene.
“Enrichment of trans-eQTLs with brain enhancers was not observed (data not shown), though enrichment in genic regions and depletion in intergenic regions was observed, particularly when restricting to trans eQTL ≥ 10 Mb from the gene location.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIsoform-level eQTL analysis identified nine genes in eight GWAS loci, with all but three already found in the gene-level analysis.
“Repeating the analyses using isoform-level eQTLs (isoQTL) identified nine genes in eight GWAS loci, with all but three genes already identified in the gene-level analysis (Supplementary data file 2).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe data supported 45,453 significant trans-eQTLs at FDR ≤ 5%, of which 20,288 were also cis-eQTL SNPs for local genes and 34% predicted expression of more than one distant gene.
“Nevertheless, the data supported 45,453 significant trans-eQTL at FDR ≤ 5%, of which 20,288 were also cis- eQTL SNPs for local genes, and 34% predicted expression of more than one distant gene.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCis-eQTLs were enriched for enhancer sequences present in brain tissues, with the strongest enrichment in DLPFC enhancers.
“Cis-eQTLs were enriched for enhancer sequences present in brain tissues (Kolmogorov-Smirnov (KS) test versus non-brain: D = 1, P = 4.5 × 10−6), and the strongest enrichment is observed in DLPFC enhancers (Z = 9.5) (Fig. 1C).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThere were 8,427 eGenes at FDR ≤ 5%, corresponding to 18 eGenes discovered per sample, matching a GTEx prediction.
“There were 8,427 eGenes at FDR ≤ 5%, or 18 eGenes discovered per sample, consistent with a prediction from GTEx.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataBecause of linkage disequilibrium, many eQTLs for a gene were highly correlated, and 32.8% of eQTL SNPs predicted expression of more than one gene.
“Many eQTLs for the same gene were highly correlated, due to linkage disequilibrium, and 32.8% of eQTL SNPs (“eSNPs”) predict expression of more than one gene.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe proportion of CMC trans-eQTLs replicating in HBCC was 18.6%, and the proportion of HBCC trans-eQTLs replicating in CMC was 29.7%.
“The proportion of trans eQTL in CMC that replicate in HBCC is 18.6% (both FDR ≤ 5%). The proportion of HBCC trans eQTL that replicate in CMC is 29.7%.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationCis-eSNPs were enriched in genic elements and non-coding RNAs, especially within 100 kb of transcription start and end sites, and were depleted in intergenic regions.
“Cis-eSNPs were enriched within genic elements and non-coding RNAs, particularly within 100 kb of the transcription start and end sites12, and depleted in intergenic regions (Fig. 1A, B).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12] Veyrieras, J.B. et al. High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet. 4, e1000214 (2008). source
Not checked in the free run.
May combine two claims. The quote only partly states this claim.
Findingown dataCMC eQTLs captured most eQTLs found in other independent brain samples, with replication π1 values of 0.98 for GTEx v6 and 0.70-0.93 for several microarray datasets.
“Considering microarray-based eQTLs from the Harvard Brain Bank 15, BrainCloud16, NIH17, and the UK Brain Expression Consortium (UKBEC)18, we estimated π1 to be 0.75, 0.70, 0.79, and 0.93, respectively, indicating that our results captured most eQTLs found in other independent samples.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [15] Zhang, B. et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell 153, 707–720 (2013). source
Not checked in the free run.
- cites [16] Colantuoni, C. et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 478, 519–523 (2011). source
Not checked in the free run.
- cites [17] Gibbs, J.R. et al. Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet. 6, e1000952 (2010). source
Not checked in the free run.
May combine two claims.
Findingown dataThe cis-eQTL model found 2,154,331 significant cis-eQTLs at FDR ≤ 5%, covering 13,137 of 16,423 genes, or 80%.
“The model identified 2,154,331 significant cis-eQTLs, (i.e., within 1 Mb of a gene) at a false discovery rate (FDR) ≤ 5%, for 13,137 (80%) of 16,423 genes.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOverexpression of SNAP91 or CLCN3 had no statistically significant effect on zebrafish head size.
“Relative to control embryos, overexpression of TSNARE1 or CNTN4 resulted in a significant decrease in head size, 9.5% (P < 0.001) and 3.5% (P = 0.018), respectively, while SNAP91 or CLCN3 showed no statistically significant effect (Fig. 3A, B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAcross the genome, assuming 10,000 genes, the median number of cases and controls needed for 80% power is approximately 28,500, which exceeds the size of any available dataset.
“Genome-wide, the median number of cases and controls needed to obtain 80% power assuming 10,000 genes is ~28,500, well beyond any available dataset (Fig. 7B,C).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe CMC data include a comprehensive compilation of gene expression patterns and an intensive evaluation of eQTLs across the genome.
“They include a comprehensive compilation of gene expression patterns, together with intensive evaluation of eQTLs across the genome.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMixture analysis of P values for 16,423 genes suggested that approximately 44% of genes are perturbed in schizophrenia, and the excess of low P values disappeared when case and control labels were permuted.
“Analysis of the distribution of P values for the 16,423 genes was tested for a mixture of disease-associated and null distributions for 25 cases and 25 controls and suggests that approximately 44% of genes are perturbed in SCZ; this excess of low P values disappears when case and control labels are permuted.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe differentially expressed genes had modest fold changes, with a mean of 1.09 and a range of 1.03 to 1.33.
“All had modest fold changes (Fig. 5B), with a mean of 1.09 and range 1.03–1.33 (inverting down-regulated expression ratios).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe M2c module was associated with differential expression, OR = 2.3 and P = 1 × 10−13, and was enriched for GWAS loci, rare CNV, and rare nonsynonymous variants.
“Of these, however, only one (M2c) shows association with differential expression (OR = 2.3, P = 1 × 10−13) and multiple prior genetic associations with SCZ; the latter encompasses genes in GWAS loci (FE [fold-enrichment] = 1.36, P = 0.04), rare CNV (FE = 1.52, P = 0.051), and rare nonsynonymous variants (FE = 1.18, P = 2 × 10−4) (Supplementary table 3).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn an independent HBCC cohort, differential expression test statistics correlated with CMC for 480 of 693 differentially expressed genes, r = 0.58, and across all 10,928 common genes, r = 0.28.
“there was high correlation of test statistics for differential expression in CMC compared to HBCC for the differentially expressed genes also present in the HBCC data (480 of 693), Pearson correlation r = 0.58 (P < 10−16); the correlation remains high (r = 0.28, P < 10−16) across all 10,928 genes common to both platforms after QC (Fig. 5C).”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationAmong the top 100 differentially expressed genes were GABRA5 and CALB1, genes previously reported as differentially expressed in cortical tissue from schizophrenia patients, suggesting GABAergic interneuron dysfunction.
“Also included among the top 100 differentially expressed genes are the alpha 5 subunit of the GABA A receptor (GABRA5) and calbindin (CALB1), genes previously reported as differentially expressed in cortical tissue from schizophrenia patients, suggesting GABAergic interneuron dysfunction45.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] Sakai, T. et al. Changes in density of calcium-binding-protein-immunoreactive GABAergic neurons in prefrontal cortex in schizophrenia and bipolar disorder. Neuropathology 28, 143–150 (2008). source
Not checked in the free run.
May combine two claims.
Findingown dataWithout a fold-change threshold, 693 genes were differentially expressed between schizophrenia cases and controls at FDR ≤ 5%, with 332 up-regulated and 361 down-regulated.
“Without imposing a threshold on the magnitude of fold change in mean expression between SCZ and controls, we find 693 genes to be differentially expressed after correction for multiple testing (FDR ≤ 5%), 332 up-regulated and 361 down-regulated (Fig. 5A, Supplementary data file 3).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataA subnetwork of approximately 1,400 genes involved in synaptic transmission is significantly altered in schizophrenia and shows strong enrichment for schizophrenia genetic risk signal.
“Finally, we identified a subnetwork of ~1400 genes sub-serving functions related to synaptic transmission that is significantly perturbed in SCZ and is highly enriched for SCZ genetic signal.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe control co-expression network contained 35 modules with 30 to 1,900 genes each, plus about 3,600 unclustered genes.
“The co-expression network generated from the controls consisted of 35 modules each containing between 30 and 1,900 genes, along with ~3,600 unclustered genes (Supplementary data file 5).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe 239 differentially expressed isoforms came from 223 genes, were enriched for overlap with the 693 differentially expressed genes, P = 2 × 10−131, and 136 were differentially expressed at both gene and isoform levels.
“These isoforms derive from 223 genes, which are enriched, as expected, for overlap with the 693 differentially expressed genes (P = 2 × 10−131, Fisher’s exact test), and 136 are differentially expressed at both the gene and isoform levels (Supplementary Fig. 11).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe M2c module showed a loss of density in schizophrenia cases, permutation Z = −1.79 and one-tailed P = 0.037, but no loss of connectivity.
“The M2c module exhibits a loss of density in the SCZ cases (permutation Z = −1.79, one-tailed P = 0.037, Fig. 6B) but no loss of connectivity.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataAfter filtering, 43,817 isoforms from 12,329 genes remained for analysis.
“After filtering, a total of 43,817 isoforms of 12,329 genes remained for analysis.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn CMC eQTL data, the only overlap between SCZ association and eQTLs was for MLH1, with up-regulation predicted to be associated with genetic risk variation, but this overlap was below genome-wide significance (Sherlock P = 6 × 10−5, Bonferroni corrected P = 0.69).
“In our CMC eQTL data, there is only overlap between the SCZ association and eQTLs for MLH1, with up-regulation of expression predicted to be associated with the genetic risk variation; however, this overlap is below the genome-wide threshold, Sherlock P = 6 × 10−5, Bonferroni corrected P = 0.69.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFor the 13 genes tested, the Pearson correlation between qPCR expression ratios and voom-normalized log(CPM) was above 0.5 for 9 genes, between 0.1 and 0.3 for 3 genes, and negative for HIVEP2.
“The Pearson correlation between these expression ratios and the voom-normalized log(CPM) levels for the same subjects was greater than 0.5 for 9 of the 13 genes (Supplementary Fig. 3A); for an additional 3 genes, it was between 0.1 and 0.3, and only for one gene (HIVEP2) was the correlation negative.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Findingown dataThe enhancer-overlap analysis used 13,137 cis- and 851 trans-eSNPs, defined as the most significantly associated SNP per gene.
“We tested for enrichment of significant eQTLs at FDR ≤ 5%, using as an index eQTL SNP (eSNP) the most significantly associated SNP per gene (“max-eQTL”), which resulted in 13,137 and 851 cis- and trans-eSNPs, respectively.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThere were 3,355,111 significant cis-isoQTLs at FDR ≤ 5%, representing 27,691 isoforms of 10,779 genes.
“Using similar techniques to derive isoform expression quantitative trait loci (isoQTLs), we identified 3,355,111 significant cis-isoQTLs at FDR ≤ 5%, representing 27,691 isoforms of 10,779 genes.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn the CMC cohort, differential expression t-statistics for the 172 youngest cases and controls (mean age 45.5, range 20-60) correlated with those from the full cohort at Pearson r = 0.62, and this correlation was not significantly lower than that for 100 random subsets of the same size (mean r = 0.69, P = 0.28).
“for the 172 cases and controls whose age of death was youngest (mean age 45.5, range 20–60), the t-statistics for differential expression were highly correlated with those from the full cohort (Pearson r = 0.62), yet somewhat lower (though not significantly, P = 0.28) than for 100 random subsets of the same size (mean r = 0.69, standard deviation = 0.13)”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data58% of isoQTLs were cis-eQTLs for the parent gene at FDR ≤ 5%, and 71% of cis-eQTLs for genes with at least one represented isoform were isoQTLs at FDR ≤ 5%.
“IsoQTLs and gene-level eQTLs overlapped substantially; 58% of isoQTLs were cis-eQTLs for the parent gene at FDR ≤ 5%; conversely, 71% of cis-eQTLs for genes with at least one represented isoform were isoQTLs at FDR ≤ 5%.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataOmitting the Sherlock exclusion for SNPs not in 1000 Genomes affected 49,612 (4.4%) of the 1,127,447 eSNPs also found in PGC SCZ2 GWAS data.
“We also slightly modified the Sherlock source code, omitting the exclusion criterion for SNPs (and genes whose expression is associated with those SNPs) that could not be found in the 1000 Genomes data, which encompassed only 49,612 [4.4%] of the 1,127,447 eSNPs also found in the PGC SCZ2 GWAS data 3.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014). source
Not checked in the free run.
May combine two claims.
Findingown dataPermutation of disease status showed that overlaps between case-derived and control-derived eQTL were similar to what is expected for two homogeneous sets of these sample sizes, with limited evidence for condition-specific eQTL.
“However, permutation of disease status indicated that the overlaps between case-derived eQTL and control-derived eQTL were similar to the amount expected for two homogeneous sets of these sample sizes, and there was limited evidence for condition-specific eQTL.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThere were 39,414 significant trans-isoQTLs, representing 964 isoforms from 836 genes, and 61% of these were also trans-eQTLs for the same gene.
“At the isoform level, there were 39,414 significant trans-isoQTLs, representing 964 isoforms (836 genes), of which 61% were also trans-eQTLs for the same gene.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Findingown dataAfter preprocessing and quality control, the HBCC replication microarray cohort contained 131 schizophrenia and 176 control DLPFC samples (plus 43 bipolar disorder and 88 major depressive disorder samples used only for eQTL derivation).
“After preprocessing and quality control to check for outliers and sex mismatches, there remained 131 SCZ and 176 control samples (as well as 43 BP and 88 MDD samples, where these latter samples were used only for eQTL derivation).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataHaloperidol signature genes were significantly enriched among CMC schizophrenia differentially expressed genes (P = 1 × 10−9), whereas the clozapine signature was not (P = 0.29).
“Significant enrichment was observed (Supplementary Table 2A) for the haloperidol signatures, but not the clozapine signature (P = 1 × 10−9 and 0.29, respectively).”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Findingown dataUsing a nominal P ≤ 0.01 cutoff, haloperidol and clozapine treatment signatures yielded human-orthologous gene sets of 237 and 31 genes, respectively.
“we used a nominal P ≤ 0.01 cutoff to identify signatures for haloperidol and clozapine treatment, which resulted in human-orthologous gene sets of size 237 and 31, respectively.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataGene sets appearing in three or more or two or more rodent studies did not reach statistical significance but showed a trend for overlap (P = 0.084 and 0.071, respectively).
“Sets of genes that appeared in 3 or more studies, or 2 or more studies, also did not reach statistical significance but did show a trend for overlap (P = 0.084 and 0.071, respectively).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataThe gene set curation yielded 2,902 sets in total: 1,938 from Gene Ontology, 824 from Reactome, and 140 gene families.
“This procedure yielded 2,902 gene sets in total: 1,938 sets from GO, 824 from Reactome, and 140 gene families.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn rodent drug signatures, none were significantly enriched after Bonferroni correction (Pbonferroni > 0.05), but two signatures were significantly less concordant than expected by chance after multiple test correction (Pbonferroni = 0.01 and 0.01).
“using the KS test for enrichment, none of the gene signatures were strictly significant after Bonferroni correction (Pbonferroni > 0.05), though two signatures were significantly less concordant than expected by chance after multiple test correction (Pbonferroni = 0.01 and 0.01, Supplementary Table 2B).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn the controls-only polygenic risk score analysis, no single gene was significantly associated with PRS after FDR 5% correction, but the P-value distribution was inflated (π1 = 0.22).
“While no single gene was found to be significantly associated with PRS after correction for multiple testing using an FDR approach (cutoff of 5%), there was inflation of the P value distribution101 consistent with a non-uniform distribution (π1 = 0.22).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [101] Storey, J.D. & Tibshirani, R. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. USA 100, 9440–9445 (2003). source
Not checked in the free run.
Classified as probably not a substantial claim.
Findingown dataIn permuted sets, network statistics also showed large differences with module size.
“In the permuted sets, we again observed large differences of the network statistics with module size.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe haloperidol signature was significantly less concordant in direction than expected by chance (35 of 237 genes, one-sided P < 1 × 10−4), while the clozapine signature showed significant concordance (22 of 31 genes, one-sided P = 0.013).
“We found the haloperidol signature significantly less concordant than expected by chance (35 out of 237 genes concordant, one-sided P < 1 × 10−4), while the clozapine signature showed significant concordance, despite the lack of enrichment in the previous test (22 of 31 genes concordant, one-sided P = 0.013).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataA set of 693 genes was significantly differentially expressed at FDR ≤ 5% between schizophrenia cases and controls and was used for genetic overlap tests.
“we tested the associations for enrichment in a gene set consisting of the 693 genes found to be significantly (FDR ≤ 5%) differentially expressed between SCZ cases and controls (up- or down-regulated).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn CMC, Pitt samples make up 26% of all schizophrenia cases and controls, and 63% of the 20-60 age group samples are from Pitt.
“while Pitt samples compose 26% of all SCZ cases and controls in CMC, 63% of the aged 20–60 CMC samples are from Pitt”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn independent rodent datasets, drug-impacted genes overlapped with disease-associated genes, but the directions of effect on expression were opposite.
“Using the independent rodent datasets, we found overall similar results as that in the monkeys, with some overlaps of genes impacted by drugs and associated with disease, but with opposite directions of effect on gene expression.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Findingown dataAfter conditioning on DLPFC expression, de novo mutations included 103 loss-of-function mutations in 101 genes and 638 nonsynonymous mutations across 605 genes.
“Conditioning on DLPFC expression, there were 103 loss-of-function mutations in 101 genes, and a total of 638 nonsynonymous mutations across 605 genes.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAmong differentially expressed DLPFC genes, 236 genes had one or more singleton loss-of-function variants and 440 genes had singleton damaging nonsynonymous variants.
“Looking only at differentially expressed DLPFC genes, there were 236 genes with one or more singleton loss-of-function variants and a total of 440 genes harboring singleton damaging nonsynonymous variants.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataAfter conditioning on DLPFC expression, the 12 schizophrenia-associated CNV regions spanned 127 genes.
“After conditioning on DLPFC expression, the 12 regions spanned 127 genes.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn the HBCC replication cohort, 2,288 genes were differentially expressed at FDR 5% between schizophrenia cases and controls, with 1,166 up-regulated and 1,122 down-regulated.
“We performed differential expression analysis with adjustment for covariates, using linear regression models in limma and identified 2,288 differentially expressed genes at FDR 5%, among which 1,166 and 1,122 were up-regulated and down-regulated in SCZ, respectively.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe most represented rodent drug signature genes showed a non-significant trend toward enrichment (p = 0.061), and one gene, ATRX, was significant in the CMC DLPFC data at FDR ≤ 5% (FDR = 4.5%).
“A one-sided test of enrichment for these “most represented” genes showed a non-significant trend towards enrichment (p = 0.061), with one gene from the signature significant in the CMC DLPFC data at FDR ≤ 5% (ATRX, FDR = 4.5%).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataA set of 21 genes appeared in four or more rodent drug signatures; 16 of these had orthologs in the normalized data, and 8 showed concordant direction in all four studies.
“we identified a set of 21 genes that appeared in 4 or more of the gene signatures; 16 of these genes were represented by orthologs in our normalized data, and 8 showed concordant direction in all 4 studies.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAfter intersecting with DLPFC-expressed genes, 87 of the 108 schizophrenia GWAS loci spanned one or more genes, encompassing 489 genes.
“After intersecting with DLPFC-expressed genes from this paper, there were 87 loci spanning one or more genes, encompassing a total of 489 genes.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingnone givenThe CommonMind Consortium is the largest existing collection of collaborating brain banks and includes over 1,150 samples.
“The CMC is the largest existing collection of collaborating brain banks and includes over 1,150 samples.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAltering expression of FURIN, TSNARE1, or CNTN4 changes neurodevelopment in zebrafish.
“Altering expression of FURIN, TSNARE1, or CNTN4 changes neurodevelopment in zebrafish”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationCis-eSNPs are enriched within genic elements and non-coding RNAs, particularly within 100 kb of transcription start and end sites, and depleted in intergenic regions.
“Cis-eSNPs were enriched within genic elements and non-coding RNAs, particularly within 100 kb of the transcription start and end sites12, and depleted in intergenic regions (Fig. 1A, B).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12] Veyrieras, J.B. et al. High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet. 4, e1000214 (2008). source
Not checked in the free run.
May combine two claims.
Findingown dataTrans-eQTLs were not enriched with brain enhancers, but were enriched in genic regions and depleted in intergenic regions, particularly for trans-eQTLs at least 10 Mb from the gene location.
“Enrichment of trans-eQTLs with brain enhancers was not observed (data not shown), though enrichment in genic regions and depletion in intergenic regions was observed, particularly when restricting to trans eQTL ≥ 10 Mb from the gene location.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataeQTLs for FURIN, CLCN3, and SNAP91 replicated in ROS/MAP with the same direction of effect; TSNARE1 and CNTN4 had alleles in the same direction but did not reach significance.
“The most significant GWAS SNP was also a significant eQTL with the same direction of effect as in CMC for FURIN (rs4702: P = 1 × 10−6), CLCN3 (rs10520163: P = 9 × 10−6), and SNAP91 (rs3798869: P = 3 × 10−4); TSNARE1 (rs4129585: P = 0.057) and CNTN4 (rs17194490: P = 0.07) also had alleles in the same direction of effect as in CMC but did not reach significance.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [26] De Jager, P.L. et al. Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat. Neurosci. 17, 1156–1163 (2014). source
Not checked in the free run.
May combine two claims.
Findingown dataThe proportion of trans-eQTLs in CommonMind Consortium that replicate in HBCC is 18.6%, and the proportion of HBCC trans-eQTLs that replicate in CommonMind Consortium is 29.7%.
“The proportion of trans eQTL in CMC that replicate in HBCC is 18.6% (both FDR ≤ 5%). The proportion of HBCC trans eQTL that replicate in CMC is 29.7%.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataReplication was lower for a meta-analysis of mixed brain regions (π1 = 0.62) and for blood eQTLs (π1 = 0.54).
“Replication was somewhat lower for a recent meta-analysis that included a mix of several distinct brain regions19 (π1 = 0.62), and for eQTLs detected in blood (π1 = 0.54)20.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [19] Kim, Y. et al. A meta-analysis of gene expression quantitative trait loci in brain. Transl. Psychiatry 4, e459 (2014). source
Not checked in the free run.
- cites [20] Wright, F.A. et al. Heritability and genomics of gene expression in peripheral blood. Nat. Genet. 46, 430–437 (2014). source
Not checked in the free run.
May combine two claims.
Findingown dataThe data supported 45,453 significant trans-eQTLs at FDR ≤ 5%, of which 20,288 were also cis-eQTL SNPs for local genes, and 34% predicted expression of more than one distant gene.
“Nevertheless, the data supported 45,453 significant trans-eQTL at FDR ≤ 5%, of which 20,288 were also cis- eQTL SNPs for local genes, and 34% predicted expression of more than one distant gene.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataAfter normalization, 16,423 genes were expressed at levels sufficient for analysis, of which 14,222 were protein coding.
“Following data normalization, 16,423 genes (based on Ensembl models) were expressed at levels sufficient for analysis, of which 14,222 were protein coding.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataCommonMind Consortium eQTLs replicate most eQTLs found in other independent samples, with π1 values of 0.98 for GTEx v6, 0.75 for Harvard Brain Bank, 0.70 for BrainCloud, 0.79 for NIH, 0.93 for UKBEC, and 0.77 for HBCC.
“GTEx v6 is the largest public dataset of eQTLs from DLPFC tissue (n = 92) assayed by RNA-seq; its replication in CMC is π1 = 0.98.”
- Also stated in: § Generation of a brain eQTL resource · hedged
“Considering microarray-based eQTLs from the Harvard Brain Bank 15, BrainCloud16, NIH17, and the UK Brain Expression Consortium (UKBEC)18, we estimated π1 to be 0.75, 0.70, 0.79, and 0.93, respectively”
- Also stated in: § Generation of a brain eQTL resource · plain
“We also derived eQTL for 279 DLPFC samples as part of the NIMH Human Brain Collection Core (HBCC) microarray data and found replication π1 = 0.77.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [15] Zhang, B. et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell 153, 707–720 (2013). source
Not checked in the free run.
- cites [16] Colantuoni, C. et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 478, 519–523 (2011). source
Not checked in the free run.
- cites [17] Gibbs, J.R. et al. Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet. 6, e1000952 (2010). source
Not checked in the free run.
- cites [18] Ramasamy, A. et al. Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat. Neurosci. 17, 1418–1428 (2014). source
Not checked in the free run.
- Also stated in: § Generation of a brain eQTL resource · hedged
May combine two claims.
Findingown dataIsoform-level eQTL analysis identified nine genes in eight GWAS loci, with all but three already identified in the gene-level analysis.
“Repeating the analyses using isoform-level eQTLs (isoQTL) identified nine genes in eight GWAS loci, with all but three genes already identified in the gene-level analysis (Supplementary data file 2).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataCis-eQTLs are enriched for enhancer sequences present in brain tissues, with the strongest enrichment in DLPFC enhancers.
“Cis-eQTLs were enriched for enhancer sequences present in brain tissues (Kolmogorov-Smirnov (KS) test versus non-brain: D = 1, P = 4.5 × 10−6), and the strongest enrichment is observed in DLPFC enhancers (Z = 9.5) (Fig. 1C).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] GTEx Consortium. Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348, 648–660 (2015).
Not checked in the free run.
May combine two claims.
Findingown dataThere were 8,427 eGenes at FDR ≤ 5%, or 18 eGenes discovered per sample, consistent with a prediction from GTEx.
“There were 8,427 eGenes at FDR ≤ 5%, or 18 eGenes discovered per sample, consistent with a prediction from GTEx.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] Dunham, I. et al. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74 (2012). source
Not checked in the free run.
May combine two claims.
Findingown dataThese isoforms derive from 223 genes, are enriched for overlap with the 693 differentially expressed genes (P = 2 × 10−131), and 136 are differentially expressed at both gene and isoform levels.
“These isoforms derive from 223 genes, which are enriched, as expected, for overlap with the 693 differentially expressed genes (P = 2 × 10−131, Fisher’s exact test), and 136 are differentially expressed at both the gene and isoform levels (Supplementary Fig. 11).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataSuppression of furin_a led to a 24% decrease in head size, replicated in CRISPR/Cas9 mutants and with a second splice-blocking morpholino.
“Suppression of furin_a led to a 24% decrease in head size (Fig. 3A, B); this observation was replicated in CRISPR/Cas9 mutants (Supplementary Fig. 8) and in embryos injected with a second sbMO targeting exon 5 (data not shown)”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data239 isoforms were differentially expressed between schizophrenia cases and controls: 94 up-regulated and 145 down-regulated.
“We identified 239 isoforms differentially expressed between SCZ cases and controls: 94 up-regulated and 145 down-regulated.”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationGenes affected by antipsychotics are often the same as those altered in schizophrenia, but the impact of antipsychotic drugs tends to be in the opposite direction of that observed in schizophrenia subjects.
“Although analyses of experiments performed using either monkeys or rodents indicate that genes whose expression are affected by antipsychotics are often the same as those we find altered in individuals with SCZ, the impact of antipsychotic drugs nevertheless tends to be significantly in the opposite direction of that observed in the SCZ subjects (Supplementary Table 2).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data693 genes were differentially expressed at FDR ≤ 5%, with 332 up-regulated and 361 down-regulated.
“we find 693 genes to be differentially expressed after correction for multiple testing (FDR ≤ 5%), 332 up-regulated and 361 down-regulated (Fig. 5A, Supplementary data file 3).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe loss of density replicates in the HBCC cohort (Z = −3.02, P = 0.003), indicating that regulatory coordination of genes in this module is disrupted in schizophrenia.
“The loss of density replicates in the HBCC cohort (Z = −3.02, P = 0.003), indicating that the regulatory coordination of genes in this module is disrupted in SCZ.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOverexpression of TSNARE1 or CNTN4 in zebrafish decreased head size by 9.5% and 3.5%, respectively; SNAP91 or CLCN3 had no statistically significant effect.
“Relative to control embryos, overexpression of TSNARE1 or CNTN4 resulted in a significant decrease in head size, 9.5% (P < 0.001) and 3.5% (P = 0.018), respectively, while SNAP91 or CLCN3 showed no statistically significant effect (Fig. 3A, B).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe control co-expression network consisted of 35 modules each containing between 30 and 1,900 genes, along with about 3,600 unclustered genes.
“The co-expression network generated from the controls consisted of 35 modules each containing between 30 and 1,900 genes, along with ~3,600 unclustered genes (Supplementary data file 5).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAll differentially expressed genes had modest fold changes, with a mean of 1.09 and range 1.03-1.33.
“All had modest fold changes (Fig. 5B), with a mean of 1.09 and range 1.03–1.33 (inverting down-regulated expression ratios).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOverexpression of CNTN4 and suppression of furin_a decreased proliferating PH3 cells by 9.8% and 29.8%, respectively; overexpression of TSNARE1 increased proliferating cells by 9.5%.
“Overexpression of CNTN4 and suppression of furin_a led to a 9.8% (P = 0.003) and a 29.8% (P < 0.001) decrease, respectively, in proliferating cells marked by phospho-histone3 (PH3), and overexpression of TSNARE1 led to a 9.5% increase (P = 0.018) in proliferating cells (N = 20 per experiment; Fig. 3C, D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe M2c module shows association with differential expression (OR = 2.3, P = 1 × 10−13) and multiple prior genetic associations with schizophrenia: GWAS loci (FE = 1.36, P = 0.04), rare CNV (FE = 1.52, P = 0.051), and rare nonsynonymous variants (FE = 1.18, P = 2 × 10−4).
“only one (M2c) shows association with differential expression (OR = 2.3, P = 1 × 10−13) and multiple prior genetic associations with SCZ; the latter encompasses genes in GWAS loci (FE [fold-enrichment] = 1.36, P = 0.04), rare CNV (FE = 1.52, P = 0.051), and rare nonsynonymous variants (FE = 1.18, P = 2 × 10−4) (Supplementary table 3).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the independent HBCC sample, correlation of differential expression test statistics was r = 0.58 for 480 of 693 genes and r = 0.28 across all 10,928 common genes.
“there was high correlation of test statistics for differential expression in CMC compared to HBCC for the differentially expressed genes also present in the HBCC data (480 of 693), Pearson correlation r = 0.58 (P < 10−16); the correlation remains high (r = 0.28, P < 10−16) across all 10,928 genes common to both platforms after QC (Fig. 5C).”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationThe top 100 differentially expressed genes include GABRA5 and CALB1, genes previously reported as differentially expressed in cortical tissue from schizophrenia patients, suggesting GABAergic interneuron dysfunction.
“Also included among the top 100 differentially expressed genes are the alpha 5 subunit of the GABA A receptor (GABRA5) and calbindin (CALB1), genes previously reported as differentially expressed in cortical tissue from schizophrenia patients, suggesting GABAergic interneuron dysfunction45.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] Sakai, T. et al. Changes in density of calcium-binding-protein-immunoreactive GABAergic neurons in prefrontal cortex in schizophrenia and bipolar disorder. Neuropathology 28, 143–150 (2008). source
Not checked in the free run.
May combine two claims.
Findingown dataThe study identified a subnetwork of about 1,400 genes involved in synaptic transmission that is significantly perturbed in schizophrenia and highly enriched for schizophrenia genetic signal.
“Finally, we identified a subnetwork of ~1400 genes sub-serving functions related to synaptic transmission that is significantly perturbed in SCZ and is highly enriched for SCZ genetic signal.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataGenome-wide, assuming 10,000 genes, the median number of cases and controls needed for 80% power is about 28,500, which exceeds any available dataset.
“Genome-wide, the median number of cases and controls needed to obtain 80% power assuming 10,000 genes is ~28,500, well beyond any available dataset (Fig. 7B,C).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAnalysis of P values suggests approximately 44% of genes are perturbed in schizophrenia; this excess of low P values disappears when case and control labels are permuted.
“Analysis of the distribution of P values for the 16,423 genes was tested for a mixture of disease-associated and null distributions for 25 cases and 25 controls and suggests that approximately 44% of genes are perturbed in SCZ; this excess of low P values disappears when case and control labels are permuted.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe M2c module exhibits a loss of density in schizophrenia cases (permutation Z = −1.79, one-tailed P = 0.037) but no loss of connectivity.
“The M2c module exhibits a loss of density in the SCZ cases (permutation Z = −1.79, one-tailed P = 0.037, Fig. 6B) but no loss of connectivity.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAmong differentially expressed DLPFC genes, 236 carried at least one singleton loss-of-function variant and 440 carried singleton damaging nonsynonymous variants.
“Looking only at differentially expressed DLPFC genes, there were 236 genes with one or more singleton loss-of-function variants and a total of 440 genes harboring singleton damaging nonsynonymous variants.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe most-represented rodent genes had a non-significant enrichment trend (p = 0.061); one gene, ATRX, was significant in CMC DLPFC at FDR ≤ 5% (FDR = 4.5%).
“A one-sided test of enrichment for these “most represented” genes showed a non-significant trend towards enrichment (p = 0.061), with one gene from the signature significant in the CMC DLPFC data at FDR ≤ 5% (ATRX, FDR = 4.5%).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFor isoforms, 39,414 significant trans-isoQTLs were found, covering 964 isoforms from 836 genes; 61% of these were also trans-eQTLs for the same gene.
“At the isoform level, there were 39,414 significant trans-isoQTLs, representing 964 isoforms (836 genes), of which 61% were also trans-eQTLs for the same gene.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataPermutation of disease status showed that the overlap between case-derived and control-derived eQTL was similar to that expected for two homogeneous sets of these sample sizes, providing limited evidence for condition-specific eQTL.
“However, permutation of disease status indicated that the overlaps between case-derived eQTL and control-derived eQTL were similar to the amount expected for two homogeneous sets of these sample sizes, and there was limited evidence for condition-specific eQTL.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataGene sets present in at least three or at least two rodent studies were not significant but trended toward overlap (P = 0.084 and 0.071, respectively).
“Sets of genes that appeared in 3 or more studies, or 2 or more studies, also did not reach statistical significance but did show a trend for overlap (P = 0.084 and 0.071, respectively).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAcross 1,000 case-control permutations, the mean count of significant genes at FDR ≤ 0.05 was 4.3, far lower than the 693 observed in the sample.
“Significance was also assessed by permuting case-control status for 1,000 experiments. Of these experiments, the average number of significant genes at FDR ≤ 0.05 was 4.3, well below 693 found in our sample.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataWith a nominal P ≤ 0.01 threshold, the haloperidol and clozapine signatures produced human-orthologous sets of 237 and 31 genes, respectively.
“we used a nominal P ≤ 0.01 cutoff to identify signatures for haloperidol and clozapine treatment, which resulted in human-orthologous gene sets of size 237 and 31, respectively.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn CMC eQTL data, MLH1 was the sole gene showing overlap with the SCZ association, with up-regulation predicted to be linked to genetic risk variation; this overlap fell below the genome-wide threshold (Sherlock P = 6 × 10^-5, Bonferroni corrected P = 0.69).
“In our CMC eQTL data, there is only overlap between the SCZ association and eQTLs for MLH1, with up-regulation of expression predicted to be associated with the genetic risk variation; however, this overlap is below the genome-wide threshold, Sherlock P = 6 × 10−5, Bonferroni corrected P = 0.69.”
Quote in the paperNot a substantial claim- The authors state this as an assumption: When a risk gene's expression is altered by genetic variation, the same SNPs should show genetic association with disease.
- The authors state this as an assumption: If a gene's expression changes mediate disease risk, then its cis- and trans-eQTLs should also associate with the disease.
- Rests on an assumption: For most SNPs without clear schizophrenia association, selecting the major or minor allele is essentially random and unbiased.
May combine two claims.
Findingown dataIn the HBCC microarray DLPFC cohort, 2,288 genes were differentially expressed at FDR 5% between SCZ cases and controls, with 1,166 up-regulated and 1,122 down-regulated in SCZ.
“identified 2,288 differentially expressed genes at FDR 5%, among which 1,166 and 1,122 were up-regulated and down-regulated in SCZ, respectively.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAmong isoQTLs, 58% were cis-eQTLs for the parent gene at FDR ≤ 5%; among cis-eQTLs for genes with at least one represented isoform, 71% were isoQTLs at FDR ≤ 5%.
“IsoQTLs and gene-level eQTLs overlapped substantially; 58% of isoQTLs were cis-eQTLs for the parent gene at FDR ≤ 5%; conversely, 71% of cis-eQTLs for genes with at least one represented isoform were isoQTLs at FDR ≤ 5%.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe haloperidol signature showed significant enrichment in the CMC SCZ differential expression test (P = 1 × 10−9), but the clozapine signature did not (P = 0.29).
“Significant enrichment was observed (Supplementary Table 2A) for the haloperidol signatures, but not the clozapine signature (P = 1 × 10−9 and 0.29, respectively).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenIn CMC, 26% of schizophrenia cases and controls come from Pitt.
“while Pitt samples compose 26% of all SCZ cases and controls in CMC”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataA total of 3,355,111 cis-isoQTLs reached FDR ≤ 5%, covering 27,691 isoforms from 10,779 genes.
“Using similar techniques to derive isoform expression quantitative trait loci (isoQTLs), we identified 3,355,111 significant cis-isoQTLs at FDR ≤ 5%, representing 27,691 isoforms of 10,779 genes.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFor de novo mutations, after restricting to DLPFC expression, 103 loss-of-function mutations fell in 101 genes and 638 nonsynonymous mutations in 605 genes.
“Conditioning on DLPFC expression, there were 103 loss-of-function mutations in 101 genes, and a total of 638 nonsynonymous mutations across 605 genes.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFor 9 of the 13 genes tested, the Pearson correlation between qPCR expression ratios and voom-normalized log(CPM) levels in the same subjects exceeded 0.5; for 3 additional genes it was between 0.1 and 0.3, and for one gene (HIVEP2) it was negative.
“The Pearson correlation between these expression ratios and the voom-normalized log(CPM) levels for the same subjects was greater than 0.5 for 9 of the 13 genes (Supplementary Fig. 3A); for an additional 3 genes, it was between 0.1 and 0.3, and only for one gene (HIVEP2) was the correlation negative.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe mRIN statistic distribution is centered near zero and has no extreme negative values.
“The distribution is centered near zero and has no extreme negative values.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTwenty-one genes occurred in at least four rodent signatures; orthologs for 16 were present in the normalized data, and 8 had concordant direction across all four studies.
“we identified a set of 21 genes that appeared in 4 or more of the gene signatures; 16 of these genes were represented by orthologs in our normalized data, and 8 showed concordant direction in all 4 studies.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataRodent drug datasets showed some overlap between drug-affected genes and disease-associated genes, but the directions of effect were opposite.
“Using the independent rodent datasets, we found overall similar results as that in the monkeys, with some overlaps of genes impacted by drugs and associated with disease, but with opposite directions of effect on gene expression.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataAmong CMC samples aged 20-60, 63% originated from Pitt.
“63% of the aged 20–60 CMC samples are from Pitt”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataCuration produced 2,902 gene sets: 1,938 GO, 824 Reactome, and 140 gene-family sets.
“This procedure yielded 2,902 gene sets in total: 1,938 sets from GO, 824 from Reactome, and 140 gene families.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationMore than one hundred common genetic variants have been conclusively linked to schizophrenia risk.
“including rare copy number variants2 and >100 common variants3.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014). source
Not checked in the free run.
May combine two claims.
PremisereasoningFindings from prior schizophrenia expression studies are frequently inconsistent and rarely replicated.
“Results are often inconsistent and there are few replicated findings.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationOver fifty schizophrenia case-control expression studies have been published, often using overlapping samples and mostly at modest scale, with prior RNA sequencing studies examining only five to thirty-one cases.
“More than 50 gene expression studies of SCZ cases and controls have been reported, often of overlapping samples and mostly of modest scale (prior RNA sequencing studies evaluated only 5–31 cases, Supplementary data file 1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Supplementary data file 1
Not checked in the free run.
May combine two claims.
Study design and conductown dataKnown covariates including RIN, library batch, institution, diagnosis, age at death, genetic ancestry, PMI, and sex explained 0.42 of the average variance in gene expression and were used to adjust all analyses.
“Covariates for RIN, library batch, institution (brain bank), diagnosis, age of death, genetic ancestry, PMI, and sex together explained a substantial fraction (0.42) of the average variance of gene expression, and were thus employed to adjust the data for all analyses.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationCLCN3, SNAP91, and TSNARE1 are direct synaptic components, while CNTN4 and FURIN function in neurodevelopment.
“CLCN3, SNAP91, and TSNARE1 are direct synaptic components, and CNTN4 and FURIN play roles in neurodevelopment.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataExperimental manipulation of three genes affected neuroanatomical and developmental attributes in model systems, making them strong candidates for further biological investigation.
“Experimental manipulation of three of these genes had an impact on neuroanatomical and developmental attributes in model systems, making these genes excellent candidates for further biological investigation.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenCases were excluded if they had neuropathology related to Alzheimer's or Parkinson's disease, acute neurological insults immediately before death, or were on ventilators near death.
“Cases were excluded if they had neuropathology related to Alzheimer’s disease and/or Parkinson’s disease, acute neurological insults (anoxia, strokes, and/or traumatic brain injury) immediately prior to death, or were on ventilators near the time of death.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataReplicable differences in gene expression in schizophrenia point to subtle but broad disruption in transcription, consistent with the polygenic nature of genetic risk.
“We also detected replicable differences in gene expression in SCZ that point to subtle but broad disruption in transcription, which is consistent with the polygenic nature of genetic risk underlying SCZ.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe M2c module of about 1,400 genes with synaptic transmission functions is enriched for differential expression, overlaps schizophrenia genetic signal, and has some genes with less dense co-expression in schizophrenia cases.
“Overall, our results point to the M2c module of ~1400 genes that possess functions related to synaptic transmission as being enriched for differential expression, overlapping SCZ genetic signal, and with some genes having less dense co-expression in SCZ cases.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductnone givenPostmortem tissue from schizophrenia and affective disorder cases was included only if it met DSM-IV diagnostic criteria, as determined by consensus conferences after reviewing medical records, clinical assessments, and family interviews.
“Postmortem tissue from schizophrenia (SCZ) and bipolar or other affective/mood disorder (AFF) cases were included if they met the appropriate diagnostic DSM-IV criteria, as determined in consensus conferences after review of medical records, direct clinical assessments, and interviews of family members or care providers.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataAge at death and cell type proportions did not explain significant differential expression.
“An assessment of the impact of age at death or cell type proportions suggests that these variables do not explain significant differential expression (Supplementary Fig. 12).”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThe differential expression observed in CMC is smaller than in earlier studies but is consistent with plausible models for average differential expression and the polygenic inheritance of schizophrenia.
“The differential expression observed here is smaller than that reported in earlier studies (Supplementary data file 1), but it is consistent with plausible models for average differential gene expression and the polygenic inheritance of SCZ (Supplementary Text, “Differential gene expression: expectation, variability, and power analyses”).”
Quote in the paperSubstantial claimMay combine two claims.
Premiseown dataIn monkey and rodent experiments, genes affected by antipsychotics often overlap with genes altered in schizophrenia, but the antipsychotic effect tends to be in the opposite direction.
“Although analyses of experiments performed using either monkeys or rodents indicate that genes whose expression are affected by antipsychotics are often the same as those we find altered in individuals with SCZ, the impact of antipsychotic drugs nevertheless tends to be significantly in the opposite direction of that observed in the SCZ subjects (Supplementary Table 2).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Supplementary Table 2
Not checked in the free run.
May combine two claims.
Interpretationown dataThe loss of M2c density replicated in the HBCC cohort, Z = −3.02 and P = 0.003, indicating that regulatory coordination of genes in this module is disrupted in schizophrenia.
“The loss of density replicates in the HBCC cohort (Z = −3.02, P = 0.003), indicating that the regulatory coordination of genes in this module is disrupted in SCZ.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe genes highlighted by the schizophrenia case-control contrast do not largely trace their differential expression to antipsychotic medications, although they suggest a mechanism for the efficacy of these drugs.
“Thus, our analyses find that genes highlighted by the contrast of SCZ cases versus control subjects do not largely trace their differential expression to antipsychotic medications, although intriguingly they do suggest a mechanism for the efficacy of these drugs46.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [46] Carboni, L. & Domenici, E. Proteome effects of antipsychotic drugs: learning from preclinical models. Proteomics Clin. Appl. 10, 430–441 (2016). source
Not checked in the free run.
May combine two claims.
InterpretationcitationFor a gene whose differential expression is mainly driven by case-control allele frequency differences at an eQTL SNP, the expected fold-change magnitude is on the order of the allele frequency differences, about 1-2%, matching the CMC data.
“For that gene, the expected magnitude of differential expression fold change will be on the order of the allele frequency differences seen in the recent large Psychiatric Genomic Consortium SCZ genetic association study (~1–2%)3, precisely what is observed in the CMC data.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataOnly karyotypically normal hiPSC lines were used in subsequent studies.
“Karyotyping analysis was performed by Wicell Cytogenetics (Madison WI); only karyotypically normal lines were used for subsequent studies.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductcitationInitial genotyping quality control removed markers with zero alternate alleles, call rate ≤ 0.98, Hardy-Weinberg P < 5 × 10−5, and individuals with genotyping call rate < 0.90.
“Initial QC was preformed using PLINK 57 to remove markers with: zero alternate alleles, genotyping call rate ≤ 0.98, Hardy-Weinberg P value < 5 × 10−5, and individuals with genotyping call rate < 0.90.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataThe hiPSC forebrain NPCs were derived from three controls selected irrespective of their genotype at FURIN-eQTL SNP rs4702; two were heterozygous G/A and one was homozygous risk G/G.
“These samples were selected irrespective of their genotypes for the FURIN-eQTL SCZ-risk variant at SNP rs4702, with two being heterozygous G/A and the third homozygous risk G/G.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataSamples with an RNA Integrity Number below 5.5 were excluded from the study.
“51 samples with RIN < 5.5 were excluded from the study”
- Also stated in: § RNA Sample QC · plain
“Samples were excluded if RIN < 5.5 or genetic information from the sample was inconsistent with subject descriptors such as sex.”
Quote in the paperNot a substantial claim- Also stated in: § RNA Sample QC · plain
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductcitationHidden covariates were derived for use in eQTL analyses and included in the normalization and adjustment steps.
“Next, hidden covariates were derived (for use in eQTL analyses only, as is common practice13). These covariates were then included for adjustment in the normalization and adjustment steps.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] Dunham, I. et al. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74 (2012). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataAncestry was inferred using clusterGem in GemTools, which found that five dimensions and seven clusters sufficiently described the ancestry space, and 667 subjects were assigned ancestry based on DNA genotypes.
“Ancestry was determined using clusterGem in GemTools (arXiv:1104.116260,61, http://www.wpic.pitt.edu/wpiccompgen/GemTools/GemTools.htm). Gemtools found that 5 dimensions and 7 clusters were sufficient to describe the ancestry space. Because one sample was missing key phenotypic information, 667 subjects were assigned ancestry based on DNA genotypes.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites arXiv:1104.116260
Not checked in the free run.
- cites [61] Luca, D. et al. On the use of general control samples for genome-wide association studies: genetic matching highlights causal variants. Am. J. Hum. Genet. 82, 453–463 (2008). source
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductnone givenFor most analyses, a linear regression of gene expression on disease status plus selected covariates was performed using weighted regression with voom confidence weights.
“For most analyses, we perform a variant of the following basic linear regression: gene expression~Dx+selected covariates where Dx is the disease status of an individual, the gene expression is given in log(CPM), and weighted regression is performed using the voom confidence weights from above.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataThe entire quality control process yielded 592 high-quality samples for analysis, comprising 258 schizophrenia cases, 279 controls, and 55 affective disorder cases.
“The entire QC process yielded 592 high-quality samples for analysis (258 SCZ, 279 control individuals, and 55 AFF [47 bipolar disorder, 6 major depressive disorder, and 2 mood disorder, unspecified])”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductown dataThe final covariate model included 12 sample variables (Dx, Institution, Sex, AOD, PMI, RIN, RIN2, and 5 ancestry vectors) and 1 experiment variable (clustered LIB), accounted for 23 df, and had an average r2 of 0.42.
“The final model, which we call “the covariate model”, included 12 sample variables (Dx [3], Institution [3], Sex [2], AOD, PMI, RIN, RIN2, and 5 ancestry vectors) and 1 experiment variable (clustered LIB [9]), where the number of levels for factor variables is noted here in square brackets. Counting the intercept term, this model accounted for 23 df and yielded an average r2 of 0.42”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductown dataFURIN knockdown was validated by qPCR.
“FURIN knockdown was validated by qPCR using TaqMan® RNA-to-Ct™ 1-Step Kit (ThermoFisher Scientific – 4392938).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataRNA-seq outliers were detected by two independent groups, and 10 samples identified as outliers by both groups were eliminated from all subsequent analyses.
“In total, 10 samples were identified as outliers by both groups and these were eliminated from all subsequent analyses.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S1 (asserted), S4 (based). May combine two claims.
Study design and conductown dataDNA and RNA data were verified to come from a single individual by comparing SNP calls from RNA-seq and genotyping arrays; this process identified one sample mix-up and three contaminated samples, which were removed.
“We ensured DNA and RNA data were from a single individual by making SNP calls from RNA-seq results using samtools and bcftools 0.1.19, using the author-recommended protocol, which includes the “Bayesian inference” option.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductown dataHBCC eQTL were generated using 279 genetically-inferred Caucasian samples (76 controls, 72 SCZ, 43 BP, 88 MDD) in a manner analogous to CMC, adjusting for diagnosis and 5 ancestry components.
“Next, eQTL were generated using N = 279 genetically-inferred Caucasian samples (76 controls, 72 SCZ, 43 BP, 88 MDD) in an analogous manner to CMC, adjusting for diagnosis and 5 ancestry components.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductown dataGenes were filtered to retain 16,423 genes with at least 1 CPM in at least 50% of individuals for all subsequent analyses.
“we filtered out all genes with lower expression in a substantial fraction of the cohort, with 16,423 genes remaining with at least 1 CPM in at least 50% of the individuals; note that only these genes were carried forward into all subsequent analyses.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductown dataThe order of extraction for schizophrenia-affected and control samples was randomized with respect to brain bank, diagnosis, and all other sample characteristics, and Pitt matched pairs were processed in the same batch.
“The order of extraction for SCZ-affected and control samples was assigned randomly with respect to brain bank, diagnosis, and all other sample characteristics.”
- Also stated in: § Tissue, RNA and DNA preparation · plain
“Samples were processed in batches of 12, and the Pitt matched case/control pairs were always processed in the same batch.”
Quote in the paperSubstantial claim- Also stated in: § Tissue, RNA and DNA preparation · plain
Classified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenPitt specimens were provided as matched case-control pairs, perfectly matched for sex and as closely as possible for age and race, and members of a pair were always processed together for RNA-seq.
“Specimens from Pitt were provided as matched case/control pairs. These were perfectly matched for sex, and as closely as possible for age (73% of pairs were matched within 5 years, and 95% within 10 years) and race (71% of pairs were matched for race). Members of a pair were always processed together for RNA-seq.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductnone givenPenn diagnoses were made using DSM-IV criteria through clinical interview by a psychiatrist and review of medical records.
“Disease diagnoses were made based on DSM-IV criteria and obtained through a clinical interview by psychiatrist and review of medical records.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationown dataThe Allen Human Brain Atlas ISH data suggest that genes identified by differential expression analysis display various degrees of cell-type specificity.
“The data suggest that genes identified by DE analysis display various degrees of cell-type specificity.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenAll zebrafish experiments were replicated twice and aggregate data were compiled.
“All experiments were replicated twice and aggregate data was compiled.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductreasoningTo avoid population stratification, the first 500 ROS/MAP subjects were randomly selected from self-reported white, non-Hispanic subjects with genome-wide genotype data confirming that ancestry.
“To avoid population stratification artifacts in the genetic analyses, the first 500 subjects were randomly selected from among those subjects that are self-reported to be of white, non-Hispanic ancestry, and have genome-wide genotype data (N = 1,709 for the entire ROS and MAP studies) that confirm this self-reported ancestry.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningThe gender-neutral model for X chromosome SNPs was appropriate because gene expression had already been adjusted for gender.
“The regression modeling was performed for SNPs on the X chromosome in the same manner as for those on the autosomes (i.e., with a dosage scaling between 0 and 2 for both males and females); this gender-neutral model was appropriate here since the gene expression was already adjusted for gender.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataTechnical validation compared RNA-seq results to qPCR for 13 genes previously reported to be altered in the same brain region in 57 schizophrenia cases and 57 matched controls from the Pitt cohort.
“For a selected set of 13 genes that had been previously reported to be altered in this same brain region in 57 SCZ cases relative to 57 matched controls among the Pitt cohort (Supplementary Fig. 3), we compared results from RNA-seq to that of qPCR when these quantifications are taken from different tissue samples, although they were taken from the same subject and roughly the same brain region.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenProcessing order was re-randomized before ribosomal RNA depletion, and samples were processed in batches of eight.
“Processing order was re-randomized prior to ribosomal RNA (rRNA) depletion, and samples were processed in batches of 8.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataFor 85% of analyzed isoforms, the correlation across samples between unique reads per isoform and isoform-level CPM was above 0.2.
“For 85% of the analyzed isoforms, the correlation across samples between the number of unique reads per isoform, arguably, the most direct measure of relative isoform abundance from RNA-seq, and the isoform-level CPM was above 0.2.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenPitt case-control pairs were batched together in each processing step, including Ribo-Zero depletion, library preparation, and sequencing lane.
“The Pitt case/control pairs were batched together in each processing step, including Ribo-Zero depletion, sequence library preparation, and sequencing lane.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenNPC experiments used passage-matched populations between passages 9 and 12.
“NPC experiments were conducted on passage-matched populations, between passages 9 and 12.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductown dataCross-validation randomly split the full cohort into an 80% discovery and 20% replication cohort with equal proportions of SCZ cases and controls, repeated 20 times.
“We performed cross-validation of the differential expression by randomly splitting the full cohort into an 80% “discovery” cohort and 20% “replication” cohort (with equal proportions of SCZ cases and controls into the two parts of the split). This splitting process was repeated 20 times.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataSamples were retained for downstream analysis only if they had at least 50 million mapped reads and less than 5% rRNA-aligned reads; 15 samples failed these criteria and were discarded.
“Samples with a minimum of 50 million mapped reads (~25 million paired end reads) and less than 5% rRNA-aligned reads were retained for downstream analysis.”
- Also stated in: § RNA Library Preparation and Sequencing · plain
“In the end, a total of 15 samples did not meet these sequencing criteria (see “Sample QC” below) and were discarded.”
Quote in the paperNot a substantial claim- Also stated in: § RNA Library Preparation and Sequencing · plain
May combine two claims.
Premisenone givenThe CMC eQTL data are substantially larger than existing brain eQTL datasets, which were more limited in power for eQTL discovery.
“Then, because the data herein are substantially larger than existing brain eQTL datasets that were therefore more limited in power for eQTL discovery, we focused on testing the sensitivity of our eQTL towards recapitulating publicly available eQTL.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataThree case samples with leukotomies or a history of head injury prior to diagnosis were included, and they were not outliers on any metrics used to evaluate the samples.
“Three case samples (2 with leukotomies, and 1 with a history of a head injury prior to diagnosis) were included; these were not outliers on any metrics that we used to evaluate our samples”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductown dataPEER was applied to ROS/MAP gene expression data to account for non-genetic factors such as batch effects, age, gender, and technical artifacts.
“To account for non-genetic factors such as batch effects, age, gender, and technical artifacts in the gene expression data, PEER70 was applied.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningFor most SNPs in the genome that are not clearly associated with SCZ, the choice of major or minor allele is essentially random and unbiased.
“Still, for most SNPs in the genome, those not clearly associated with SCZ, the choice of major or minor allele is essentially random and unbiased.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductreasoningThe 5 ancestry vectors were included in the eQTL model to control for ancestry differences in SNP allele frequencies.
“The 5 ancestry vectors were included instead in the eQTL model to control for ancestry differences in SNP allele frequencies.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll hiPSC and NPC lines were tested monthly with MycoAlert to ensure they remained mycoplasma free.
“All hiPSC and NPCs in the laboratory are tested monthly using MycoAlert (Lonza) to ensure they remain mycoplasma free.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductown dataBecause of module-size dependency, the authors performed 1,000 permutations of disease status and estimated module-size-dependent null distributions for binned module sizes.
“Thus, as an alternative, we performed 1,000 permutations of disease status for the final cohort analyzed for co-expression (278 control and 254 schizophrenia samples), followed by generation of gene co-expression networks and estimation of network preservation statistics.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductreasoningEnrichment analysis used a combination of gene permutation and subject permutation methods, and the results were merged.
“here we used a combination of methods and then merged the results.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductreasoningAll genetic enrichment tests were conditioned on a background set of 16,423 genes with above-threshold expression in DLPFC.
“we conditioned all enrichment tests on the background set of 16,423 genes with above-threshold expression that we had included in differential expression analysis”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenIn the mouse haloperidol experiment, all experimental procedures were randomized to minimize batch artifacts, including assignment to treatment, home cage, dissection order, RNA extraction, and assay batch.
“All experimental procedures were randomized to minimize batch artifacts, including assignment of mice to receive haloperidol (HAL) or placebo (PLA), home cage, order of dissection, RNA extraction, and assay batch.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductown dataDifferential expression and eQTL analyses in the HBCC cohort adjusted for diagnosis, age of death, sex, PMI, pH, RIN, clustered processing batch, and ancestry markers.
“The following covariates were used in the differential expression (and eQTL) analysis: Dx, Age of death, sex, PMI, pH, RIN, clustered processing batch, and ancestry markers.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationQuality control and analysis for all data types conformed to those developed in the authors' prior publications.
“Quality control and analysis for all data types conformed to those developed in our prior publications19.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] Kim, Y. et al. A meta-analysis of gene expression quantitative trait loci in brain. Transl. Psychiatry 4, e459 (2014). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataFor co-expression analysis, 5 outlier samples were removed, leaving a final cohort of 278 control samples and 254 schizophrenia cases.
“we first removed 5 samples as outliers based on IAC analysis, specifically those more than 4 standard deviations from the mean), leaving a final cohort for co-expression analysis consisting of 278 control samples and 254 cases with schizophrenia.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationRare copy number variants and more than 100 common variants have been conclusively identified as genetic risk factors for schizophrenia.
“only recently have specific genetic risk factors been conclusively identified, including rare copy number variants2 and >100 common variants3”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [2] Kirov, G. CNVs in neuropsychiatric disorders. Hum. Mol. Genet. 24, R45–R49 (2015). source
Not checked in the free run.
- cites [3] Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014). source
Not checked in the free run.
May combine two claims.
PremisereasoningResults of prior gene expression studies are often inconsistent and few findings have been replicated.
“Results are often inconsistent and there are few replicated findings.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAvailable data implicate synaptic components, including calcium channel subunits and post-synaptic elements, in schizophrenia.
“The available data are incomplete but implicate synaptic components, including calcium channel subunits and post-synaptic elements5–7.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [5] Purcell, S.M. et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506, 185–190 (2014). source
Not checked in the free run.
- cites [6] Walsh, T. et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320, 539–543 (2008). source
Not checked in the free run.
- cites [7] Fromer, M. et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 506, 179–184 (2014). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenFifty-five cases with affective disorder were included to increase power to detect eQTLs.
“Fifty-five cases with affective disorder were included to increase power to detect eQTLs.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataThe median number of paired-end reads per sample was 41.6 million, with low numbers of rRNA reads.
“The median number of paired end reads per sample was 41.6 million, with low numbers of rRNA reads (Supplementary Fig. 2).”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataCovariates for RIN, library batch, institution, diagnosis, age of death, genetic ancestry, PMI, and sex explained 0.42 of the average variance of gene expression and were used to adjust the data.
“Covariates for RIN, library batch, institution (brain bank), diagnosis, age of death, genetic ancestry, PMI, and sex together explained a substantial fraction (0.42) of the average variance of gene expression, and were thus employed to adjust the data for all analyses.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductown dataMultiple randomization steps and centralized DNA and RNA isolation and library preparation were used to control batch effects.
“To control for batch effects, multiple randomization steps were introduced and DNA and RNA isolation and library preparation were performed at one site (Supplementary Fig. 1A).”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMore than 50 gene expression studies of schizophrenia cases and controls have been reported, often with overlapping samples and mostly modest scale; prior RNA sequencing studies evaluated only 5-31 cases.
“More than 50 gene expression studies of SCZ cases and controls have been reported, often of overlapping samples and mostly of modest scale (prior RNA sequencing studies evaluated only 5–31 cases, Supplementary data file 1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Supplementary data file 1
Not checked in the free run.
May combine two claims.
PremisecitationCLCN3, SNAP91, and TSNARE1 are direct synaptic components, and CNTN4 and FURIN play roles in neurodevelopment.
“CLCN3, SNAP91, and TSNARE1 are direct synaptic components, and CNTN4 and FURIN play roles in neurodevelopment.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [27] Guzman, R.E., Alekov, A.K., Filippov, M., Hegermann, J. & Fahlke, C. Involvement of ClC-3 chloride/proton exchangers in controlling glutamatergic synaptic strength in cultured hippocampal neurons. Front. Cell. Neurosci. 8, 143 (2014). source
Not checked in the free run.
- cites [28] Shimoda, Y. & Watanabe, K. Contactins: emerging key roles in the development and function of the nervous system. Cell Adh Migr 3, 64–70 (2009). source
Not checked in the free run.
- cites [29] Kaneko-Goto, T., Yoshihara, S., Miyazaki, H. & Yoshihara, Y. BIG-2 mediates olfactory axon convergence to target glomeruli. Neuron 57, 834–846 (2008). source
Not checked in the free run.
May combine two claims.
InterpretationcitationFor a gene whose differential expression is mainly determined by case-control allele frequency difference at an eQTL SNP, the expected fold change is on the order of the allele frequency differences (~1-2%), matching the CommonMind Consortium data.
“For that gene, the expected magnitude of differential expression fold change will be on the order of the allele frequency differences seen in the recent large Psychiatric Genomic Consortium SCZ genetic association study (~1–2%)3, precisely what is observed in the CMC data.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIGF2 can rescue neurogenesis and cognitive deficits in certain mouse models of schizophrenia.
“can rescue neurogenesis and cognitive deficits in certain mouse models of schizophrenia44”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [44] Ouchi, Y. et al. Reduced adult hippocampal neurogenesis and working memory deficits in the Dgcr8-deficient mouse model of 22q11.2 deletion-associated schizophrenia can be rescued by IGF2. J. Neurosci. 33, 9408–9419 (2013). source
Not checked in the free run.
May combine two claims.
Interpretationown dataOverall results point to the M2c module of about 1,400 genes with synaptic transmission functions being enriched for differential expression, overlapping schizophrenia genetic signal, and with some genes having less dense co-expression in schizophrenia cases.
“Overall, our results point to the M2c module of ~1400 genes that possess functions related to synaptic transmission as being enriched for differential expression, overlapping SCZ genetic signal, and with some genes having less dense co-expression in SCZ cases.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThe differential expression observed is smaller than earlier studies but consistent with plausible models for average differential gene expression and polygenic inheritance of schizophrenia.
“The differential expression observed here is smaller than that reported in earlier studies (Supplementary data file 1), but it is consistent with plausible models for average differential gene expression and the polygenic inheritance of SCZ”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataDetected replicable differences in gene expression in schizophrenia point to subtle but broad disruption in transcription, consistent with the polygenic nature of genetic risk underlying schizophrenia.
“We also detected replicable differences in gene expression in SCZ that point to subtle but broad disruption in transcription, which is consistent with the polygenic nature of genetic risk underlying SCZ.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataExperimental manipulation of three of the single-gene loci genes had an impact on neuroanatomical and developmental attributes in model systems, making these genes excellent candidates for further biological investigation.
“Experimental manipulation of three of these genes had an impact on neuroanatomical and developmental attributes in model systems, making these genes excellent candidates for further biological investigation.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe order of extraction for schizophrenia-affected and control samples was randomized with respect to brain bank, diagnosis, and other sample characteristics.
“The order of extraction for SCZ-affected and control samples was assigned randomly with respect to brain bank, diagnosis, and all other sample characteristics.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataPitt matched case-control pairs were always processed in the same RNA extraction batch.
“Samples were processed in batches of 12, and the Pitt matched case/control pairs were always processed in the same batch.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Interpretationown dataIn situ hybridization data suggest that genes identified by differential expression analysis display various degrees of cell-type specificity, which could affect estimated fold changes.
“Available in situ hybridization data from DLPFC suggest that genes identified by DE analysis display various degrees of cell-type specificity, which could affect the estimated fold changes (Supplementary Fig. 10).”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataThe analyses find that genes highlighted by the schizophrenia case-control contrast do not largely trace their differential expression to antipsychotic medications, although they suggest a mechanism for the efficacy of these drugs.
“Thus, our analyses find that genes highlighted by the contrast of SCZ cases versus control subjects do not largely trace their differential expression to antipsychotic medications, although intriguingly they do suggest a mechanism for the efficacy of these drugs46.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [46] Carboni, L. & Domenici, E. Proteome effects of antipsychotic drugs: learning from preclinical models. Proteomics Clin. Appl. 10, 430–441 (2016). source
Not checked in the free run.
May combine two claims.
Interpretationown dataBody length and somitic structures were similar across embryos, suggesting the observations were unlikely due to gross developmental delay.
“Body length and somitic structures were similar across all embryos, suggesting that our observations were unlikely due to gross developmental delay.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningModeling can explain the difference between earlier studies and CommonMind Consortium results; larger differential expression in smaller earlier studies is consistent with Winner's Curse or false positives.
“Beyond case-control difference in allele frequency, our modeling can also explain the difference between earlier studies and CMC results (Supplementary Fig. 9); because earlier studies tend to be far smaller in sample size, their larger differential expression is consistent with either the well-known “Winner’s Curse”41 or false positives that may occur in smaller samples.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [41] Xiao, R. & Boehnke, M. Quantifying and correcting for the winner's curse in genetic association studies. Genet. Epidemiol. 33, 453–462 (2009). source
Not checked in the free run.
May combine two claims.
Interpretationnone givenThe dysregulation of M2c in schizophrenia is not due to medication effect or clinical and technical confounds.
“The dysregulation of M2c in SCZ is not due to medication effect or clinical and technical confounds.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningFive ancestry vectors were added to the eQTL regression to adjust for population differences in SNP allele frequencies.
“The 5 ancestry vectors were included instead in the eQTL model to control for ancestry differences in SNP allele frequencies.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenProcessing order was re-randomized before ribosomal RNA depletion.
“Processing order was re-randomized prior to ribosomal RNA (rRNA) depletion, and samples were processed in batches of 8.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataIn 85% of analyzed isoforms, the correlation across samples between unique reads per isoform and isoform-level CPM exceeded 0.2.
“For 85% of the analyzed isoforms, the correlation across samples between the number of unique reads per isoform, arguably, the most direct measure of relative isoform abundance from RNA-seq, and the isoform-level CPM was above 0.2.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductreasoningAll overlap enrichment tests used a background of 16,423 genes that passed the expression threshold.
“we conditioned all enrichment tests on the background set of 16,423 genes with above-threshold expression that we had included in differential expression analysis”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenLaboratory hiPSC and NPC cultures underwent monthly MycoAlert testing for mycoplasma.
“All hiPSC and NPCs in the laboratory are tested monthly using MycoAlert (Lonza) to ensure they remain mycoplasma free.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataRNA-seq outliers were identified by consensus between two independent analysis groups, and the 10 samples flagged by both were removed.
“The results from analysis (i) and (ii), were compared for consensus. In total, 10 samples were identified as outliers by both groups and these were eliminated from all subsequent analyses.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataThe RNA-seq versus qPCR comparison accounts for possible differences in pathological sampling of brain region and variability in RNA extraction.
“Therefore our results also account for possible differences in pathological sampling of brain region and variability in RNA extraction.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Interpretationnone givenThe CMC eQTL data are substantially larger than existing brain eQTL datasets, which were therefore more limited in power for eQTL discovery.
“Then, because the data herein are substantially larger than existing brain eQTL datasets that were therefore more limited in power for eQTL discovery, we focused on testing the sensitivity of our eQTL towards recapitulating publicly available eQTL.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationown dataThe lower correlation cannot be attributed to age alone.
“It is important to note, however, that the effect of age is not the only possible explanation for a lower correlation”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductown dataDNA and RNA data were verified to come from the same individual by comparing SNP calls from RNA-seq and genotyping.
“We ensured DNA and RNA data were from a single individual by making SNP calls from RNA-seq results using samtools and bcftools 0.1.19, using the author-recommended protocol, which includes the “Bayesian inference” option.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataFifteen samples failed the sequencing criteria and were discarded.
“In the end, a total of 15 samples did not meet these sequencing criteria (see “Sample QC” below) and were discarded.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
PremisereasoningBecause RNA-seq avoids microarray hybridization problems like background noise, it has greater dynamic range and can measure low-abundance transcripts.
“Given the broader dynamic range of RNASeq and its ability to detect low abundance transcripts – because it does not suffer from hybridization-based limitations associated with microarray such as background noise – we would expect to see large fold-changes, if they existed, even for genes displaying low expression; or expression and differential expression restricted to a specific subset of cells.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataPitt specimens were provided as matched case-control pairs, perfectly matched for sex and closely matched for age and race.
“Specimens from Pitt were provided as matched case/control pairs. These were perfectly matched for sex, and as closely as possible for age (73% of pairs were matched within 5 years, and 95% within 10 years) and race (71% of pairs were matched for race).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataThe final covariate model included 12 sample variables and 1 experiment variable, accounted for 23 degrees of freedom, and yielded an average r2 of 0.42.
“The final model, which we call “the covariate model”, included 12 sample variables (Dx [3], Institution [3], Sex [2], AOD, PMI, RIN, RIN2, and 5 ancestry vectors) and 1 experiment variable (clustered LIB [9]), where the number of levels for factor variables is noted here in square brackets. Counting the intercept term, this model accounted for 23 df and yielded an average r2 of 0.42”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenMembers of each Pitt case-control pair were always processed together for RNA-seq.
“Members of a pair were always processed together for RNA-seq.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataSubsequent studies used only hiPSC lines with normal karyotypes.
“Karyotyping analysis was performed by Wicell Cytogenetics (Madison WI); only karyotypically normal lines were used for subsequent studies.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataGenotyping plates included an internal HapMap control in two unique locations.
“Samples for genotyping were aliquoted onto 96 well plates, where each plate had an internal control from the HapMap project (NA12878 - Coriell Institute) in two unique locations.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataIn the mouse haloperidol study, randomization was used across procedures to reduce batch artifacts, covering drug assignment, home cage, dissection order, RNA extraction, and assay batch.
“All experimental procedures were randomized to minimize batch artifacts, including assignment of mice to receive haloperidol (HAL) or placebo (PLA), home cage, order of dissection, RNA extraction, and assay batch.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductown dataThe HBCC differential expression analysis adjusted for diagnosis, age at death, sex, postmortem interval, pH, RNA integrity number, processing batch, and ancestry markers.
“The following covariates were used in the differential expression (and eQTL) analysis: Dx, Age of death, sex, PMI, pH, RIN, clustered processing batch, and ancestry markers.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThe correspondence between qPCR and RNA-seq expression estimates is notable because the two methods differ and the samples were drawn independently for the two experiments.
“The correspondence between estimates is notable because of the different measurement methodologies and because, while the samples came from the same subject and brain region, they were drawn independently for the qPCR and RNA-seq experiments.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataEach zebrafish experiment was run twice, and the results were pooled.
“All experiments were replicated twice and aggregate data was compiled.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataInitial genotype quality control removed markers with zero alternate alleles, call rate at or below 0.98, Hardy-Weinberg P below 5e-5, and individuals with call rate below 0.90.
“Initial QC was preformed using PLINK 57 to remove markers with: zero alternate alleles, genotyping call rate ≤ 0.98, Hardy-Weinberg P value < 5 × 10−5, and individuals with genotyping call rate < 0.90.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningAffective disorder cases and matched controls from Pitt were randomized among the remaining schizophrenia and control samples still queued for extraction.
“Because the affective disorder cases (AFF) and matched controls from Pitt were not available until after the processing of the SCZ and controls was underway, these samples were randomized among the remaining 132 SCZ and control samples still queued for extraction at that time.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll NPC experiments used passage-matched cells at passages 9 through 12.
“NPC experiments were conducted on passage-matched populations, between passages 9 and 12.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationown dataThe haloperidol result-enrichment with opposite-direction concordance-may fit a model where antipsychotics act on these genes in a direction opposite to disease causation.
“For haloperidol, the enrichment of significance but depletion of concordance is perhaps consistent with a scenario in which such antipsychotic drugs target these genes and affect them in the opposite direction of what etiologically occurs in the course of disease (hence their efficacy).”
Quote in the paperNot a substantial claim- The authors state this as an assumption: The directional-concordance hypergeometric test assumes that drug-responsive up- and down-regulated genes were drawn at random from genes up- or down-regulated in the CMC SCZ differential expression tests.
Classified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenSamples were retained for downstream analysis only if they had at least 50 million mapped reads and less than 5% rRNA-aligned reads.
“Samples with a minimum of 50 million mapped reads (~25 million paired end reads) and less than 5% rRNA-aligned reads were retained for downstream analysis.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataOf 633 samples sent for sequencing, 15 were removed because they had fewer than 50 million total reads or more than 5% rRNA-aligned reads after two attempts.
“Of the 633 samples sent for sequencing (those with RIN ≥ 5.5), 15 samples were removed because they yielded < 50 million total reads (~25 million paired end reads) or had > 5% of reads aligning to rRNA, based on two attempts to produce quality sequence”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataGenotyping quality control removed two samples from the analysis.
“This removed 2 samples from the analysis.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductown dataAfter quality control, 668 individuals genotyped at 767,368 markers were used for imputation.
“After QC, 668 individuals genotyped at 767,368 markers were used for imputation.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenFifty-one samples with RNA integrity number below 5.5 were excluded from the study.
“51 samples with RIN < 5.5 were excluded from the study (see Sample QC below).”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenSamples were excluded if RNA integrity number was below 5.5 or if genetic information was inconsistent with subject descriptors such as sex.
“Samples were excluded if RIN < 5.5 or genetic information from the sample was inconsistent with subject descriptors such as sex.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataAfter preprocessing and quality control, the HBCC DLPFC microarray cohort contained 131 SCZ and 176 control samples.
“there remained 131 SCZ and 176 control samples”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductreasoningHBCC data were processed with a pipeline intended to match the CMC RNA-seq workflow.
“To maximize comparability with the CMC data, we designed an analysis pipeline analogous to that which we used for the CMC RNA-seq processing.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductown dataThe full quality-control process yielded 592 high-quality samples for analysis: 258 schizophrenia cases, 279 controls, and 55 affective disorder cases.
“The entire QC process yielded 592 high-quality samples for analysis (258 SCZ, 279 control individuals, and 55 AFF [47 bipolar disorder, 6 major depressive disorder, and 2 mood disorder, unspecified]), with demographic breakdown of the cases and controls as described in Supplementary Table 1.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationFor RNA-seq, GOSeq is advantageous because it models the detection bias affecting long and highly expressed transcripts.
“Compared to the hypergeometric and Fisher’s tests, GOSeq has an advantage for RNA-seq data in that it explicitly accounts for the detection bias of long and highly expressed transcripts.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [111] Young, M.D., Wakefield, M.J., Smyth, G.K. & Oshlack, A. Gene ontology analysis for RNA-seq: accounting for selection bias. Genome Biol. 11, R14 (2010). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataCo-expression analysis excluded five outlier samples identified by IAC as more than four standard deviations from the mean, leaving 278 controls and 254 schizophrenia cases.
“we first removed 5 samples as outliers based on IAC analysis, specifically those more than 4 standard deviations from the mean), leaving a final cohort for co-expression analysis consisting of 278 control samples and 254 cases with schizophrenia.”
Quote in the paperNot a substantial claim
The authors state this as an assumption.
How schizophrenia-associated genetic variants confer liability is uncertain.
“yet how these variants confer liability is uncertain”
The paper relies on this without support.
Dorsolateral prefrontal cortex gene expression is a valid tissue for understanding the molecular etiology of schizophrenia.
“The roots of these deficits lie in cortical function and integration, at least in part tracing to the DLPFC.”
“Here we have used gene expression derived from this tissue to understand how genetic liability is related to the molecular etiology of SCZ.”
The paper relies on this without support.
Case-control differences in allele frequencies for schizophrenia risk variants are small.
“Yet the magnitude of differential expression will be determined largely by case-control differences in allele frequencies, which we know are small.”
The authors state this as an assumption.
When a risk gene's expression is altered by genetic variation, the same SNPs should show genetic association with disease.
“Its underlying principle is that genetic-driven changes in expression levels of risk genes (discovered as eSNPs) should ultimately also manifest as genetic association of those same SNPs with disease (GWAS SNPs).”
The authors state this as an assumption.
If a gene's expression changes mediate disease risk, then its cis- and trans-eQTLs should also associate with the disease.
“Specifically, we expect that cis-eQTL and trans-eQTL for a risk gene should be associated with disease (if risk is mediated by expression changes of that gene); note that the converse need not be true (since not all associated SNPs need be related to the function of any single disease gene).”
The paper relies on this without support.
For most SNPs without clear schizophrenia association, selecting the major or minor allele is essentially random and unbiased.
“Still, for most SNPs in the genome, those not clearly associated with SCZ, the choice of major or minor allele is essentially random and unbiased.”
The paper relies on this without support.
The CMC cases carry an aggregate common polygenic schizophrenia risk burden.
“Since the CMC cases bear an aggregate common polygenic schizophrenia risk burden, we subsequently performed an independent controls-only analysis”
The authors state this as an assumption.
The directional-concordance hypergeometric test assumes that drug-responsive up- and down-regulated genes were drawn at random from genes up- or down-regulated in the CMC SCZ differential expression tests.
“this was tested using a hypergeometric test whose null hypothesis assumes that up- and down-regulated drug-mediated genes were randomly sampled from genes either up- or down-regulated (at any P value) in the CMC SCZ differential expression tests.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Initial brain-specific functional genomics work provided greater insight but could be enhanced with larger sample sizes.
“Initial work focusing on brain-specific functional genomics has provided greater insight but could be enhanced with larger sample sizes (11, 12).”
From Comprehensive functional genomic resource and integrative model for the human brain (2018) · cites this paper as [11]
This estimate identified substantially more eQTLs and associated eGenes than previous studies, reflecting the large sample size.
“This estimate identified substantially more eQTLs and associated eGenes than previous studies, reflecting our large sample size (8, 11, 21).”
From Comprehensive functional genomic resource and integrative model for the human brain (2018) · cites this paper as [11]
The schizophrenia genes represent an increase from the 22 genes reported in an earlier QTL study and a larger number than can be linked by genomic proximity (176).
“Overall, the SCZ genes represent an increase from the 22 genes reported in an earlier QTL study and a larger number than can be linked simply by genomic proximity (176) (Fig. 6A) (11, 47).”
From Comprehensive functional genomic resource and integrative model for the human brain (2018) · cites this paper as [11]
DGE effect sizes were concordant with previous RNA-seq studies of individual disorders.
“and with previous RNA-Seq studies of individual disorders (ASD: ⍴=0.96, ref (19); SCZ ⍴=0.78, ref (2); SCZ ⍴=0.80, ref (24); BD ⍴=0.85, ref (1); Spearman ⍴ of log2FC, all P’s<10−16).”
From Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder (2018) · cites this paper as [2]
The study combined RNA-seq data from eight studies through a uniform processing pipeline, yielding 2188 samples that passed QC, from 1695 unique subjects, including 279 technical replicates.
“Data was generated across eight studies (2, 19, 20), uniformly processed, and combined through a consolidated genomic data processing pipeline ((21); Fig S1), yielding a total of 2188 samples passing quality control (QC) for this analysis, representing frontal and temporal cerebral cortex from 1695 unique subjects across the lifespan, including 279 technical replicates (Fig S2).”
From Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder (2018) · cites this paper as [2]
Previous studies identified alterations in local splicing events in ASD and in smaller cohorts in SCZ and BD.
“Previous studies have identified alterations in local splicing events in ASD (19, 30) and in smaller cohorts in SCZ (2, 24) and BD (31).”
From Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder (2018) · cites this paper as [2]
Multiple neuronal and synaptic signaling pathways have been previously demonstrated to be downregulated in a diminishing gradient across ASD, SCZ, and BD brains without clear disease-specific signals.
“Multiple neuronal and synaptic signaling pathways have been previously demonstrated to be downregulated in a diminishing gradient across ASD, SCZ, and BD brains without identification of clear disease-specific signals for these neuronal-synaptic gene sets (1, 2, 16, 19, 56, 57).”
From Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder (2018) · cites this paper as [2]
DEGs in 22q11DS were enriched for schizophrenia-associated variants, but not for DEGs found in ASD or schizophrenia postmortem brain tissue.
“We observed an enrichment for variants associated with schizophrenia, but not for DEG found in ASD or SCZ postmortem brain tissue35,36.”
From Neuronal defects in a human cellular model of 22q11.2 deletion syndrome (2020) · cites this paper as [36]
The differential expression observed in this study is smaller than that reported in earlier differential expression studies of alcoholism, but it is consistent with differential expression studies of larger sample size.
“The differential expression observed here is smaller than that reported in earlier differential expression studies of alcoholism, but it is consistent with differential expression studies of larger sample size37.”
From Analysis of whole genome-transcriptomic organization in brain to identify genes associated with alcoholism (2019) · cites this paper as [37]
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- Consistentz = -3.02reported p = .003 · recomputed p = .003
“(Z = −3.02, p = .003”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Expected count of P values below 0.05 is overstated
MinorFor 537 samples, a 0.05 chance per sample gives an expected count of 26.85, or about 27, rather than 29.
Reported 29 · recomputed 26.85
“We computed mRIN on the 537 SCZ case and control samples for 18,338 (17,527 uniquely identified) RefSeq transcripts using the mRIN package by Feng et al.”
Cites
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709 · see citing works
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206 · see citing works
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364 · see citing works
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089 · see citing works
Self-citationWGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252 · see citing works
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219 · see citing works
A global reference for human genetic variation
The 1000 Genomes Project Consortium, authors, C., Auton, A., Abecasis, G. R., Steering committee, Altshuler, D. M., Durbin, R. M., Abecasis, G. R., Bentley, D. R., Chakravarti, A., et al. (2015) · Nature · doi:10.1038/nature15393 · Cited by 18,247 · see citing works
Self-citationAn integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072 · see citing works
GSVA: gene set variation analysis for microarray and RNA-Seq data
Hänzelmann, S., Castelo, R., & Guinney, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-7 · Cited by 15,440 · see citing works
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,380 · see citing works
RNA-Seq: a revolutionary tool for transcriptomics
Wang, Z., Gerstein, M., & Snyder, M. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2484 · Cited by 13,174 · see citing works
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R., Carey, V., Bates, D., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 13,133 · see citing works
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692 · see citing works
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658 · see citing works
A scaling normalization method for differential expression analysis of RNA-seq data
Robinson, M. D., & Oshlack, A. (2010) · Genome Biology · doi:10.1186/gb-2010-11-3-r25 · Cited by 7,876 · see citing works
An integrated map of genetic variation from 1,092 human genomes
The 1000 Genomes Project Consortium (2012) · Nature · doi:10.1038/nature11632 · Cited by 7,711 · see citing works
Biological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577 · see citing works
Gene ontology analysis for RNA-seq: accounting for selection bias
Young, M. D., Wakefield, M. J., Smyth, G. K., & Oshlack, A. (2010) · Genome Biology · doi:10.1186/gb-2010-11-2-r14 · Cited by 7,107 · see citing works
Integrative analysis of 111 reference human epigenomes
Roadmap Epigenomics Consortium, Kundaje, A., Meuleman, W., Ernst, J., Bilenky, M., Yen, A., Heravi-Moussavi, A., Kheradpour, P., Zhang, Z., Wang, J., et al. (2015) · Nature · doi:10.1038/nature14248 · Cited by 6,368 · see citing works
Self-citationvoom: precision weights unlock linear model analysis tools for RNA-seq read counts
Law, C. W., Chen, Y., Shi, W., & Smyth, G. K. (2014) · Genome Biology · doi:10.1186/gb-2014-15-2-r29 · Cited by 6,155 · see citing works
A General Framework for Weighted Gene Co-Expression Network Analysis
Zhang, B., & Horvath, S. (2005) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1128 · Cited by 5,684 · see citing works
Self-citationGenome-wide atlas of gene expression in the adult mouse brain
Lein, E. S., Hawrylycz, M. J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., Boe, A. F., Boguski, M. S., Brockway, K. S., Byrnes, E. J., et al. (2007) · Nature · doi:10.1038/nature05453 · Cited by 5,572 · see citing works
Self-citationThe Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
The GTEx Consortium, Ardlie, K. G., Deluca, D. S., Segrè, A. V., Sullivan, T. J., Young, T. R., Gelfand, E. T., Trowbridge, C. A., Maller, J. B., Tukiainen, T., et al. (2015) · Science · doi:10.1126/science.1262110 · Cited by 5,062 · see citing works
Self-citationZhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875 · see citing works
Common polygenic variation contributes to risk of schizophrenia and bipolar disorder
The International Schizophrenia Consortium (2009) · Nature · doi:10.1038/nature08185 · Cited by 4,821 · see citing works
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336 · see citing works
Self-citationHierarchical Organization of Modularity in Metabolic Networks
Ravasz, E., Somera, A. L., Mongru, D. A., Oltvai, Z. N., & Barabási, A.-L. (2002) · Science · doi:10.1126/science.1073374 · Cited by 4,224 · see citing works
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
Barbie, D. A., Tamayo, P., Boehm, J. S., Kim, S. Y., Moody, S. E., Dunn, I. F., Schinzel, A. C., Sandy, P., Meylan, E., Scholl, C., et al. (2009) · Nature · doi:10.1038/nature08460 · Cited by 3,869 · see citing works
An anatomically comprehensive atlas of the adult human brain transcriptome
Hawrylycz, M. J., Lein, E. S., Guillozet-Bongaarts, A. L., Shen, E. H., Ng, L., Miller, J. A., van de Lagemaat, L. N., Smith, K. A., Ebbert, A., Riley, Z. L., et al. (2012) · Nature · doi:10.1038/nature11405 · Cited by 3,083 · see citing works
Synaptic, transcriptional and chromatin genes disrupted in autism
Study, T. D., De Rubeis, S., Autism, H. M. C. F., UK10K Consortium, The Autism Sequencing Consortium, He, X., Goldberg, A. P., Poultney, C. S., Samocha, K., Ercument Cicek, A., et al. (2014) · Nature · doi:10.1038/nature13772 · Cited by 2,746 · see citing works
Self-citationThe contribution of de novo coding mutations to autism spectrum disorder
Iossifov, I., O’Roak, B. J., Sanders, S. J., Ronemus, M., Krumm, N., Levy, D., Stessman, H. A., Witherspoon, K. T., Vives, L., Patterson, K. E., et al. (2014) · Nature · doi:10.1038/nature13908 · Cited by 2,585 · see citing works
Schizophrenia risk from complex variation of complement component 4
Sekar, A., Bialas, A. R., de Rivera, H., Davis, A., Hammond, T. R., Kamitaki, N., Tooley, K., Presumey, J., Baum, M., Van Doren, V., et al. (2016) · Nature · doi:10.1038/nature16549 · Cited by 2,394 · see citing works
Genetics of rheumatoid arthritis contributes to biology and drug discovery
the RACI consortium, Okada, Y., the GARNET consortium, Wu, D., Trynka, G., Raj, T., Terao, C., Ikari, K., Kochi, Y., Ohmura, K., et al. (2014) · Nature · doi:10.1038/nature12873 · Cited by 2,310 · see citing works
Self-citationSchizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
McGrath, J., Saha, S., Chant, D., & Welham, J. (2008) · Epidemiologic Reviews · doi:10.1093/epirev/mxn001 · Cited by 2,280 · see citing works
FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.013 · Cited by 2,072 · see citing works
The Reactome pathway knowledgebase
Croft, D., Mundo, A. F., Haw, R., Milacic, M., Weiser, J., Wu, G., Caudy, M., Garapati, P., Gillespie, M., Kamdar, M. R., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1102 · Cited by 1,889 · see citing works
Transcriptomic Analysis of Autistic Brain Reveals Convergent Molecular Pathology
Voineagu, I., Wang, X., Johnston, P., Lowe, J. K., Tian, Y., Horvath, S., Mill, J., Cantor, R. M., Blencowe, B. J., & Geschwind, D. H. (2011) · Nature · doi:10.1038/nature10110 · Cited by 1,874 · cited 1× · see citing works
“440 441 Consistent with prior studies of the brain transcriptome (27, 67-70), we find gene co442 expression to be organized into modules of distinct cellular and functional categories (data file 443 7).”
A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen
Moffat, J., Grueneberg, D. A., Yang, X., Kim, S. Y., Kloepfer, A. M., Hinkle, G., Piqani, B., Eisenhaure, T., Luo, B., Grenier, J. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.040 · Cited by 1,803 · see citing works
Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia
Walsh, T., McClellan, J. M., McCarthy, S. E., Addington, A. M., Pierce, S. B., Cooper, G. M., Nord, A. S., Kusenda, M., Malhotra, D., Bhandari, A., et al. (2008) · Science · doi:10.1126/science.1155174 · Cited by 1,800 · see citing works
Fast and accurate genotype imputation in genome-wide association studies through pre-phasing
Howie, B., Fuchsberger, C., Stephens, M., Marchini, J., & Abecasis, G. R. (2012) · Nature Genetics · doi:10.1038/ng.2354 · Cited by 1,737 · see citing works
Matrix eQTL: ultra fast eQTL analysis via large matrix operations
Shabalin, A. A. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts163 · Cited by 1,694 · see citing works
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657 · see citing works
Self-citationDecreased Dendritic Spine Density on Prefrontal Cortical Pyramidal Neurons in Schizophrenia
Glantz, L. A., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.65 · Cited by 1,636 · see citing works
Self-citationDe novo mutations in schizophrenia implicate synaptic networks
Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., Gormley, P., Georgieva, L., Rees, E., Palta, P., Ruderfer, D. M., et al. (2014) · Nature · doi:10.1038/nature12929 · Cited by 1,617 · see citing works
Self-citationDiagnostic exome sequencing in persons with severe intellectual disability
de Ligt, J., Willemsen, M. H., van Bon, B. W. M., Kleefstra, T., Yntema, H. G., Kroes, T., Vulto-van Silfhout, A. T., Koolen, D. A., de Vries, P., Gilissen, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206524 · Cited by 1,546 · see citing works
Genome-wide association analysis identifies 13 new risk loci for schizophrenia
Multicenter Genetic Studies of Schizophrenia Consortium, Ripke, S., Psychosis Endophenotypes International Consortium, Wellcome Trust Case Control Consortium 2, O'Dushlaine, C., Chambert, K., Moran, J. L., Kähler, A. K., Akterin, S., Bergen, S. E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2742 · Cited by 1,496 · see citing works
Self-citationAutism genome-wide copy number variation reveals ubiquitin and neuronal genes
Glessner, J. T., Wang, K., Cai, G., Korvatska, O., Kim, C. E., Wood, S., Zhang, H., Estes, A., Brune, C. W., Bradfield, J. P., et al. (2009) · Nature · doi:10.1038/nature07953 · Cited by 1,421 · see citing works
Self-citationA polygenic burden of rare disruptive mutations in schizophrenia
Purcell, S. M., Moran, J. L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P., O’Dushlaine, C., Chambert, K., Bergen, S. E., Kähler, A., et al. (2014) · Nature · doi:10.1038/nature12975 · Cited by 1,385 · see citing works
Self-citationModelling schizophrenia using human induced pluripotent stem cells
Brennand, K. J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., Li, Y., Mu, Y., Chen, G., Yu, D., et al. (2011) · Nature · doi:10.1038/nature09915 · Cited by 1,375 · see citing works
Self-citationAnalysis and design of RNA sequencing experiments for identifying isoform regulation
Katz, Y., Wang, E. T., Airoldi, E. M., & Burge, C. B. (2010) · Nature Methods · doi:10.1038/nmeth.1528 · Cited by 1,353 · see citing works
Transcriptional landscape of the prenatal human brain
Miller, J. A., Ding, S.-L., Sunkin, S. M., Smith, K. A., Ng, L., Szafer, A., Ebbert, A., Riley, Z. L., Royall, J. J., Aiona, K., et al. (2014) · Nature · doi:10.1038/nature13185 · Cited by 1,325 · see citing works
The Reactome pathway Knowledgebase
Fabregat, A., Sidiropoulos, K., Garapati, P., Gillespie, M., Hausmann, K., Haw, R., Jassal, B., Jupe, S., Korninger, F., McKay, S., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1351 · Cited by 1,201 · see citing works
Stegle, O., Parts, L., Piipari, M., Winn, J., & Durbin, R. (2012) · Nature Protocols · doi:10.1038/nprot.2011.457 · Cited by 1,049 · see citing works
Rauch, A., Wieczorek, D., Graf, E., Wieland, T., Endele, S., Schwarzmayr, T., Albrecht, B., Bartholdi, D., Beygo, J., Di Donato, N., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61480-9 · Cited by 1,041 · see citing works
Is My Network Module Preserved and Reproducible?
Langfelder, P., Luo, R., Oldham, M. C., & Horvath, S. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1001057 · Cited by 1,012 · see citing works
Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci
De Jager, P. L., Srivastava, G., Lunnon, K., Burgess, J., Schalkwyk, L. C., Yu, L., Eaton, M. L., Keenan, B. T., Ernst, J., McCabe, C., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3786 · Cited by 956 · see citing works
Self-citationRNA-SeQC: RNA-seq metrics for quality control and process optimization
DeLuca, D. S., Levin, J. Z., Sivachenko, A., Fennell, T., Nazaire, M.-D., Williams, C., Reich, M., Winckler, W., & Getz, G. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts196 · Cited by 899 · see citing works
Kirov, G., Pocklington, A. J., Holmans, P., Ivanov, D., Ikeda, M., Ruderfer, D., Moran, J., Chambert, K., Toncheva, D., Georgieva, L., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.154 · Cited by 844 · see citing works
Self-citationAnalyzing gene expression data in terms of gene sets: methodological issues
Goeman, J. J., & Bühlmann, P. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm051 · Cited by 795 · see citing works
Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain
Gibbs, J. R., van der Brug, M. P., Hernandez, D. G., Traynor, B. J., Nalls, M. A., Lai, S.-L., Arepalli, S., Dillman, A., Rafferty, I. P., Troncoso, J., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000952 · Cited by 769 · see citing works
A decrease of reelin expression as a putative vulnerability factor in schizophrenia
Impagnatiello, F., Guidotti, A. R., Pesold, C., Dwivedi, Y., Caruncho, H. J., Pisu, M. G., Uzunov, D. P., Smalheiser, N. R., Davis, J. M., Pandey, G. N., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15718 · Cited by 753 · see citing works
Functional organization of the transcriptome in human brain
Oldham, M. C., Konopka, G., Iwamoto, K., Langfelder, P., Kato, T., Horvath, S., & Geschwind, D. H. (2008) · Nature Neuroscience · doi:10.1038/nn.2207 · Cited by 752 · cited 1× · see citing works
“440 441 Consistent with prior studies of the brain transcriptome (27, 67-70), we find gene co442 expression to be organized into modules of distinct cellular and functional categories (data file 443 7).”
The correlation between relatives on the supposition of mendelian inheritance
Kempthorne, O. (1968) · Europe PMC (PubMed Central) · Cited by 715 · see citing works
Microduplications of 16p11.2 are associated with schizophrenia
Wellcome Trust Case Control Consortium, McCarthy, S. E., Makarov, V., Kirov, G., Addington, A. M., McClellan, J., Yoon, S., Perkins, D. O., Dickel, D. E., Kusenda, M., et al. (2009) · Nature Genetics · doi:10.1038/ng.474 · Cited by 711 · see citing works
Self-citationVolk, D. W., Austin, M. C., Pierri, J. N., Sampson, A. R., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.3.237 · Cited by 697 · see citing works
Self-citationTemporal dynamics and genetic control of transcription in the human prefrontal cortex
Colantuoni, C., Lipska, B. K., Ye, T., Hyde, T. M., Tao, R., Leek, J. T., Colantuoni, E. A., Elkahloun, A. G., Herman, M. M., Weinberger, D. R., et al. (2011) · Nature · doi:10.1038/nature10524 · Cited by 685 · see citing works
Self-citationGenetic variability in the regulation of gene expression in ten regions of the human brain
UK Brain Expression Consortium, Ramasamy, A., North American Brain Expression Consortium, Trabzuni, D., Guelfi, S., Varghese, V., Smith, C., Walker, R., De, T., Coin, L., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3801 · Cited by 644 · see citing works
A polygenic theory of schizophrenia.
Gottesman, I. I., & Shields, J. (1967) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.58.1.199 · Cited by 636 · see citing works
Inferring Pathway Activity toward Precise Disease Classification
Lee, E., Chuang, H., Kim, J., Ideker, T. E., & Lee, D. (2008) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000217 · Cited by 601 · see citing works
A General Approach for Haplotype Phasing across the Full Spectrum of Relatedness
O'Connell, J., Gurdasani, D., Delaneau, O., Pirastu, N., Ulivi, S., Cocca, M., Traglia, M., Huang, J., Huffman, J. E., Rudan, I., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004234 · Cited by 593 · see citing works
Chromatin marks identify critical cell types for fine mapping complex trait variants
Trynka, G., Sandor, C., Han, B., Xu, H., Stranger, B. E., Liu, X. S., & Raychaudhuri, S. (2013) · Nature Genetics · doi:10.1038/ng.2504 · Cited by 580 · see citing works
A Mammalian Organelle Map by Protein Correlation Profiling
Foster, L. J., de Hoog, C. L., Zhang, Y., Zhang, Y., Xie, X. S., Mootha, V. K., & Mann, M. (2006) · Cell · doi:10.1016/j.cell.2006.03.022 · Cited by 573 · see citing works
Conservation and evolution of gene coexpression networks in human and chimpanzee brains
Oldham, M. C., Horvath, S., & Geschwind, D. H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605938103 · Cited by 566 · see citing works
Gulsuner, S., Walsh, T., Watts, A. C., Lee, M. K., Thornton, A. M., Casadei, S., Rippey, C., Shahin, H., Braff, D., Cadenhead, K. S., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.049 · Cited by 536 · see citing works
Self-citationHigh-Resolution Mapping of Expression-QTLs Yields Insight into Human Gene Regulation
Veyrieras, J.-B., Kudaravalli, S., Kim, S. Y., Dermitzakis, E. T., Gilad, Y., Stephens, M., & Pritchard, J. K. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000214 · Cited by 536 · see citing works
Molecular taxonomy of major neuronal classes in the adult mouse forebrain
Sugino, K., Hempel, C. M., Miller, M. N., Hattox, A. M., Shapiro, P., Wu, C., Huang, Z. J., & Nelson, S. B. (2006) · Nature Neuroscience · doi:10.1038/nn1618 · Cited by 521 · see citing works
Cognitive Impairment in Schizophrenia
Keefe, R. S. E., & Harvey, P. D. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25758-2_2 · Cited by 497 · see citing works
Genenames.org: the HGNC resources in 2015
Gray, K. A., Yates, B., Seal, R. L., Wright, M. W., & Bruford, E. A. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1071 · Cited by 493 · see citing works
Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways
Miller, J. A., Horvath, S., & Geschwind, D. H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914257107 · Cited by 480 · see citing works
Jiang, Y.-H., Yuen, R. K. C., Jin, X., Wang, M., Chen, N., Wu, X., Ju, J., Mei, J., Shi, Y., He, M., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.06.012 · Cited by 474 · see citing works
400: A Method for Combining Non-Independent, One-Sided Tests of Significance
Brown, M. B. (1975) · Biometrics · doi:10.2307/2529826 · Cited by 473 · see citing works
De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia
Xu, B., Ionita-Laza, I., Roos, J. L., Boone, B., Woodrick, S., Sun, Y., Levy, S., Gogos, J. A., & Karayiorgou, M. (2012) · Nature Genetics · doi:10.1038/ng.2446 · Cited by 442 · see citing works
De Novo Mutations in Synaptic Transmission Genes Including DNM1 Cause Epileptic Encephalopathies
Appenzeller, S., Balling, R., Barisic, N., Baulac, S., Caglayan, H., Craiu, D., De Jonghe, P., Depienne, C., Dimova, P., Djémié, T., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.08.013 · Cited by 439 · see citing works
Increased exonic de novo mutation rate in individuals with schizophrenia
Girard, S. L., Gauthier, J., Noreau, A., Xiong, L., Zhou, S., Jouan, L., Dionne-Laporte, A., Spiegelman, D., Henrion, E., Diallo, O., et al. (2011) · Nature Genetics · doi:10.1038/ng.886 · Cited by 438 · see citing works
Pathway level analysis of gene expression using singular value decomposition
Tomfohr, J. K., Lü, J., & Kepler, T. B. (2005) · BMC Bioinformatics · doi:10.1186/1471-2105-6-225 · Cited by 421 · see citing works
De Novo Mutations in Moderate or Severe Intellectual Disability
Hamdan, F. F., Srour, M., Capo-Chichi, J.-M., Daoud, H., Nassif, C., Patry, L., Massicotte, C., Ambalavanan, A., Spiegelman, D., Diallo, O., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004772 · Cited by 419 · see citing works
KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant
Golzio, C., Willer, J., Talkowski, M. E., Oh, E. C., Taniguchi, Y., Jacquemont, S., Reymond, A., Sun, M., Sawa, A., Gusella, J. F., et al. (2012) · Nature · doi:10.1038/nature11091 · Cited by 410 · see citing works
Self-citationThe Penetrance of Copy Number Variations for Schizophrenia and Developmental Delay
Kirov, G., Rees, E., Walters, J. T. R., Escott-Price, V., Georgieva, L., Richards, A. L., Chambert, K. D., Davies, G., Legge, S. E., Moran, J. L., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.07.022 · Cited by 368 · see citing works
Heritability and genomics of gene expression in peripheral blood
Wright, F. A., Sullivan, P. F., Brooks, A. I., Zou, F., Sun, W., Xia, K., Madar, V., Jansen, R., Chung, W., Zhou, Y.-H., et al. (2014) · Nature Genetics · doi:10.1038/ng.2951 · Cited by 362 · see citing works
Self-citationMcCarthy, S. E., Gillis, J., Kramer, M., Lihm, J., Yoon, S. C., Berstein, Y., Mistry, M., Pavlidis, P., Solomon, R., Ghiban, E., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.29 · Cited by 332 · see citing works
Delaloy, C., Liu, L., Lee, J.-A., Su, H., Shen, F., Yang, G.-Y., Young, W. L., Ivey, K. N., & Gao, F.-B. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.02.015 · Cited by 280 · see citing works
Statistical Methods for Identifying Differentially Expressed Genes in DNA Microarrays
Storey, J. D., & Tibshirani, R. J. (2003) · Humana Press eBooks · doi:10.1385/1-59259-364-x:149 · Cited by 253 · see citing works
A Role for Noncoding Variation in Schizophrenia
Roussos, P., Mitchell, A. C., Voloudakis, G., Fullard, J. F., Pothula, V. M., Tsang, J., Stahl, E. A., Georgakopoulos, A., Ruderfer, D. M., Charney, A., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.015 · Cited by 251 · see citing works
Self-citationSherlock: Detecting Gene-Disease Associations by Matching Patterns of Expression QTL and GWAS
He, X., Fuller, C. K., Song, Y., Meng, Q., Zhang, B., Yang, X., & Li, H. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.03.022 · Cited by 241 · see citing works
Self-citationINRICH: interval-based enrichment analysis for genome-wide association studies
Lee, P. H., O'Dushlaine, C., Thomas, B., & Purcell, S. M. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts191 · Cited by 238 · see citing works
Self-citationOptimizing the noise versus bias trade-off for Illumina Whole Genome Expression Beadchips
Shi, W., Oshlack, A., & Smyth, G. K. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq871 · Cited by 225 · see citing works
Molecular diversity of astrocytes with implications for neurological disorders
Bachoo, R. M., Kim, R. S., Ligon, K. L., Maher, E. A., Brennan, C. W., Billings, N., Chan, S., Li, C., Rowitch, D. H., Wong, W. H., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402140101 · Cited by 216 · see citing works
Quantifying and correcting for the winner's curse in genetic association studies
Xiao, R., & Boehnke, M. (2009) · Genetic Epidemiology · doi:10.1002/gepi.20398 · Cited by 192 · see citing works
Postmortem Studies in Schizophrenia
Powchik, P., Davidson, M., Haroutunian, V. H., Gabriel, S. M., Purohit, D. P., Perl, D. P., Harvey, P. D., & Davis, K. L. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033330 · Cited by 188 · see citing works
Self-citationMostafavi, S., Battle, A., Zhu, X., Potash, J. B., Weissman, M. M., Shi, J., Beckman, K., Haudenschild, C., McCormick, C., Mei, R., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.161 · Cited by 187 · see citing works
Purohit, D. P., Perl, D. P., Haroutunian, V., Powchik, P., Davidson, M., & Davis, K. L. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.3.205 · Cited by 185 · see citing works
Self-citationAdachi, N., Numakawa, T., Richards, M. C., Nakajima, S., & Kunugi, H. (2014) · World Journal of Biological Chemsitry · doi:10.4331/wjbc.v5.i4.409 · Cited by 168 · see citing works
CNVs in neuropsychiatric disorders
Kirov, G. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv253 · Cited by 159 · see citing works
Two gene co-expression modules differentiate psychotics and controls
Chen, C., Cheng, L., Grennan, K., Pibiri, F., Zhang, C., Badner, J. A., Members of the Bipolar Disorder Genome Study (BiGS) Consortium, Gershon, E. S., & Liu, C. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.146 · Cited by 157 · see citing works
Jaffe, A. E., Shin, J., Collado-Torres, L., Leek, J. T., Tao, R., Li, C., Gao, Y., Jia, Y., Maher, B. J., Hyde, T. M., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.3898 · Cited by 156 · see citing works
Ouchi, Y., Banno, Y., Shimizu, Y., Ando, S., Hasegawa, H., Adachi, K., & Iwamoto, T. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2700-12.2013 · Cited by 155 · see citing works
Immunoisolation of two synaptic vesicle pools from synaptosomes: a proteomics analysis
Morciano, M., Burré, J., Corvey, C., Karas, M., Zimmermann, H., & Volknandt, W. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03506.x · Cited by 153 · see citing works
Contactins: Emerging key roles in the development and function of the nervous system
Shimoda, Y., & Watanabe, K. (2009) · Cell Adhesion & Migration · doi:10.4161/cam.3.1.7764 · Cited by 149 · see citing works
de Jong, S., Boks, M. P., Fuller, T. F., Strengman, E., Janson, E., de Kovel, C. G. F., Ori, A. P. S., Vi, N., Mulder, F., Blom, J. D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039498 · Cited by 143 · see citing works
BIG-2 Mediates Olfactory Axon Convergence to Target Glomeruli
Kaneko-Goto, T., Yoshihara, S.-I., Miyazaki, H., & Yoshihara, Y. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.023 · Cited by 142 · see citing works
Lucas, F. A. S., Wang, G. T., Scheet, P. A., & Peng, B. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr667 · Cited by 140 · see citing works
Torkamani, A., Dean, B., Schork, N. J., & Thomas, E. A. (2010) · Genome Research · doi:10.1101/gr.101956.109 · Cited by 134 · see citing works
Luca, D., Ringquist, S., Klei, L., Lee, A. B., Gieger, C., Wichmann, H.-E., Schreiber, S., Krawczak, M., Lu, Y., Styche, A., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.11.003 · Cited by 128 · see citing works
Self-citationRichards, A. L., Jones, L., Moskvina, V, Kirov, G., Gejman, P. V., Levinson, D. F., Sanders, A. R., Molecular Genetics of Schizophrenia Collaboration (MGS), International Schizophrenia Consortium (ISC), Purcell, S., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.11 · Cited by 123 · see citing works
Self-citationDysregulation of miRNA-9 in a Subset of Schizophrenia Patient-Derived Neural Progenitor Cells
Topol, A., Zhu, S., Hartley, B. J., English, J., Hauberg, M. E., Tran, N., Rittenhouse, C. A., Simone, A., Ruderfer, D. M., Johnson, J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.090 · Cited by 122 · see citing works
Self-citationSakai, T., Oshima, A., Nozaki, Y., Ida, I., Haga, C., Akiyama, H., Nakazato, Y., & Mikuni, M. (2008) · Neuropathology · doi:10.1111/j.1440-1789.2007.00867.x · Cited by 118 · see citing works
Mudge, J., Miller, N., Khrebtukova, I., Lindquist, I. E., May, G. D., Huntley, J. J., Luo, S. J., Zhang, L., van Velkinburgh, J. C., Farmer, A. D., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003625 · Cited by 117 · see citing works
Mishra-Gorur, K., Çağlayan, A. O., Schaffer, A. E., Chabu, C. Y., Henegariu, O., Vonhoff, F., Akgumus, G. T., Nishimura, S., Han, W., Tu, S., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.12.014 · Cited by 114 · see citing works
Trynka, G., Westra, H.-J., Slowikowski, K., Hu, X., Xu, H., Stranger, B. E., Klein, R. J., Han, B., & Raychaudhuri, S. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.05.016 · Cited by 114 · see citing works
The organization of the transcriptional network in specific neuronal classes
Winden, K. D., Oldham, M. C., Mirnics, K., Ebert, P. J., Swan, C. H., Levitt, P., Rubenstein, J. L., Horvath, S., & Geschwind, D. H. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.46 · Cited by 112 · see citing works
Discovering genetic ancestry using spectral graph theory
Lee, A. B., Luca, D., Klei, L., Devlin, B., & Roeder, K. (2010) · Genetic Epidemiology · doi:10.1002/gepi.20434 · Cited by 108 · see citing works
Self-citationBorck, G., Hög, F., Dentici, M. L., Tan, P. L., Sowada, N., Medeira, A., Gueneau, L., Thiele, H., Kousi, M., Lepri, F. R., et al. (2015) · Genome Research · doi:10.1101/gr.176925.114 · Cited by 102 · see citing works
Self-citationWu, J. Q., Wang, X., Beveridge, N. J., Tooney, P. A., Scott, R. J., Carr, V. J., & Cairns, M. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036351 · Cited by 101 · see citing works
Topol, A., Zhu, S., Tran, N., Simone, A., Fang, G., & Brennand, K. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.12.028 · Cited by 98 · see citing works
Self-citationIkeda, M., Tomita, Y., Mouri, A., Koga, M., Okochi, T., Yoshimura, R., Yamanouchi, Y., Kinoshita, Y., Hashimoto, R., Williams, H. J., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.030 · Cited by 96 · see citing works
Fung, S. J., Fillman, S. G., Webster, M. J., & Weickert, C. S. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.02.021 · Cited by 93 · see citing works
A System-Level Transcriptomic Analysis of Schizophrenia Using Postmortem Brain Tissue Samples
Roussos, P., Katsel, P., Davis, K. L., Siever, L. J., & Haroutunian, V. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2012.704 · Cited by 92 · see citing works
Self-citationKimoto, S., Bazmi, H. H., & Lewis, D. A. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14010004 · Cited by 91 · see citing works
Self-citationThe DNA Methylome and Transcriptome of Different Brain Regions in Schizophrenia and Bipolar Disorder
Xiao, Y., Camarillo, C., Ping, Y., Arana, T. B., Zhao, H., Thompson, P. M., Xu, C., Su, B., Fan, H., Ordoñez, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095875 · Cited by 90 · see citing works
Transcriptome profiling of human hippocampus dentate gyrus granule cells in mental illness
Kohen, R., Dobra, A., Tracy, J. H., & Haugen, E. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.9 · Cited by 87 · see citing works
Conserved Higher-Order Chromatin Regulates NMDA Receptor Gene Expression and Cognition
Bharadwaj, R., Peter, C. J., Jiang, Y., Roussos, P., Vogel-Ciernia, A., Shen, E. Y., Mitchell, A. C., Mao, W., Whittle, C., Dincer, A., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.10.032 · Cited by 84 · see citing works
Self-citationA meta-analysis of gene expression quantitative trait loci in brain
Kim, Y., Xia, K., Tao, R., Giusti-Rodriguez, P., Vladimirov, V, van den Oord, E., & Sullivan, P. F. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.96 · Cited by 73 · see citing works
Self-citationCarvalho, C. M. B., Vasanth, S., Shinawi, M. S., Russell, C., Ramocki, M. B., Brown, C., Graakjær, J., Skytte, A., Vianna‐Morgante, A. M., Krepischi, A. C. V., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.10.006 · Cited by 73 · see citing works
Self-citationAnalyzing Schizophrenia by DNA Microarrays
Horváth, S., Janka, Z., & Mirnics, K. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.07.017 · Cited by 64 · see citing works
Neurokinin3 receptor as a target to predict and improve learning and memory in the aged organism
Silva, M. A. D. S., Lenz, B., Rotter, A., Biermann, T., Peters, O., Ramı́rez, A., Jessen, F., Maier, W., Hüll, M., Schröder, J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306884110 · Cited by 63 · see citing works
Feng, H., Zhang, X., & Zhang, C. (2015) · Nature Communications · doi:10.1038/ncomms8816 · Cited by 61 · see citing works
Mistry, M., Gillis, J., & Pavlidis, P. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-105 · Cited by 59 · see citing works
A Guide to Generating and Using hiPSC Derived NPCs for the Study of Neurological Diseases
Topol, A., Tran, N. N., & Brennand, K. J. (2015) · Journal of Visualized Experiments · doi:10.3791/52495 · Cited by 58 · see citing works
Self-citationLee, I. S., Carvalho, C. M. B., Douvaras, P., Ho, S., Hartley, B. J., Zuccherato, L. W., Ladran, I., Siegel, A. J., McCarthy, S., Malhotra, D., et al. (2015) · Schizophrenia · doi:10.1038/npjschz.2015.19 · Cited by 58 · see citing works
Self-citationChronic treatment with aripiprazole induces differential gene expression in the rat frontal cortex
Cheng, M.-C., Liao, D., Hsiung, C. A., et al. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008048 · Cited by 55 · see citing works
Huang, K.-C., Yang, K.-C., Lin, H., Tsao, T. T.-H., & Lee, S. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-s9-s6 · Cited by 51 · see citing works
Chen, Y., Zhang, J., & Deng, M. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23455 · Cited by 48 · see citing works
Orsetti, M., Brisco, F. D., Rinaldi, M., Dallorto, D., & Ghi, P. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32832ee573 · Cited by 43 · see citing works
Rizig, M., McQuillin, A., Ng, A., Robinson, M., Harrison, A., Zvelebil, M., Hunt, S., & Gurling, H. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112450780 · Cited by 39 · see citing works
Yuan, Q., Yang, F., Xiao, Y., Tan, S., Husain, N., Ren, M., Hu, Z.-H., Martinowich, K., Ng, J. S., Kim, P., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.08.019 · Cited by 38 · see citing works
Guzman, R. E., Alekov, A. K., Filippov, M., Hegermann, J., & Fahlke, C. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00143 · Cited by 38 · see citing works
Fatemi, S. H., Folsom, T. D., Reutiman, T. J., Novak, J., & Engel, R. H. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.11.013 · Cited by 30 · see citing works
An Information-Theoretic Machine Learning Approach to Expression QTL Analysis
Huang, T., & Cai, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067899 · Cited by 29 · see citing works
Kondo, M., Tajinda, K., Colantuoni, C., Hiyama, H., Seshadri, S., Huang, B., Pou, S., Furukori, K., Hookway, C., Jaaro-Peled, H., et al. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.19 · Cited by 27 · see citing works
Santoro, M. L., Ota, V., Stilhano, R. S., Silva, P. N., Santos, C. M., Diana, M. C., Gadelha, A., Bressan, R. A., Melaragno, M. I., Han, S. W., et al. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.05.015 · Cited by 25 · see citing works
Introduction to Sequencing the Brain Transcriptome
Hitzemann, R., Darakjian, P., Walter, N., Dan Iancu, O., Searles, R., & McWeeney, S. (2014) · International Review of Neurobiology · doi:10.1016/b978-0-12-801105-8.00001-1 · Cited by 20 · see citing works
Proteome effects of antipsychotic drugs: Learning from preclinical models
Carboni, L., & Domenici, E. (2016) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201500087 · Cited by 16 · see citing works
Self-citationA new role for microRNA-9 in human neural progenitor cells
Delaloy, C., & Gao, F. (2010) · Cell Cycle · doi:10.4161/cc.9.15.12699 · Cited by 13 · see citing works
Dawson, L. A., & Porter, R. A. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.122 · Cited by 11 · see citing works
Schizophrenia Genetics: Building the Foundations of the Future
Tansey, K. E., Owen, M. J., & O’Donovan, M. C. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu162 · Cited by 9 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
eQTLGen, Wray, N. R., 23andMe, the Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, Ripke, S., Mattheisen, M., Trzaskowski, M., Byrne, E. M., Abdellaoui, A., Adams, M. J., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0090-3 · Cited by 3,005 · see citing works
Self-citationJansen, I. E., Savage, J. E., Watanabe, K., Bryois, J., Williams, D. M., Steinberg, S., Sealock, J., Karlsson, I. K., Hägg, S., Athanasiu, L., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0311-9 · Cited by 2,277 · see citing works
Self-citationGERAD1 Consortium, Pardiñas, A. F., CRESTAR Consortium, Holmans, P., Pocklington, A. J., Escott-Price, V., Ripke, S., Carrera, N., Legge, S. E., Bishop, S., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0059-2 · Cited by 1,552 · see citing works
Self-citationTranscriptome-scale spatial gene expression in the human dorsolateral prefrontal cortex
Maynard, K. R., Collado-Torres, L., Weber, L. M., Uytingco, C., Barry, B. K., Williams, S. R., Catallini, J. L., Tran, M. N., Besich, Z., Tippani, M., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00787-0 · Cited by 1,222 · see citing works
Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder
Gandal, M. J., Zhang, P., Hadjimichael, E., Walker, R. L., Chen, C., Liu, S., Won, H., van Bakel, H., Varghese, M., Wang, Y., et al. (2018) · Science · doi:10.1126/science.aat8127 · Cited by 1,247 · see citing works
Self-citationIntegrative omics for health and disease
Karczewski, K. J., & Snyder, M. P. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2018.4 · Cited by 1,158 · see citing works
Wightman, D. P., Jansen, I. E., Savage, J. E., Shadrin, A. A., Bahrami, S., Holland, D., Rongve, A., Børte, S., Winsvold, B. S., Drange, O. K., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00921-z · Cited by 1,011 · see citing works
Comprehensive functional genomic resource and integrative model for the human brain
Wang, D., Liu, S., Warrell, J., Won, H., Shi, X., Navarro, F. C. P., Clarke, D., Gu, M., Emani, P., Yang, Y. T., et al. (2018) · Science · doi:10.1126/science.aat8464 · Cited by 965 · see citing works
Self-citationInitiative, A. N. G., Watson, H. J., Eating Disorders Working Group of the Psychiatric Genomics Consortium, Yilmaz, Z., Thornton, L. M., Hübel, C., Coleman, J. R. I., Gaspar, H. A., Bryois, J., Hinney, A., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0439-2 · Cited by 1,109 · see citing works
Self-citationShared molecular neuropathology across major psychiatric disorders parallels polygenic overlap
Gandal, M. J., Haney, J. R., Parikshak, N. N., Leppa, V., Ramaswami, G., Hartl, C., Schork, A. J., Appadurai, V., Buil, A., Werge, T. M., et al. (2018) · Science · doi:10.1126/science.aad6469 · Cited by 1,095 · see citing works
Self-citationThe genetic architecture of the human cerebral cortex
Grasby, K. L., Jahanshad, N., Painter, J. N., Colodro-Conde, L., Bralten, J., Hibar, D. P., Lind, P. A., Pizzagalli, F., Ching, C. R. K., McMahon, M. A. B., et al. (2020) · Science · doi:10.1126/science.aay6690 · Cited by 876 · see citing works
Self-citationIntegrative analysis of omics summary data reveals putative mechanisms underlying complex traits
Wu, Y., Zeng, J., Zhang, F., Zhu, Z., Qi, T., Zheng, Z., Lloyd-Jones, L. R., Marioni, R. E., Martin, N. G., Montgomery, G. W., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03371-0 · Cited by 685 · see citing works
Genetic identification of brain cell types underlying schizophrenia
Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, Skene, N. G., Bryois, J., Bakken, T. E., Breen, G., Crowley, J. J., Gaspar, H. A., Giusti-Rodriguez, P., Hodge, R. D., Miller, J. A., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0129-5 · Cited by 651 · see citing works
Self-citationChromosome conformation elucidates regulatory relationships in developing human brain
Won, H., de la Torre-Ubieta, L., Stein, J. L., Parikshak, N. N., Huang, J., Opland, C. K., Gandal, M. J., Sutton, G. J., Hormozdiari, F., Lu, D., et al. (2016) · Nature · doi:10.1038/nature19847 · Cited by 584 · see citing works
Gusev, A., Mancuso, N., Won, H., Kousi, M., Finucane, H. K., Reshef, Y., Song, L., Safi, A., Schizophrenia Working Group of the Psychiatric Genomics Consortium, McCarroll, S., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0092-1 · Cited by 491 · see citing works
Self-citationThe International League Against Epilepsy Consortium on Complex Epilepsies, Abou-Khalil, B., Auce, P., Avbersek, A., Bahlo, M., Balding, D. J., Bast, T., Baum, L., Becker, A. J., Becker, F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07524-z · Cited by 482 · see citing works
Defining the genetic, genomic, cellular, and diagnostic architectures of psychiatric disorders
Sullivan, P. F., & Geschwind, D. H. (2019) · Cell · doi:10.1016/j.cell.2019.01.015 · Cited by 452 · see citing works
“Similar network analysis based on gene co-expression identifies transcriptional networks dysregulated in SCZ, including co-expressed neuronal genes enriched for both common and rare SCZ-associated variants (Fromer et al., 2016).”
BackgroundSelf-citationQi, T., Wu, Y., Zeng, J., Zhang, F., Xue, A., Jiang, L., Zhu, Z., Kemper, K., Yengo, L., Zheng, Z., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04558-1 · Cited by 427 · see citing works
Self-citationThe BrainSeq Consortium, Jaffe, A. E., Straub, R. E., Shin, J. H., Tao, R., Gao, Y., Collado-Torres, L., Kam-Thong, T., Xi, H. S., Quan, J., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0197-y · Cited by 364 · see citing works
Ratnapriya, R., Sosina, O. A., Starostik, M. R., Kwicklis, M., Kapphahn, R. J., Fritsche, L. G., Walton, A., Arvanitis, M., Gieser, L., Pietraszkiewicz, A., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0351-9 · Cited by 312 · see citing works
Zhao, B., Luo, T., Li, T., Li, Y., Zhang, J., Shan, Y., Wang, X., Yang, L., Zhou, F., Zhu, Z., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0516-6 · Cited by 295 · see citing works
Dream: powerful differential expression analysis for repeated measures designs
Hoffman, G. E., & Roussos, P. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btaa687 · Cited by 319 · see citing works
Self-citationLopes, K. D. P., Snijders, G. J. L., Humphrey, J., Allan, A., Sneeboer, M. A. M., Navarro, E., Schilder, B. M., Vialle, R. A., Parks, M., Missall, R., et al. (2022) · Nature Genetics · doi:10.1038/s41588-021-00976-y · Cited by 273 · see citing works
Self-citationde Klein, N., Tsai, E. A., Vochteloo, M., Baird, D., Huang, Y., Chen, C.-Y., van Dam, S., Oelen, R., Deelen, P., Bakker, O. B., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01300-6 · Cited by 272 · see citing works
The road to precision psychiatry: translating genetics into disease mechanisms
Gandal, M. J., Leppa, V., Won, H., Parikshak, N. N., & Geschwind, D. H. (2016) · Nature Neuroscience · doi:10.1038/nn.4409 · Cited by 223 · see citing works
Untangling Genetic Risk for Alzheimer’s Disease
Pimenova, A. A., Raj, T., & Goate, A. M. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.05.014 · Cited by 223 · see citing works
Self-citationPost-mortem molecular profiling of three psychiatric disorders
Ramaker, R. C., Bowling, K. M., Lasseigne, B. N., Hagenauer, M. H., Hardigan, A. A., Davis, N. S., Gertz, J., Cartagena, P. M., Walsh, D. M., Vawter, M. P., et al. (2017) · Genome Medicine · doi:10.1186/s13073-017-0458-5 · Cited by 219 · see citing works
Neuron-specific signatures in the chromosomal connectome associated with schizophrenia risk
Rajarajan, P., Borrman, T., Liao, W., Schrode, N., Flaherty, E., Casiño, C., Powell, S., Yashaswini, C., LaMarca, E. A., Kassim, B., et al. (2018) · Science · doi:10.1126/science.aat4311 · Cited by 219 · see citing works
Self-citationEvaluation of chromatin accessibility in prefrontal cortex of individuals with schizophrenia
Bryois, J., Garrett, M. E., Song, L., Safi, A., Giusti-Rodriguez, P., Johnson, G. D., Shieh, A. W., Buil, A., Fullard, J. F., Roussos, P., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05379-y · Cited by 167 · see citing works
Self-citationNeuronal defects in a human cellular model of 22q11.2 deletion syndrome
Khan, T. A., Revah, O., Gordon, A., Yoon, S.-J., Krawisz, A. K., Goold, C., Sun, Y., Kim, C. H., Tian, Y., Li, M.-Y., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1043-9 · Cited by 186 · see citing works
Girdhar, K., Hoffman, G. E., Jiang, Y., Brown, L., Kundakovic, M., Hauberg, M. E., Francoeur, N. J., Wang, Y.-C., Shah, H., Kavanagh, D. H., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0187-0 · Cited by 139 · see citing works
Self-citationIdentification of evolutionarily conserved gene networks mediating neurodegenerative dementia
Swarup, V., Hinz, F. I., Rexach, J. E., Noguchi, K.-I., Toyoshiba, H., Oda, A., Hirai, K., Sarkar, A., Seyfried, N. T., Cheng, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0223-3 · Cited by 136 · see citing works
Self-citationWalker, K. A., Chen, J., Shi, L., Yang, Y., Fornage, M., Zhou, L., Schlosser, P., Surapaneni, A., Grams, M. E., Duggan, M. R., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adf5681 · Cited by 148 · see citing works
Sestan, N., & State, M. W. (2018) · Neuron · doi:10.1016/j.neuron.2018.10.015 · Cited by 127 · see citing works
qSVA framework for RNA quality correction in differential expression analysis
Jaffe, A. E., Tao, R., Norris, A. L., Kealhofer, M., Nellore, A., Shin, J. H., Kim, D., Jia, Y., Hyde, T. M., Kleinman, J. E., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617384114 · Cited by 114 · see citing works
Allele-specific open chromatin in human iPSC neurons elucidates functional disease variants
Zhang, S., Zhang, H., Zhou, Y., Qiao, M., Zhao, S., Kozlova, A., Shi, J., Sanders, A. R., Wang, G., Luo, K., et al. (2020) · Science · doi:10.1126/science.aay3983 · Cited by 127 · see citing works
Diurnal rhythms in gene expression in the prefrontal cortex in schizophrenia
Seney, M. L., Cahill, K., Enwright, J. F., Logan, R. W., Huo, Z., Zong, W., Tseng, G., & McClung, C. A. (2019) · Nature Communications · doi:10.1038/s41467-019-11335-1 · Cited by 108 · see citing works
Li, Z., Farias, F. H. G., Dube, U., Del-Aguila, J. L., Mihindukulasuriya, K. A., Fernandez, M. V., Ibanez, L., Budde, J. P., Wang, F., Lake, A. M., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-019-02066-0 · Cited by 85 · see citing works
Genetic control of the human brain proteome
Robins, C., Wingo, A. P., Fan, W., Duong, D. M., Meigs, J., Gerasimov, E. S., Dammer, E. B., Cutler, D. J., Jager, P. L. D., Bennett, D. A., et al. (2019) · doi:10.1101/816652 · Cited by 104 · see citing works
Self-citationKapoor, M., Wang, J.-C., Farris, S. P., Liu, Y., McClintick, J., Gupta, I., Meyers, J. L., Bertelsen, S., Chao, M., Nurnberger, J., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0384-y · Cited by 92 · see citing works
Self-citationThe endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease
Bandres‐Ciga, S., Saez‐Atienzar, S., Bonet‐Ponce, L., Billingsley, K., Vitale, D., Blauwendraat, C., Gibbs, J. R., Pihlstrøm, L., Gan‐Or, Z., The International Parkinson's Disease Genomics Consortium (IPDGC), et al. (2019) · Movement Disorders · doi:10.1002/mds.27614 · Cited by 90 · see citing works
Genomics implicates adaptive and innate immunity in Alzheimer’s and Parkinson’s diseases
Gagliano, S. A., Pouget, J. G., Hardy, J., Knight, J., Barnes, M. R., Ryten, M., & Weale, M. E. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.369 · Cited by 85 · see citing works
Mentis, A.-F. A., Lee, D., & Roussos, P. (2024) · Molecular Psychiatry · doi:10.1038/s41380-023-02047-6 · Cited by 75 · see citing works
Self-citationMah, W., & Won, H. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2019.03.007 · Cited by 38 · see citing works
Breen, M. S., Wingo, A. P., Koen, N., Donald, K. A., Nicol, M., Zar, H. J., Ressler, K. J., Buxbaum, J. D., & Stein, D. J. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.05.016 · Cited by 35 · see citing works
Self-citationSingleBrain: A Meta-Analysis of Single-Nucleus eQTLs Linking Genetic Risk to Brain Disorders
Jang, B., Kailash, B., Tokolyi, A., Cuddleston, W. H., Ravi, A., Jung, S.-H., Naito, T., Kim, B., Kim, M. S., Cho, M., et al. (2025) · doi:10.1101/2025.03.06.25323424 · Cited by 11 · see citing works
Self-citationEvaluation of chromatin accessibility in prefrontal cortex of schizophrenia cases and controls
Bryois, J., Garrett, M. E., Song, L., Safi, A., Giusti-Rodriguez, P., Johnson, G. D., Demur, A. B., Fullard, J. F., Roussos, P., Sklar, P., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/141986 · Cited by 7 · see citing works
Self-citation
- Authors
- Fromer, M., Roussos, P., Sieberts, S. K., Johnson, J. S., Kavanagh, D. H., Perumal, T. M., Ruderfer, D. M., Oh, E. C., Topol, A., Shah, H. R., Klei, L. L., Kramer, R., Pinto, D., Gümüş, Z. H., Cicek, A. E., Dang, K. K., Browne, A., Lu, C., Xie, L., Readhead, B., Stahl, E. A., Xiao, J., Parvizi, M., Hamamsy, T., Fullard, J. F., Wang, Y.-C., Mahajan, M. C., Derry, J. M. J., Dudley, J. T., Hemby, S. E., Logsdon, B. A., Talbot, K., Raj, T., Bennett, D. A., De Jager, P. L., Zhu, J., Zhang, B., Sullivan, P. F., Chess, A., Purcell, S. M., Shinobu, L. A., Mangravite, L. M., Toyoshiba, H., Gur, R. E., Hahn, C.-G., Lewis, D. A., Haroutunian, V., Peters, M. A., Lipska, B. K., Buxbaum, J. D., Schadt, E. E., Hirai, K., Roeder, K., Brennand, K. J., Katsanis, N., Domenici, E., Devlin, B., & Sklar, P.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Sage Bionetworks (US)
- Duke University (US)
- University of Pittsburgh (US)
- National Institutes of Health (US)
- Carnegie Mellon University (US)
- High Point University (US)
- Cedars-Sinai Medical Center (US)
- Broad Institute (US)
- Rush University Medical Center (US)
- University of North Carolina at Chapel Hill (US)
- Takeda (Japan) (JP)
- University of Pennsylvania (US)
- University of Trento (IT)
- Corresponding author
- Sklar, Pamela
- ORCID
- Fromer, Menachem
- Roussos, Panos
- Sieberts, Solveig K
- Johnson, Jessica S
- Perumal, Thanneer M
- Ruderfer, Douglas M
- Oh, Edwin C
- Topol, Aaron
- Shah, Hardik R
- Klei, Lambertus L
- Pinto, Dalila
- Dang, Kristen K
- Lu, Cong
- Xie, Lu
- Readhead, Ben
- Stahl, Eli A
- Xiao, Jianqiu
- Hamamsy, Tymor
- Fullard, John F
- Wang, Ying-Chih
- Derry, Jonathan M J
- Dudley, Joel T
- Hemby, Scott E
- Logsdon, Benjamin A
- Talbot, Konrad
- Raj, Towfique
- Bennett, David A
- Zhu, Jun
- Zhang, Bin
- Sullivan, Patrick F
- Chess, Andrew
- Purcell, Shaun M
- Shinobu, Leslie A
- Mangravite, Lara M
- Toyoshiba, Hiroyoshi
- Gur, Raquel E
- Lewis, David A
- Haroutunian, Vahram
- Peters, Mette A
- Buxbaum, Joseph D
- Schadt, Eric E
- Hirai, Keisuke
- Roeder, Kathryn
- Brennand, Kristen J
- Katsanis, Nicholas
- Domenici, Enrico
- Devlin, Bernie
- Sklar, Pamela
- Venue
- Nature Neuroscience
- Published
- 2016-09-26
- Volume
- 19
- Issue
- 11
- Pages
- 1442-1453
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- PMC
- PMC5083142
- OpenAlex
- W2526546796
- Semantic Scholar
- df26ac037f23bf86b0addf6308d26c68a87b0fb7
- Cited by
- 1,091
- References
- 155
- Citations by year
- 2026: 58 · 2025: 75 · 2024: 99 · 2023: 105 · 2022: 128 · 2021: 141 · 2020: 146 · 2019: 146 · 2018: 110 · 2017: 70 · 2016: 11
- FWCI
- 98.53
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- Locations
- Nature Neuroscience (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Iris (University of Trento) (submittedVersion, other-oa)
- Funders
- U.S. Department of Veterans Affairs (I01BX002395)
- National Institutes of Health (1s10od018522-01)
- National Institute on Aging (R01AG017917, R01AG036836, U01AG046152, R01AG015819, P30AG010161, RF1AG015819, R01AG050986)
- National Institute of Mental Health (P50MH084053, P50MH096891, HHSN271201300031C, U01MH096296, R01MH093725, P50MH066392, R01MH109706, R21MH105881, R01MH109677, R01MH075916, R01MH085542, R37MH057881, R01MH097276, R01MH101454, R01MH074313, R01MH095034, R01MH110555, P50MH094268, T32MH087004)
- National Human Genome Research Institute (U01HG008451)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- schizophrenia, polygenic risk, gene expression, dorsolateral prefrontal cortex, furin, CNTN4, CLCN3, brain development, zebrafish, gene co-expression network, genetic susceptibility
- MeSH terms
- Brain, Female, Gene Expression Regulation, Humans, Male, Risk, Schizophrenia, Genetic Predisposition to Disease, Multifactorial Inheritance, Polymorphism, Single Nucleotide, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review